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Abstract 
This thesis investigated three commonly used nutritional interventions that are often claimed to alter 
substrate metabolism and improve exercise performance: green tea extract (GTE), coffee and vitamin 
D.  
Prior studies have suggested that endurance exercise capacity may be improved when fat oxidation is 
increased through an intervention, thereby lowering the reliance on skeletal muscle glycogen. GTE 
and caffeine have both been hypothesized to increase fat oxidation at rest and during exercise, but the 
evidence to date remains equivocal. Using a metabolomics approach, we observed that 7 days GTE 
supplementation resulted in an increase in metabolites related to fat and energy metabolism at rest but 
not during moderate intensity exercise (56±4% VO2max). The metabolic effects of GTE were 
independent of changes in catecholamines, making it less likely that the often cited catechol-O-
methyltransferase (COMT) mechanism would be responsible for suggested increases in fat oxidation 
following GTE in vivo. The current thesis also found that endurance exercise performance can be 
improved to the same extent by either using coffee or caffeine (5 mg/kg body mass). However, these 
improvements in endurance exercise performance following coffee and caffeine were independent of 
changes to fat oxidation during exercise. Consequently, it seems unlikely that increasing fat oxidation 
with nutritional supports such as green tea and coffee can lead to improvements to endurance exercise 
performance.  
It may also be important to prevent the development of nutritional deficiencies which could have a 
negative impact on exercise performance. Recent evidence has shown that vitamin D deficiency is 
highly prevalent worldwide, which is known to have deleterious effects on skeletal muscle function (at 
least in elderly). Yet to date, little is known about the prevalence of vitamin D deficiency in athletes 
and the impact on exercise performance. Chapters 4 and 5 in this thesis demonstrate that athletes 
living in Birmingham, United Kingdom (52.4-52.5°N), display a high prevalence of vitamin D 
deficiency (25-hydroxyvitamin D < 50 nmol/L) during the winter. The poor vitamin D status observed 
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is likely explained by the high latitude and climate of the test site as well as the observed low dietary 
intake of vitamin D by the athletes. However, despite the high prevalence of vitamin D deficiency, 
there was no association between vitamin D status and skeletal muscle function or exercise 
performance (aerobic, anaerobic, strength). Short term (28 days) vitamin D supplementation 
(1500IU/d, 3000IU/d or 6000IU/d) at doses above the current recommended daily allowance (200IU) 
were highly effective in correcting vitamin D deficiency to vitamin D sufficiency (25-hydroxyvitamin 
D > 75 nmol/L). The current thesis also showed that no further improvement to vitamin D status was 
observed above 1500IU/d. This data suggests that doses above 1500IU/d do not provide any additional 
benefit to vitamin D status. The improvements in vitamin D status to sufficiency did not result in 
exercise performance (aerobic, anaerobic, strength) being improved following supplementation. Taken 
together vitamin D supplementation, at a dose of at least 1500IU/d, is warranted in athletes in the 
United Kingdom during the winter to avoid deficiency. However, to date the optimal concentration of 
vitamin D required to avoid the deleterious effects to skeletal muscle function remains to be a subject 
of debate. Consequently the impact vitamin D has on exercise performance in athletes remains 
unclear.  
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“That which does not destroy us makes us stronger” 
Friedrich Nietzsche 1844-1900 
 
 
 
 
“If you want to win something, run 100 metres. If you want to experience something, run a 
marathon”. 
Emil Zátope, Czech Republican Long Distance Runner 1922-2000. 
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1.1 Perspective and overview 
Today, there is a plethora of nutritional interventions which are often claimed to improve exercise 
performance or surrogate measures thereof [1]. Amongst these nutritional interventions there are a 
small number that are regularly talked about or used by athletes. This is perhaps because of the 
potential health benefits or ergogenic effects they offer. Alternatively, athletes may use nutritional 
interventions regardless of any scientific supporting evidence, but rather because they are „trending 
nutrition hot topics‟. Green tea, coffee and vitamin D are three such commonly used nutritional 
interventions, often cited in the literature and used by athletes to promote health and improve exercise 
performance. Further, green tea, coffee and vitamin D are readily available to athletes in whole foods 
and drinks, making them easily accessible. The health promoting effects of green tea have been 
associated with improvements in conditions including: diabetes, obesity, atherosclerosis and cancer 
[2]. However, caffeine found in green tea and coffee, is cited to induce negative health effects 
specifically relating to insulin resistance and hypertension [3]. In contrast the consumption of coffee 
has a number of health promoting effects similar to green tea [3]. Nonetheless, the metabolic and 
physiological similarities and differences between caffeine and coffee are yet to be determined, despite 
coffee being the predominant source of caffeine in an athlete‟s diet [4]. It has been proposed that green 
tea and caffeine augments fat metabolism [2, 5], which would be beneficial to health, and may also be 
important for athletic performance [6]. However, there is very little evidence to show that green tea 
increases fat oxidation, particularly during exercise. Further, while there is a great deal of evidence 
that explores the metabolic and ergogenic effects of caffeine, there is a paucity of evidence for the role 
of coffee improving athletic performance [5]. 
Vitamin D has been associated with benefits to mortality, diabetes, rheumatoid arthritis and other 
chronic diseases [7], in addition to its well known role in the maintenance of bone health throughout 
the life span [8]. Vitamin D has also been associated with improvements in skeletal muscle function, 
structure and composition [9] and could thus affect exercise performance [10]. However, evidence of 
the role of vitamin D in exercise performance is further exacerbated by the fact vitamin D deficiency 
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is high prevalent worldwide today [11]. The prevalence of vitamin D deficiency as well as the role of 
vitamin D on muscle function and exercise performance in athletes remains to be investigated.  
Gaining a better comprehensive understanding of the metabolic and physiological effects of green tea, 
coffee and vitamin D is important to decide whether or not these nutritional interventions are 
important for athletes to improve exercise performance.  Therefore, the studies in this thesis present 
data on the effects of green tea, coffee, and vitamin D in the context of endurance exercise.   
1.2 Substrate utilisation for endurance exercise performance 
Endurance exercise performance is partly determined by the supply and resynthesis of adenosine 
triphosphate (ATP) through aerobic and anaerobic metabolism. Fat and carbohydrate are the two 
major substrates that are responsible for the resynthesis of ATP during exercise [12]. This is 
particularly obvious when exercise duration increases beyond a couple of minutes [13].  
It has been known since the turn of the century that both carbohydrate and fat are fuels used in the 
skeletal muscle at varying contributions at rest and during exercise [12, 14]. This early work showed 
using the respiratory exchange ratio (RER) that at rest, fat was the predominant substrate, while during 
exercise there appeared to be an increased contribution of carbohydrate. The contribution of 
carbohydrate was increased at higher exercise intensities (>65% VO2 max), over shorter exercise 
durations and following a high carbohydrate diet [12, 14]. Under these conditions, there was a 
concomitant decrease in fat oxidation. Numerous other studies have also shown that the utilisation of 
fat and carbohydrate during exercise is also determined by dietary intake of macronutrients [15-18], 
gender [19], metabolic health [20] and training status [12, 21-25].  
More recently, the early work by Krogh and Lindhard [14] and Christensen and Hansen [12] has been 
confirmed by Romijn et al [26] and van Loon et al [27] using isotope tracer methodology. Both 
authors showed that carbohydrate oxidation increased as exercise intensity rose (25-85% VO2 max), 
while fat oxidation peaked at moderate exercise intensity (50-65% VO2 max) when compared to the 
lower and higher exercise intensities. Similarly, Achten et al [28] performed a well controlled study to 
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elucidate the exact intensity in which maximal fat oxidation rates occurred (FatMax). It was observed 
that during graded cycling exercise FatMax was at 64±4 % VO2 max in moderately trained men, with 
a steep reduction in fat oxidation and a large increase in carbohydrate oxidation as the exercise 
intensity increased. However, while carbohydrate oxidation is the predominant substrate during higher 
exercise intensity, it is important to highlight that the store of glycogen (skeletal muscle and liver) is 
small when compared to the stores of fat in the human body (1785-2000 kcal and 80,000-140,000 
kcal, respectively) [29]. As a result skeletal muscle glycogen depletion can occur when exercise is 
performed at higher exercise intensities (>70% VO2 max) [30, 31], which also coincides with the onset 
of fatigue [6, 32]. Interestingly, altering the provision of skeletal muscle glycogen has been shown to 
dictate fuel selection and consequently endurance exercise capacity. The seminal work by Bergstrom 
et al [32] illustrated that carbohydrate feeding was able to increase pre exercise muscle glycogen 
content which led to a delayed onset of fatigue. Furthermore, Coggan et al [31] showed that 
carbohydrate feeding during high intensity exercise (70% VO2 max) to fatigue, significantly increased 
carbohydrate oxidation, endurance exercise capacity as well as elevated skeletal muscle glycogen at 
the termination of exercise when compared to placebo. In addition, increasing the supply of fatty acids 
(FA) during exercise, through intra lipid-heparin infusions [33, 34] or more recently through the 
feeding of a high fat/low CHO diet [15-18], has been reported to increase fat oxidation and spare 
skeletal muscle glycogen during high intensity exercise (>70% VO2 max). Augmenting the availability 
of FA, while also reducing carbohydrate availability and oxidation, is a highly effective strategy to 
optimise fat oxidation during exercise. Therefore, identifying nutritional interventions that are capable 
of augmenting FA availability and oxidation would be of interest to athletes in the hope of improving 
endurance exercise performance.  
1.3 Regulatory factors of fat metabolism during endurance exercise  
Fat oxidation is predominantly dependent on the exercise intensity and duration which regulates the 
utilisation of multiple fat sources. The predominant store of fat is triacylglycerols (TG) found in 
subcutaneous and visceral adipose tissue, with smaller stores found within skeletal muscle fibres as 
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intramuscular triacylglycerol (IMTG) and in between muscle fibres (extramuscular TG) [29]. Through 
the process of lipolysis, FA can be released from TG which is transported in the blood bound to 
albumin or incorporated into lipoproteins (chylomicrons, very-low-density lipoproteins (VLDL), low-
density lipoproteins (LDL), intermediate-density lipoproteins (IDL) and high-density lipoproteins 
(HDL)). Romijn et al [26] revealed that by using stable isotope methodology ([6,6-
2
H2] glucose and 
[
2
H2] palmitate) FA rate of disappearance (Rd), which was assumed to equal oxidation, peaked at 65% 
VO2 max when compared to 25% and 85% VO2 max. Additionally, it was shown that fat oxidation 
was mainly driven by the oxidation of FA at low and moderate exercise intensities (25 and 44% VO2 
max, respectively) when compared to other fat sources including intramuscular plus lipoprotein 
derived TG (IMTG). These data were later confirmed by van Loon et al [27] who also implemented a 
stable isotope methodology ([6,6-
2
H2] glucose and [U-
13
C] palmitate) by accurately measuring FA 
oxidation from 
13
CO2 in expired air. Similarly, FA oxidation peaked at 57% VO2 max compared to 
44% and 72% VO2 max, but FA oxidation was significantly reduced at the highest exercise intensity 
when compared to the other intensities. Hence, the work by van Loon et al [27] and Romijn et al [26] 
clearly illustrate that sources of fat in the human body are highly regulated by the intensity of exercise. 
The availability of FA and their subsequent oxidation appears to be the predominant substrate used 
during exercise, especially at low to moderate exercise intensities. However, before FA can be 
oxidised in the mitochondria, they must first be released from the adipose tissue, be transported in the 
circulation to the skeletal muscle, be taken up and transported across the cytoplasm of the skeletal 
muscle, released from IMTG, before then being transported across the inner and outer mitochondrial 
membranes [35]. These steps may be regulatory components responsible for the limitations that are 
observed in fat oxidation during exercise at varying exercise intensity. Having a better understanding 
of the regulatory components of fat oxidation during exercise, as well as the specific mechanisms of 
each, may be advantageous when developing novel nutritional interventions that may be able to 
augment fat oxidation 
.  
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1.3.1 Fatty acid metabolism during exercise 
FA metabolism includes the release, transport in the circulation and uptake of FA from adipose tissue 
into the skeletal muscle. It is these regulatory components that may limit fat oxidation rates across 
varying exercise intensities, particularly when exercise is performed at high intensity (>70% VO2 
max) [26, 27]. 
1.3.1.1 Fatty acid release into the circulation during exercise  
Lipolysis is the process in which FA and glycerol are liberated from TG through lipase enzymes 
namely: hormone sensitive lipase (HSL), adipose triacylglycerol lipase (ATGL) and monoacylglycerol 
lipase (MGL) [36]. The activity of these lipase enzymes are controlled by the sympathetic nervous 
system (SNS), through the stimulatory action of catecholamines on β-adrenergic receptors [37]. 
Lipolysis is inhibited by insulin, via its prevention of the phosphorylation of HSL [38]. It has also 
been shown that lactate, formed as a consequence of increased rates of glycolysis, may also reduce FA 
release from the adipose tissue. Boyd et al [39] showed that whole body FA and glycerol release 
during low intensity exercise (40% VO2 max) was reduced when sodium lactate was infused in males. 
Additionally, FA release from perfused dog abdominal fat pads when exposed to high lactate 
concentrations were also shown to be reduced [40].  
These regulatory steps to lipolysis provide evidence for the greater Ra of FA from the rest to exercise 
transition, the continued increase in Ra during graded exercise [26, 27, 41] and the subsequent 
reduction in FA Ra, firstly at high exercise intensities due to higher glycolytic rate and secondly due to 
the rise in insulin with carbohydrate feeding [25, 42, 43]. Collectively this supports carbohydrate 
oxidation having a reciprocal regulation on fat oxidation during exercise. This is in contrast to the 
traditional glucose-FA cycle hypothesis proposed by Randle and Co-workers [44]. The subsequent 
reduction in FA release and oxidation at higher exercise intensities or following carbohydrate feeding 
has been shown to be somewhat diminished when FA concentrations have been restored through lipid-
heparin infusions. Romijn et al [33] showed that increasing the availability of FA during high intensity 
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exercise (85% VO2 max), to a similar concentration observed at moderate exercise intensities, partially 
increased fat oxidation by 27%. Horowitz et al [43] illustrated that carbohydrate feeding suppressed 
lipolysis and fat oxidation during exercise which was rescued by 30% when FA concentrations were 
increased using an intra-lipid heparin infusion. This evidence shows FA release and availability during 
exercise appear to be an important factor in maintaining fat oxidation. But other factors inherent in the 
skeletal muscle have also been identified as responsible for regulating FA oxidation, which will be 
discussed below.  
Increasing lipolysis through greater circulating catecholamine concentrations may be advantageous to 
increasing fat oxidation during exercise. In support, Mora-Rodriguez et al [45] reported that increasing 
the adrenaline concentrations during low intensity exercise (25% VO2 max) resulted in a progressive 
elevation in lipolysis, measured as glycerol Ra. However, adrenaline infusion at medium and high 
concentrations during low intensity exercise led to a significant reduction in FA oxidation when 
compared to a control trial. This firstly illustrates that catecholamine concentrations are highly 
controlled during exercise to ensure lipolysis matches FA oxidation and secondly supports the fact that 
catecholamines are also responsible for stimulating glycogenolysis and glycolysis during exercise 
[46]. Catecholamines only stimulate glycogenolysis under high exercise intensities when combined 
with an elevation in 5‟adenosione monophosphate activated protein kinase (AMPK) [47]. The rise in 
AMPK occurs when ATP utilisation increases or ATP synthesis reduces leading to an increase in 
AMP:ATP ratio. In vivo this change in energy status ratio occurs under higher exercise intensity and 
durations [48, 49]. Mora-Rodriguez et al [45] did however see a small significant increase in FA 
oxidation during the late stages of low intensity exercise when small increases in catecholamines were 
induced.  
Collectively this evidence suggests that identifying nutritional interventions that are capable of 
augmenting FA availability and inducing changes to the sympathetic nervous system may be effective 
in augmenting fat oxidation. 
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1.3.1.2 Fatty acid uptake into the skeletal muscle during exercise 
Before FA can enter the mitochondria for oxidation they first must pass through endothelium, 
interstitial space, plasma membrane, cytoplasm and mitochondrial membranes [50]. It was originally 
believed that FA could diffuse through membranes and there was a linear relationship between release, 
uptake and oxidation of FAs [51]. However, it was shown that the uptake of FA into the skeletal 
muscle at rest and during exercise can become saturated [52], and could potentially limit FA supply 
for oxidation. 
A number of transport proteins found in the plasma membrane of skeletal muscle are responsible for 
the uptake and transport of FA. However, the exact mechanisms that regulate the transport proteins, 
particularly at higher exercise intensities when FA oxidation is limited, remains to be elucidated. 
These transport proteins include: fatty acid binding protein found in the plasma membrane (FABPpm), 
fatty acid transport proteins (FATP1 and FATP4), fatty acid translocase (FAT/CD36) and fatty acid 
transport protein in the cytoplasm (FATPc) [50]. It is postulated that all of the transport proteins work 
in unison to facilitate the uptake of FA and collectively these transport proteins are critical in the 
uptake of FA. They therefore form an important regulatory component of fat oxidation.  
1.3.2 IMTG regulation during exercise 
The contribution of FA to fat oxidation intrinsically within the skeletal muscle is sourced from IMTG. 
This fat source within the skeletal muscle provides a readily available substrate for fat oxidation at rest 
and during exercise, particularly during low to moderate intensity exercise [26, 27]. Similar to adipose 
tissue, the rate of IMTG hydrolysis during exercise is principally controlled by the enzyme hormone 
sensitive lipase (HSL). Adipose tissue triglyceride lipase (ATGL) is also an important enzyme 
responsible for hydrolysis of triglycerides to diacylglycerides (DAG) in skeletal muscle [53]. Watt et 
al [54] has shown that HSL is highly active during exercise lasting 1-10 minutes, even as exercise 
intensity increases from 30-90% VO2 max. This suggests that IMTG may be an important substrate at 
the onset of exercise before plasma FA concentrations have begun to increase. During prolonged 
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moderate intensity exercise IMTG have also been shown to be important. van Loon et al [55] 
demonstrated a 60% reduction in IMTG in type I muscle fibres following cycling at 60% VO2 max for 
2 hours. Others have reported 50-70% IMTG depletion after 2-3 hours of moderate endurance exercise 
[56, 57]. Watt et al [57] observed a similar depletion of IMTG after 2 hours of cycling at 57% VO2 
max, but there were no further reductions in IMTG depletion after 4 hours of exercise. This attenuated 
depletion in the latter half of exercise may be driven by the inhibitory effect of FA-acyl CoA, as a 
result of the continued increase in adipose tissue lipolysis during exercise [26]. In support, Watt et al 
[58] reported that nicotinic acid, which is known to suppress plasma FA concentration, caused a 
significant increase in IMTG degradation during moderate intensity exercise (180 min 60% VO2 max) 
despite a significant reduction in total fat oxidation. This data firstly shows that IMTG are greatly 
utilised during moderate intensity exercise and contribute to fat oxidation. Secondly this highlights the 
high importance of plasma FA concentration, rather than IMTG hydrolysis alone, during moderate 
intensity exercise in order to achieve maximal fat oxidation. This further supports the aforementioned 
notion that nutritional interventions that are capable of increasing plasma FA concentrations may be 
advantageous to increasing fat oxidation during exercise, particularly at the onset of exercise. 
Currently there is no evidence to date that suggests that IMTG hydrolysis limits fat oxidation. Hence, 
integral components within the skeletal muscle, specifically within the mitochondria, may regulate fat 
oxidation during exercise.  
1.3.3 Fatty acid uptake into the mitochondria 
Once FA are made available in the cytoplasm they must pass through the outer and inner membranes 
of the mitochondria before being oxidised [59]. Long chain FAs are dependent on transporters through 
the mitochondrial membranes. In comparison short and medium chain FAs are able to diffuse freely 
into the mitochondria [60]. Long chain FAs are firstly activated by the addition of a coenzyme A 
(CoA) group to form long chain fatty acyl-CoA, catalysed by acyl CoA synthetase (ACS). Carnitine 
palymitoyl transporter I (CPTI) which is found on the outer membrane of the mitochondria, is then 
responsible for converting FA-acyl CoA to acyl-carnitine. The acyl-carnitine is then able to pass 
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through the inner membrane to mitochondrial matrix by free-carnitine via acylcarnitine translocase 
(ACT). Acyl-carnitine then undergoes transesterification back to FA-acyl CoA and free carnitine by 
carnitine palmitoyltransferase 2 (CPTII). FA-acyl CoA is then free to undergo β-oxidation in the 
mitochondria to form acetyl-CoA.  
1.3.3.1 Regulation of CPTI activity 
The activity of CPTI as well as the availability of free carnitine in the mitochondrial membranes 
together forms important regulatory components in the transport and oxidation of FA [59, 61]. This is 
supported by studies that have abolished the activity of CPTI during ex vivo muscle contractions, 
through the use of extomoxir, and observed severe reductions in FA oxidation [62]. Early in vitro 
evidence from rat skeletal muscle reported that at rest the activity of CPTI is allosterically inhibited by 
malonyl-CoA resulting in alterations to fat oxidation [63]. Malonyl-CoA is produced as a consequence 
of an accumulation of acetyl-CoA, from accelerated glycolytic flux, which stimulates the activity of 
acetyl-CoA carboxylase (ACC). Furthermore, a rise in AMPK in animal and humans, from both 
pharmaceutical activation [64] or alternatively through muscle contractions [65, 66], phosphorylates 
ACC (thus lowering the activity) and reduces the formation of malonyl-CoA. This gives rationale for 
the role of nutritional interventions that may be capable of altering energy status (ATP:ADP:AMP) or 
directly targeting ACC and malonyl-CoA activity.  
On the other hand, there is equivocal evidence in humans to support the role of malonyl-CoA in 
regulating fat oxidation either during moderate intensity exercise [67, 68] or in the recovery period 
after high intensity exercise [34]. Roepstorff et al [67] reported that malonyl-CoA concentrations 
decreased in skeletal muscle during prolonged moderate intensity exercise (60% VO2 max) which was 
paralleled by an increase in fat oxidation. However, the decrease of malonyl-CoA during exercise was 
not different between trials that elicited high and low fat oxidation rates.  Further, others have 
demonstrated that malonyl-CoA concentrations in human skeletal muscle did not change between 
varying exercise intensities [69, 70] or durations [71]. It must be noted, however, that in the studies to 
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date mixed muscle malonyl-CoA concentration was measured and it cannot be excluded that 
differences in local malonyl-CoA concentrations are important for the regulation of CPTI (i.e., 
Malonyl-CoA in and around mitochondria). Although the importance of localized malonyl-CoA 
concentrations cannot be dismissed, other mechanistic controls may be in place within the skeletal 
muscle to regulate fat oxidation, specifically CPTI, at rest and during exercise [34].  
CPTI may also be regulated by skeletal muscle pH [72, 73]. Bezaire et al [74] showed in isolated 
intermyofibrillar and subsarcolemmal mitochondria from human vastus lateralis muscles, that 
reducing the pH from 7.1 to 6.8 reduced CPTI activity by 34-40%. This is supportive of the increased 
acidic environment that may occur within the skeletal muscle as a consequence of elevated glycolysis 
and H
+ 
accumulation through an increase in exercise intensity [26, 27]. 
1.3.3.2 Regulatory role of carnitine in FA uptake in the mitochondria  
The role of carnitine within the skeletal muscle is vital in order for long chain FA to enter the 
mitochondria. Carnitine is considered as one of the most important regulators of fat oxidation at rest 
and during exercise. In support, carnitine deficiency within the skeletal muscle (lipid storage 
myopathy) has been reported to reduce long chain FA oxidation in vitro by 75% [75]. The importance 
of carnitine is further exacerbated by the role it plays in buffering excess acetyl-CoA, when glycolytic 
flux is in excess of TCA cycle incorporation. Consequently, carnitine accepts an acetyl group, 
catalysed by carnitine acetyl transferase (CAT), to produce acetyl-carnitine. The production of acetyl-
carnitine also maintains the mitochondrial co-enzyme A pool (CoASH) for continued glycolytic flux 
of pyruvate to acetyl-CoA [27, 57]. Stephens et al [59] showed that at lower exercise intensities (≤ 
40% VO2 max) free carnitine and acetyl-carnitine content does not change when compared to rest. The 
depletion of free carnitine at higher, but not at lower exercise intensities, is hypothesised to reduce the 
availability of carnitine for CPTI resulting in a decrease of fat oxidation [76]. This is not only 
supported by the reduced FA oxidation at higher exercise intensities [26, 27], but also the correlation 
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between the reductions in fat oxidation and the depletion of free carnitine during increasing exercise 
intensity [27].  
The importance of carnitine in regulating fat oxidation during exercise has meant it has gained a large 
amount of interest as a potential target for interventions that are able to manipulate its content.  
Through a series of experiments, Stephens et al [59] have successfully reported that carnitine content 
can be increased in the skeletal muscle through chronic daily L-carnitine supplementation, only when 
combined with carbohydrate feeding (80 g). More recently, Wall et al [77] increased carnitine content 
in the skeletal muscle by 21% by feeding L-carnitine (1.2 g) with carbohydrate polymer (80 g) twice 
per day for 24 weeks. The increase in carnitine content resulted in a 55% reduction in skeletal muscle 
glycogen use and a 31% reduction in pyruvate dehydrogenase complex (PDC) activity status during 
exercise at 50% VO2 max when compared to the control trial. This evidence suggests that fat oxidation 
is highly regulated during exercise, principally by carnitine availability within the skeletal muscle. In 
addition, it is clear that nutritional interventions, such as carnitine supplementation, may be capable of 
overcoming the regulatory components to fat oxidation. In turn this may increase fat oxidation, spare 
skeletal muscle glycogen and improve endurance exercise performance. However, to date, carnitine is 
one of the few nutritional interventions to receive extensive research to investigate the efficacy of 
increasing fat oxidation during exercise. Future research is therefore required to elucidate novel 
nutritional interventions that are 1) capable of targeting the regulatory components of fat oxidation, 2) 
significantly increase fat oxidation during exercise.  
1.4 Effects of endurance exercise training on fat metabolism 
One of the most effective and documented strategies for increasing the capacity to oxidise fat during 
exercise is adaptation to chronic endurance exercise training. Both longitudinal training studies [12, 
78-85] and cross sectional studies comparing trained and untrained individuals [21-25, 86] illustrate an 
improvement in fat oxidation at both the same relative and absolute pre-training exercise intensity. 
The observed increase in fat oxidation following training is explained by adaptations to the regulatory 
Chapter 1   General Introduction 
 
-13- 
 
components of fat metabolism, these include: a greater uptake of FA by a larger number of cytoplasm 
transport proteins, greater IMTG hydrolysis as well as an improved uptake of FA across the 
mitochondrial membrane. These adaptations to endurance training are a consequence of the 
accumulation of specific proteins, induced by an up regulation of gene expression (mRNA). Gene 
expression is induced by various molecular signals and pathways through physiological and metabolic 
perturbations from exercise. Recent evidence has accumulated to show that these molecular signals 
induced by exercise maybe altered by nutrient availability [87].  
Thus, the interaction between exercise and nutrition may be important in not only maximising fat 
oxidation but also optimising the adaptations to endurance training. In turn this may develop 
nutritional interventions, which when combined with regular endurance exercise, may augment the 
adaptations to fat metabolism. With this in mind, the following sections will provide a brief summary 
of the adaptations to fat metabolism following training and the molecular signals responsible for these 
adaptations.    
1.4.1 Fatty acid uptake following endurance training 
The increase in fat oxidation following endurance exercise training has been shown to be due to a 
greater FA uptake and oxidation [21, 23, 84, 88]. In a study conducted by Turcotte et al [21] a plateau 
in net FA uptake across the exercising leg during was observed in an untrained individual, however 
net FA uptake continued to increase in the trained individual after 2 hours of exercise. During whole 
body exercise, Phillips et al [79] observed that 31 days of cycling exercise training led to a reduced 
whole body and regional lipolysis. This suppressed lipolytic rate is a consequence of a paralleled 
suppression of catecholamine concentrations following endurance training at the same pre training 
absolute exercise intensity [79, 89].  
The greater oxidation of FA, despite a lower FA release, following training is explained by an 
improved uptake of FA into the skeletal muscle. In support, FA transport capacity across the plasma 
membrane and mitochondrial membranes has been well documented. Talanian et al [90] reported that 
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following 6 weeks of high intensity interval training, FAT/CD36 increased in both whole muscle and 
mitochondrial membranes. In addition, the authors also showed that FABPpm increased in the 
cytoplasm and at the mitochondrial membrane. At the same time, it has been shown that endurance 
training improves the FA transport capacity of mitochondrial membranes, namely CPTI [91]. Tunstall 
et al [91] showed that CPTI mRNA expression was increased following 9 days of endurance training. 
This was also accompanied with an elevated FAT/CD36 mRNA expression.   
1.4.2 IMTG hydrolysis following endurance training 
A number of studies to date have also shown that the contribution of IMTG to fat oxidation following 
endurance exercise training is increased. This is principally based on studies that have implemented  
stable isotope methodology before and after endurance training [79, 85, 92, 93] or have compared 
trained and untrained individuals [22, 24, 25]. In support, Wallis et al [94] reported that net glycerol 
release from the skeletal muscle increased following 9 weeks of endurance training when using both 
isotope tracers and arterial femoral difference techniques. Tarnopolsky et al  [93] demonstrated that 
following seven weeks of endurance training, IMTG content was increased due to a 42% increase in 
lipid droplets which were surrounded by a larger number of mitochondria. More recently, Shaw et al 
[82] showed that 6 months of endurance training caused a 2 fold increase in IMTG content in both 
type I and II fibres, which was paralleled with a 1.6 fold increase in mitochondrial content. These 
findings confirm that in addition to the adaptations to IMTG hydrolysis and contribution to fat 
oxidation, the endogenous store of fat within the skeletal muscle is increased.  
1.4.3 Mitochondrial enzyme and content following endurance training 
Endurance exercise training leads to an increase in the number of mitochondria within the skeletal 
muscle, otherwise known as mitochondrial biogenesis. In addition numerous adaptations to the 
intermediary metabolism within the matrix of the mitochondria also occur. This has been 
demonstrated by the improvement in TCA cycle flux following endurance training due to the greater 
expression and activity of the TCA enzymes: succinate dehydrogenase [95, 96] and citrate synthase 
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[93, 95, 97, 98]. This ensures a greater production of NADH and FADH2 for the electron transport 
chain (ETC) as part of oxidative phosphorylation. With the increase in TCAI following endurance 
training an improvement to VO2 max [95] and exercise performance [99] have also been reported 
suggesting that TCA cycle adaptations play a critical role in energy metabolism and performance for 
endurance trained individuals. In addition, Gollnick and Saltin [100] illustrated that the improved 
capacity to oxidise fat following endurance training was due to enhanced enzyme activity in β 
oxidation pathway. It has consistently been shown in humans that endurance training increases the 
content of 3-hydroxyacyl-CoA dehydrogenase (HAD) an important intermediary and rate limiting 
enzyme in β oxidation [93, 97, 98, 101]. Endurance training also increases the flux of electrons, from 
NADH and FADH2, through the electron transfer chain to resynthesise ATP through oxidative 
phosphorylation in the mitochondrial matrix. More specifically, a number of investigations have 
demonstrated that endurance training increases the transmembrane protein complex cytochrome C 
oxidase (COX IV) [102, 103].  
Consequently, endurance exercise training improves the capacity to oxidise fat by not only 
overcoming the regulatory components of fat metabolism, but also increasing the intrinsic machinery 
required to oxidise fat.   
1.4.4 The molecular response to endurance exercise training  
The adaptations to fat metabolism following endurance training are explained by alterations in gene 
transcription that lead to increased expression of specific proteins [104]. The adaptations to fat 
metabolism are controlled by a number of perturbations which include an increase in AMPK, the 
transient increase in calcium release from the sarcoplasmic reticulum (SR) as well as disturbances to 
mechanotransduction [104]. Through these primary messengers induced by exercise, a number of 
signalling cascades are induced which lead to the up regulation of transcription factors and 
transcription co-activators, which are responsible for the adaptations to endurance exercise as outlined 
above. These include: nuclear respiratory factor-1 and 2 (NRF 1/2) [105] and mitochondrial 
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transcription factor A (Tfam) [106], peroxisome proliferator activated receptor (PPAR) –γ coactivator 
(PGC1α) [107], and peroxisome proliferator activated receptor (PPAR) [108].  
The up regulation of transcription factors and transcription co-activators as a result of endurance 
exercise is well documented [106]. More recent evidence has suggested that nutrient availability may 
alter the contraction induced gene expression and molecular signalling [87]. AMPK is known to be a 
potent activator to numerous transcription factors [104] and has been shown to be critical in inducing 
the endurance training adaptations [109]. The rise in AMPK occurs with an increase in AMP:ATP 
ratio, which is achieved when manipulation to carbohydrate availability during training occurs. This is 
specifically through glycogen depleted exercise training [110] or high intensity exercise training [81], 
which has resulted in superior adaptations to fat metabolism (3-hydroacyl-CoA dehydrogenase (β-
HAD), FAT/CD36, IMTG hydrolysis and citrate synthase) when compared to traditional training. 
Similar findings have also been documented when endurance exercise training is completed under a 
low carbohydrate/high fat diet [15, 17, 111, 112]. Therefore, reducing the reliance on endogenous 
carbohydrate stores, while at the same time, increasing the availability and utilisation of fat at the 
skeletal muscle may be advantageous to the adaptations to fat metabolism following endurance 
training.  
Altering nutrient availability can also change hormone concentrations which may also have important 
roles in not only regulating substrate metabolism but also in training induced adaptations. An elevation 
in catecholamines, especially following high intensity exercise training [113], up regulates cAMP 
response element binding protein (CREB), which phosphorylates PGC1α [114]. In addition, in vitro 
studies have shown that FA are capable of binding to PPARs and increase the activity of the 
transcription factor [113]. As already discussed, catecholamines are responsible for increasing plasma 
FA concentrations during exercise. Therefore, increasing catecholamine concentrations and fat 
availability may also play a role in augmenting transcription factor activity during exercise.  
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The nutrient-exercise interactions that have been discussed above are powerful tools to potentially 
activate the molecular signalling for endurance training adaptations to fat metabolism. Performing 
exercise that acutely alters nutrient and hormonal concentrations may be of interest to endurance 
athletes. Hypothetically this may suggest that nutritional interventions that acutely 1) alter  energy 
status (ADP:AMP) of the skeletal muscle during exercise, 2) increase the availability of FA at rest and 
during exercise 3) up regulate catecholamines at rest and during exercise may optimise the training 
induced adaptations to fat metabolism [87, 115]. However, to date, very little evidence is available to 
identify nutritional interventions capable of inducing these metabolic perturbations, increasing the 
activity of transcription factors or inducing adaptations to fat metabolism with or without endurance 
exercise training. This demonstrates that future studies are required to elucidate this further.  
1.5 Nutritional interventions to augment fat oxidation and exercise performance 
A number of bioactive ingredients that originate from plants have become of interest for their potential 
in increasing fat oxidation [116] as well as interacting with the molecular signals that are responsible 
for the adaptations to endurance exercise training [87]. There are an abundance of bioactive 
ingredients that may offer nutritional interventions and support to endurance training on the sports 
nutrition market today [1, 116, 117]. However, the evidence to support the putative claims are mostly 
equivocal. In a recent review [116] a variety of bioactive ingredients that have been proposed to 
increase fat oxidation at rest and during exercise were critically discussed. Of the eight ingredients that 
were mentioned in the review, green tea was shown to be the most promising ingredient to increase fat 
oxidation at rest, while there was a paucity of evidence during exercise. Furthermore, caffeine which is 
found abundantly in coffee as well as in green tea, has been suggested to increase the capacity to 
oxidise fat during exercise since the first study on this topic by Costill et al in 1978 [118]. Early 
studies showed an improvement to endurance exercise capacity, which coincided with a sparing of 
skeletal muscle glycogen [118, 119]. However, to date the evidence that caffeine increases fat 
oxidation and spares skeletal muscle glycogen is equivocal, with numerous studies showing 
improvements to endurance exercise performance independent of changes to fat metabolism [5, 120, 
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121]. Surprisingly though, despite caffeine being a well documented nutritional intervention to 
improve endurance exercise performance, there is little supporting evidence for the use of coffee [122-
125].  
The importance of examining the role of green tea and caffeine, particularly when ingested as coffee, 
is that they are readily available nutritional interventions and supports which are frequently consumed 
by athletes today and are often cited as nutrition „trending nutrition hot topics‟. In support, tea and 
coffee are two of the most popular beverages consumed worldwide, with tea being the second most 
consumed beverage after water [126, 127]. The predominant source of caffeine in the human diet is 
sourced from coffee [128]. In athletes, similar trends have also been observed. Tunnicliffe et al [129] 
reported that 70% of Canadian athletes, from a variety of sports, used caffeine before or during 
training. The average daily intake was 59±6 mg/d, ranging from 0-895 mg/d with coffee being the 
primary source of caffeine intake by the athletes. Furthermore, Chester et al [130] reported that 97% of 
UK track athletes and cyclists were found to use caffeine prior to competition, with the major source 
of caffeine found to be from coffee. Chester et al [130], as well as others [131] have shown that 
caffeine intake appears to be higher, especially in coffee format, amongst endurance athletes, 
specifically triathlon, cycling and rowing. Less is known about the prevalence of use of green tea 
amongst athletes. However, it could be considered that due to the rise in commercial green tea 
beverages, in the form of ice teas and energy drinks [132], combined with the high accessibility of 
green tea supplements on the sports nutrition market, the use by athletes may be high.  
1.6 Caffeine as a nutritional intervention to augment fat metabolism and exercise performance 
1.6.1 Composition of caffeine and metabolism in humans 
Caffeine is a trimethylxanthine that is rapidly and completely absorbed through the gastrointestinal 
tract. It is metabolised in the liver by the cytochrome P450 enzyme, specifically through the 
isoenzyme CYP1A2 and other isoforms to form three primary dimethlxanthines, namely: 
paraxanthine, theobromine and theophylline [133]. It is understood that CYP1A2 activity can vary up 
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to 40-fold within and between individuals [134], altering the bioavailability, clearance and ultimately 
the physiological effects of plasma caffeine. Following intake, plasma caffeine can appear in the 
circulation within 15 minutes and result in a time to peak (Tmax) of ~1 h [135], with a half life of 5-30 
h [136]. A standard cup of coffee (250 mL) will consist of 60-85 mg caffeine, which will result in an 
average plasma caffeine concentration of ~7-10 µM [137].  
1.6.2 Performance effects of caffeine 
1.6.2.1 Time to exhaustion  
Caffeine has been recognised for some time to improve endurance exercise performance, with over 40 
years of supporting research [138-141]. The seminal work by Costill et al [118, 142] was the first to 
report the ergogenic effects of caffeine. On two occasions, nine cyclists completed a time to 
exhaustion (TTE) test (80% VO2 max) 60-min after consuming decaffeinated coffee (decaf) with 
added caffeine (330 mg) or decaf only [118]. Following ingestion of caffeine, performance was 
significantly improved by 15 min when compared to decaf. Costill et al [118] concluded that the 
improvements to endurance exercise capacity were a consequence of an increase in fat oxidation, 
which in turn would spare skeletal muscle glycogen. Since this early work, numerous studies have 
shown similar performance enhancing effects of caffeine using a TTE protocol, for both prolonged 
sub-maximal exercise (>90 min) and constant higher intensity exercise (20-60 min) (75-90 %VO2 
max) [118-120, 122, 143-150]. A recent meta-analysis, which included 40 double blind studies from a 
variety of exercise tests (endurance, graded and short), concluded that the overall improvement to 
exercise performance following caffeine intake was 12% when compared to placebo (95% CI 9.1-
15.4). Further, the improvement to performance was larger during endurance (TTE) exercise (20% 
improvement in performance) compared to graded or short term high intensity exercise tests (2% 
improvement in performance) [138].It should be noted that not all studies tested whether fat oxidation 
was augmented following caffeine intake. 
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1.6.2.2 Time trial performance 
The ergogenic effects of caffeine are well documented when using the time to exhaustion test as the 
predominant performance measure. However, assessing endurance capacity in this manner may lack 
sufficient ecological validity to translate results to real life endurance sporting events [151]. Taking 
this into consideration, more recent investigations have implemented the use of time trial (TT) 
protocols to assess endurance exercise performance [152-155] which has been shown to be a highly 
reliable [156]. A recent meta-analysis, only including studies that measured endurance exercise 
performance using a TT, showed that overall caffeine improved performance by 3.2 ± 4.3%, however 
this improvement was highly variable between studies (-0.3 to 17.3 %) [139]. The ergogenic effects of 
caffeine were mainly investigated in endurance athletes. More recent evidence has shown that caffeine 
(6 mg/kg body mass (BM)) is ergogenic in sedentary men when using a time trial protocol [157]. 
Interestingly, caffeine was predominantly delivered through fluid or capsules with no study using a 
coffee beverage, despite it being the predominant source of dietary caffeine [128-130, 158].  
1.6.3 Dose response and timing of caffeine intake 
The dose of caffeine required to improve performance is believed to be between 3-6 mg/kg BM, 
resulting in plasma caffeine concentrations 30-70 µM [5]. Graham et al [145] illustrated that 3 and 6 
mg/kg BM improved TTE (80% VO2 max) to a similar extent when compared to a water control. 
However, increasing the dose to 9 mg/kg BM did not result in a significant improvement in 
performance. Pasman et al [149] confirmed these findings by showing that 5, 9 and 13 mg/kg BM 
improved TTE (80% VO2 max) compared to placebo, however no differences were observed between 
the caffeine doses. These findings have also been confirmed using a TT protocol, whereby 3 and 6 
mg/kg BM both significantly improved performance, yet doubling the dose to 6 mg/kg BM did not 
offer any further benefits [153]. It also appears that using lower doses of caffeine (1-3 mg/kg BM) can 
be effective in improving endurance exercise performance when using a time trial protocol [152, 154, 
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159]. Interestingly, caffeine doses as low as 90 mg have been shown to improve time trial 
performance, resulting in low plasma caffeine concentrations (~8µM) [152]. 
The timing of caffeine ingestion may be important in observing the ergogenic effects. The majority of 
studies to date have provided caffeine 1 h prior to exercise to coincide with the Tmax of plasma 
caffeine [5]. In agreement, a recent study reported that time trial performance was only improved 
when exercise was performed 1 h after caffeine rather than after an individual‟s plasma caffeine Tmax 
(150-180 min), when compared to placebo [155]. In addition, it is evident that the Tmax differs 
between caffeine consumed as a capsule when compared to coffee consumed as a beverage [160]. 
Many athletes have been shown to consume caffeine during endurance exercise, particularly during 
prolonged events [158]. Cox et al [152] performed a well designed study in which cyclists performed a 
2 h cycling bout (70% VO2 max) having consumed either: caffeine 1 h prior to exercise (6 mg/kg 
BM), caffeine in small doses throughout exercise (6 x 1 mg/kg BM every 20 min), low caffeine in the 
form of a cola beverage (2 x 5 mL/kg (~13mg/100 mL) at 100 and 120 min) or placebo. Despite the 
difference in time of intake, TT performance was improved by ~3% across all interventions. 
Subsequently, Kovacs et al [159] showed that a variety of doses of caffeine (2.1, 3.2, 4.5 mg/kg BM) 
consumed in combination with carbohydrate (68.8 g/L) during exercise improved time trial 
performance when compared to placebo and carbohydrate only. Therefore, the timing and form of 
caffeine intake may determine the ergogenic effects. Studies show that caffeine intake prior to and 
during endurance exercise is an effective nutritional support to improve exercise performance, 
however studies investigating whether these effects are greater or less, when caffeine is taken in as 
coffee, are lacking. 
1.6.4 Performance effects of coffee  
The performance effects of coffee are less clear, despite coffee being frequently ingested by endurance 
athletes on a daily basis. Since the work of Costill et al [118, 142], very few studies have investigated 
the effects of coffee or decaf plus caffeine. Table 1.1 summarises the studies to date. Using a 
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comparable study design to Costill et al [118], Butts & Crowell et al [125] did not observe an 
improvement in time to exhaustion (75% VO2 max) following decaf plus caffeine (330 mg) compared 
to decaf only. Yet, Wiles et al [124] demonstrated that 1500-m simulated treadmill running time was 
significantly improved by 4.2 sec following coffee (~2.0-2.5 mg/kg BM) compared to decaf. In 
addition, the authors also showed that coffee significantly improved running speed in an „all out 
sprint‟ in the final minute of a subsequent 1500-m simulated treadmill run when compared to decaf. 
These results are difficult to interpret due to the different forms of coffee used (decaf plus caffeine, 
decaf only) with little comparison to regular coffee or caffeine only. In order to address this question, 
Graham et al [122] compared the effects of caffeine, regular coffee, decaf, decaf plus caffeine or a 
placebo, 1 h prior to completing a running TTE test (80% VO2 max). All caffeinated trials consisted of 
4.5 mg/kg BM. The authors observed a significant improvement in TTE with caffeine when compared 
to the other conditions. Surprisingly, regular coffee and decaf plus caffeine did not improve 
performance, despite having the same caffeine content. Based on this evidence, the authors concluded 
that coffee may be inferior to caffeine at improving endurance exercise performance. A difference in 
the bioavailability of caffeine or paraxanthines was not responsible for this diverse ergogenic effect 
[122]. It has been proposed that compounds in coffee may interfere with the physiological effects of 
caffeine. Coffee is composed of ~2% caffeine, with the remainder being made up of chlorogenic acids, 
ferulic acid, caffeic acid, nicotinic acid as well as other compounds with many currently unidentifiable 
[136]. However, it has been observed that regular coffee containing caffeine (1.1mg/kg BM) 
consumed prior to the ingestion of different doses of caffeine (3-7mg/kg BM) does not impair the 
improvements to exercise performance induced by caffeine [123] . Herein, chapter 3 of this thesis 
describes a study that aimed to explore the performance effects of coffee compared to caffeine using a 
time trial protocol. 
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Table 1.1 Overview of the available literature investigating the effect of coffee on exercise performance 
 
Reference Performance  
protocol 
Participants Beverages Time 
before 
exercise 
Caffeine  
dose 
Performance  
outcome 
 
Coffee 
ergogenic 
+ / ↔ 
Costill et al [118] 80% VO2 max TTE 7 M 2 F 
 
D+C v D 1 h 300mg (4.4 M, 5.8 F)# D+C 90.2*; D 75.5 (min) + 
 
Butts & Crowell [125] 75% VO2 max TTE 
 
13 M 15 F D+C v D 1h 300mg (4.0 M, 5.1 F)# D+C 68.5; D 63.8 (min) ↔ 
Wiles et al [124] Treadmill 1500 m run 
 
18 M Cof v D 1h 3g Cof ~200 mg (2.0-2.5)# C 286*; D 290 (sec) + 
 
Wiles et al [124] Treadmill 1500 m run + 1 
min sprint 
 
10 M Cof v D 1h 3g Cof ~200 mg (2.0-2.5)# 1 min sprint Cof 23.5*; D 
22.9 (km/h)* 
+ 
 
Trice & Haymes [161] ~90% VO2 max 
intermittent sprints  
 
8 M D+C v D 1h 5 mg/kg BM D+C 77.5; D 61.3 (min) ↔ 
Graham et al [122] 85% VO2 max TTE 
 
9 M C v Cof v D+C v D v 
Pla  
 
1h 4.45 mg/kg BM C 41* Cof 32 D+C 32 D 32 
Pla 31 (min) 
↔ 
McLellan et al [123] 80% VO2 max TTE 
 
9 M 4 M Cof-C$, Pla-Caf, D-Pla, 
D-C 
 
1.5h 
 
Cof 1.1 mg/kg BM,  
$C 3,5,7mg/kg BM 
Cof-C (3) 25.1*; Cof-C (5) 
27.8* ; Cof-C (7) 26.4*; 
Pla-Caf (5) 26.8*, D-Pla 
21.7, D-C (5) 29.0* (min) 
 
+ 
 
Lamina et al [162]  20 m shuttle run  12 M Cof v Pla 1 h 5, 10, 15 mg/kg BM  No ergogenic effect of any 
dose. Data not reported.  
↔ 
        
Abbreviations:  TTE Time to Exhaustion, M Males, F Female, D+C Decaffeinated coffee + Caffeine, C Caffeine, D Decaffeinated coffee, Cof Coffee - includes 
instant and filter varieties,  Pla Placebo, BM Bodyweight, (x) Caffeine dose provided in McLellan et al study.  
 
# Absolute doses provided relative to body weight for M and F. $ Three different Caf doses consumed after Cof  *Significantly different to control 
(PLA or Decaf). + Improved performance, ↔ No change in performance. 
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1.6.5 Mechanisms to describe the ergogenic effects of caffeine 
Traditionally it was believed that caffeine is capable of augmenting fat oxidation during exercise, 
which in turn would spare skeletal muscle glycogen [118, 142]. However, due to caffeine‟s ability to 
cross numerous biological membranes in the human body [141], caffeine may not just alter substrate 
metabolism, but also have direct effects on the brain and the skeletal muscle which may delay the 
onset of central and peripheral fatigue during exercise. These mechanisms of action of caffeine that 
may explain the ergogenic effects are discussed below.  
1.6.5.1 Alterations to fat metabolism following caffeine intake 
Costill and colleagues [142, 163], were the first to propose that the mechanism of action of caffeine 
was due to a sparing of muscle glycogen, as a result of an increase in fat oxidation. A small number of 
investigations have since also supported this hypothesis [119, 164, 165]. Spriet et al [119] reported 
that consuming 9 mg/kg BM caffeine significantly improved endurance exercise capacity (80% VO2 
max) which was also accompanied by a 55% reduction in glycogenolysis during the initial 15 minutes 
of exercise when compared to a placebo. The authors also observed that at rest, but not during 
exercise, skeletal muscle citrate and acetyl CoA/CoA-SH ratio were increased. The authors concluded 
this was a consequence of the elevated FA and glycerol concentration. Furthermore, the elevated 
lipolytic rate may have been induced by the significant increase in adrenaline at rest and throughout 
exercise due to caffeine ingestion. Essig et al [164] also observed a 42% reduction in glycogen 
utilisation during 30 minutes of cycling exercise (70% VO2 max) following the ingestion of coffee 
compared to decaffeinated coffee. This was also accompanied with a modest rise in plasma FA and 
glycerol and a 1.5 fold greater IMTG utilisation. However, this only resulted in a 50% increase in fat 
oxidation during exercise. The finding that caffeine elevates plasma FA is fairly consistent through 
studies undertaken at rest and during exercise [118-121, 142, 146, 148, 166, 167]. This is both due to 
the caffeine induced rise in adrenaline stimulating lipolysis [168] and also via caffeine directly 
antagonizing adenosine receptors A1 at adipocytes to also increase lipolysis [120, 121]. Despite the 
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greater availability of FA for oxidation during exercise, very few studies have shown an improvement 
in fat oxidation or a change in RER following caffeine intake [121, 147, 148, 150, 168, 169].  To gain 
a better insight into the metabolic perturbations that may be occurring following caffeine intake a 
number of studies employed stable isotope methodology and arterio-venous balance methods. Studies 
by both Raguso et al [169] and Graham et al [168] showed that caffeine increased arterial lactate and 
glucose concentrations during exercise, possibly due to a reduced uptake by the skeletal muscle. Both 
studies observed increases in adrenaline following caffeine ingestion and suggest that caffeine is able 
to augment the SNS, which consequently may increase lipolysis from adipose tissue whilst also 
stimulating glycolysis. Alternatively, glucose and lactate may be increased due to caffeine inhibiting 
the uptake and clearance of glucose and lactate. In both studies, these metabolic perturbations did not 
result in changes to fat oxidation. A number of other studies have also not shown the glycogen sparing 
effect following caffeine intake [145-148, 168] with others showing a paradoxical increase in 
glycogen utilisation [169, 170]. In a more recent review paper, Graham et al [171] combined data from 
a number of studies that had investigated the effect caffeine intake had on skeletal muscle metabolic 
changes including glycogen, citrate, acetyl-CoA, glucose-6-phosphate and cAMP. The combined data 
sets clearly indicated that, despite an increase in SNS activity, caffeine did not alter fat oxidation or 
inhibit carbohydrate oxidation during exercise.  
Thus, these studies are unable to explain the ergogenic effects of caffeine.  The studies introduced here 
have all used anhydrous caffeine rather than coffee. The ergogenic effects of coffee are largely 
unclear, however as coffee is heavily habitually consumed, it may be interesting to examine whether 
coffee induces similar metabolic effects when compared to caffeine. With this in mind, in Chapter 3 of 
this thesis the metabolic effects of caffeine and coffee was be investigated alongside the performance 
effects of both of these nutritional interventions.   
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1.6.5.2 Effects of caffeine on central and peripheral factors 
One popular hypothesis is that caffeine induces its ergogenic effects through its ability to act as an 
adenosine antagonist, blocking the interaction of adenosine to adenosine receptors (A1 and A2A) which 
are found ubiquitously in the human body [172]. Accordingly, caffeine has the potential to alter both 
central and peripheral components of fatigue. Adenosine is considered a “fine-tuning modulator” of 
neuronal activity which can inhibit the release of excitatory neurotransmitters in the brain [173]. 
Secondary to the antagonism of adenosine receptors caffeine has been associated with inducing a 
dopaminergic response [172]. Dopamine D2 receptors are found alongside adenosine receptors (A2A) 
located predominantly on dopaminergic neurons [172]. These neurons influence motor control and 
behavioural processes, such as mood and motivation. Caffeine increases antagonism of both adenosine 
and dopamine receptors, thus, has the potential to alter feelings of pain, pleasure/displeasure as well as 
modifying motor control [174]. Chronic intake of caffeine has been shown in vitro to modify the 
antagonism of caffeine on adenosine receptors, specifically through A1 receptor blocking [175] and 
thus reducing the physiological effects of caffeine. However, while this has been shown in vitro, in 
most studies the ergogenic effects of caffeine are similar in users and non users, with or without with 
drawl from caffeine [166, 176]. Consequently caffeine is believed to affect both the central (CNS) and 
peripheral nervous system (PNS), through adenosine receptor antagonism, which in turn improves the 
ability and potential for the skeletal muscle to contract [174].  
Caffeine has been shown to alter the CNS which may induce reductions to the central fatigue 
hypothesis (serotonin induced) and central pain during exercise [174]. Studies both agree [177] and 
disagree [178], with this hypothesis. These differences may be explained by the intensity of exercise, 
where it is believed that caffeine offers little benefit during high intensity exercise [178], perhaps due 
to caffeine‟s preferential effect in type I rather than type II muscle fibres as discussed below [179]. 
Moreover, caffeine may also increase the CNS excitability which would increase motor unit 
recruitment, subsequently improving force during a muscle contraction and power output [174]. Yet, 
while this paradigm seems logical, particularly based on the central effects of caffeine outlined above, 
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there is very little supporting evidence to show that caffeine improves motor unit recruitment during 
maximal voluntary contraction [174].  
Concomitantly, caffeine may have effects on the PNS, specifically through direct effects on the 
skeletal muscle [120, 121, 174]. Tarnopolsky et al [180] showed that in vivo electrical stimulation of 
the peroneal nerve (evoke contraction of dorsiflexors of lower limb) at 20 Hz (similar to endurance 
exercise muscle contraction), but not 40 Hz, following caffeine intake (6 mg/kg BM) improved force 
output of the dorsiflexor muscles during a tetanic contraction. The resistance to peripheral fatigue with 
caffeine has been attributed to caffeine‟s ability to interfere with excitation-contraction coupling, 
primarily via an improved release of Ca
2+
 from the SR [181], which may become limited during 
prolonged moderate- or high intensity exercise [182]. A lack of effect observed at high frequency 
stimulations (40 Hz as observed above) is believed to cause fatigue proximal to excitation-contraction 
coupling and may involve K
+ 
accumulation. In support, caffeine ingestion (6 mg/kg BM) in humans 
enhanced fatigue resistance during intermittent high intensity exercise through a decrease in potassium 
(K
+
) accumulation in muscle interstitial space [183]. These findings  are in line with the consistent 
improvement to endurance based exercise performance and inconsistent improvement to maximal 
intensity exercise performance [184]. This is further postulated by recent data by Tallis et al [179] who 
used the work loop technique on isolated mouse muscles, showed that caffeine (50-140 µM) caused a 
significant increase in power output at maximal and sub maximal electrically stimulated slow (soleus) 
and fast twitch (extensor digitorum longus) muscle fibres. But the improvements in power output were 
greater in the slow twitch fibres when it was sub maximally stimulated. This recent data clearly shows 
that ergogenic effects of caffeine may be explained by its direct effect on skeletal muscle‟s ability to 
contract, independent of changes to substrate oxidation.  
1.7 Green tea as a nutritional intervention to augment fat metabolism  
Green tea, produced from the plant Camellia sinensis L. Species of the Theaceae family, contains 
naturally occurring flavonoids and caffeine. The compounds found in green tea have shown promise 
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as an anti-obesity nutritional intervention [185]. A recent meta-analysis has demonstrated that long 
term intake (3-23 wks) of green tea extract (GTE) (with and without caffeine) reduced body weight in 
obese and overweight individuals [186]. It is thought that the anti-obesity effects of GTE intake may 
be attributed to elevated fat oxidation and total energy expenditure [187]. A limited number of studies 
have investigated the effect of short term and long term GTE supplementation on substrate metabolism 
and energy expenditure both at rest and during exercise [187-189]. But while GTE has shown promise 
as a nutritional intervention to augment fat oxidation in some studies, the evidence remains equivocal.  
Green tea preserves a high quantity of catechin polyphenol concentration (a sub group of flavonoids) 
due to the way in which it is manufactured [190]. The four main types of catechins are: (-)-
Epigallocatechin-3-gallate (EGCG), (-)-epicatechin-3-gallate (ECG), (-)-epigallocatechin (EGC) and (-
)-epicatechin (EC). EGCG is the most abundant and thought to be the most pharmalogically active 
catechin [191], with the catechins peaking in the plasma ~ 2 h after ingestion, with a half life of ~ 8 h. 
The type of tea, origin of the leaves, brewing technique and the source of green tea can all influence 
the catechin content [190]. A standard cup of green tea (250 mL) contains between 100-300 mg of 
total catechins and 50-90 mg of caffeine [192]. The different amounts of catechins and caffeine in 
different varieties of tea are shown in Table 1.2.  
Table 1.2: Catechin and Caffeine content in a variety of tea products, data taken from [190, 192]  
Beverage Serving size / brewing 
technique 
Total Catechins  
mg /serving 
Caffeine  
mg /serving 
 
Green Tea leaves 
 
1 g tea leaves / 100 mL of hot 
water  
 
 
42-201 
 
25-43 
Lipton Green Tea 
 
Teabag / 100 mL of hot water  
 
 
195-205 32-33 
Decaf Green Tea 
 
Teabag / 100 mL of hot water  
 
 
72-73 <1 
Green Tea extract (GTE) 
supplement 
Per capsule 200-210 5-6 
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In humans, the bioavailability of GTE following ingestion determines the bioactivity [193]. While the 
bioavailability of catechins is fairly well understood, the bioactivity of each of the catechins in vivo 
remains to be elucidated. Consequently, the action of each catechin, and interaction with caffeine in 
order to affect fat oxidation, are unclear. The majority (98%) of ingested GTE undergo extensive 
conjugation in the liver and gut microbiota and appear transiently (60-120 min after ingestion) in the 
plasma [194]. Conjugated catechins are chemically different to the free catechins (found within GTE 
beverages) [194]. Therefore, the free and conjugated catechins are likely to have different 
physiological and biological effects in the human body [195]. Little is known about the bioavailability 
of the free catechins, that are found at low concentrations in plasma following GTE intake (<2%) 
[194]. Catechins are also able to pass into the colon where they are catabolised to ring fission products 
and phenolics acids [196] known as valerolactones. These catabolites of GTE are known to take longer 
to peak in the plasma (8-15 hours) and their biological effects in vivo are unknown [196].  
In order to take into account all of the evidence to date that has investigated the effect of GTE on fat 
oxidation, the following sections have been divided into the effects observed at rest and those 
observed during exercise. Additionally, due to differences in study designs, particularly the 
supplementation duration, the following sections will be broken down into shorter and longer term 
supplementation. These supplementation durations have been defined in Table 1.3.  
Table 1.3. Definition of GTE supplement durations for discussion in the sections below.  
Shorter term  
 
Acute 
 
 
Within 24 hours 
Short term 1-7 days 
 
Longer term 
 
Medium term 
 
1-4 weeks 
 
Long term >4 weeks 
 
Chronic >10 weeks 
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1.7.1 Shorter term green tea intake and its effects on resting fat metabolism. 
Dulloo et al [187] were the first to investigate whether GTE could increase fat oxidation at rest. In this 
double blind cross-over study, 3 doses of encapsulated GTE (270 mg/d EGCG + 150 mg/d caffeine), 
caffeine (150 mg/d) and placebo (cellulose) were taken over a 24 h period in a respiratory chamber. 
The authors observed that compared with placebo and caffeine, consumption of GTE significantly 
increased 24 h fat oxidation (76.2 ± 10.6 g/24hr, 81.9 ± 8.7 g/24hr and 103 ± 13 g/24 h respectively). 
Interestingly, fat oxidation rates were 20% higher following GTE when compared to caffeine. Thus, 
the authors concluded that the increase in fat oxidation, following GTE intake, was independent of its 
caffeine content per se. Using a comparable study design, Rumpler et al [197] showed that a catechin 
rich oolong tea taken over a 24 h period, (662 mg/d catechins, 270 mg/d caffeine) caused a 12% 
increase in 24 h fat oxidation rates compared to water. However, the authors showed no difference for 
a lower dose (331 mg/d catechins, 135 mg/d caffeine) suggesting that a higher catechin dose is 
required to stimulate fat oxidation.  
Berube-Parent et al [198] investigated the dose response relationship of GTE on 24 h fat oxidation. On 
4 separate occasions, subjects ingested caffeine rich (600 mg/d) GTE capsules differing in doses of 
EGCG (270, 600, 900, 1200 mg/d EGCG). All GTE doses significantly increased 24 h energy 
expenditure (EE) by 8% (750 kJ), compared to placebo. However, there were no significant 
differences between the treatment groups. However, GTE did not increase fat oxidation in any of the 
GTE groups compared with placebo. Similar results have also been shown following 3 days of GTE 
(540 mg/d) and caffeine (300 mg/d) compared to placebo [199]. However, Berube-Parent et al [198] 
speculated that due to the lack of dose response a ceiling effect at 270 mg/d EGCG may be apparent. 
In addition, the authors also speculated that the relatively high caffeine content (600 mg/d) could mask 
the effects of GTE on fat oxidation. A dose dependant response of GTE has been found in animals, 
when caffeine was absent [200]. Based on these animal data, caffeine may only work synergistically 
with catechins to augment fat oxidation in small doses (<600 mg/d). In support of this notion, 
Thielecke et al [201] showed an increase in fat oxidation at rest, in the postprandial and fasted state, 
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when EGCG (300 mg/d) and a small dose of caffeine (200 mg/d) was consumed for 3 days. For this 
reason, the exact composition of catechins and caffeine may be integral to altering fat oxidation in 
humans.  
To date, the exact composition of GTE catechins required to stimulate fat oxidation is unknown. In 
order to elucidate this in vivo, a recent study [202] compared the effects of combined (~500 mg/13 h 
total catechins) and individual (EGCG and EGC ~600 mg/ 13 h) catechins + caffeine (150 mg/13 h) 
on resting metabolism over a 13 h. Subjects received GTE in small and frequent doses (82-214 mg) 
throughout this period. The authors found no increase in fat oxidation with any of the treatments 
compared with placebo. As GTE catechins are poorly absorbed [194], ingesting small amounts, in 
bolus throughout the day, may result in low plasma catechin concentrations which may explain why 
the authors [202] did not observe a change in fat oxidation. Yet, 2 days of moderate intake of EGCG 
only in some (300mg/d) [203] but not all cases (405mg/d) [204] has been shown to increase fat 
metabolism at rest, as estimated from a measured reduction in the RER. Therefore, it currently remains 
unclear which catechin or catechins is/are required to elicit changes in fat oxidation at rest.  
Recently, a meta-analysis was published to address whether acute intake of GTE (with and without 
caffeine) or caffeine-only has the potential to increase fat oxidation at rest [189]. In total six articles 
were used following strict controls. It was found that GTE treatment groups yielded significantly 
greater mean fat oxidation rates (16% higher) compared to placebo. This effect was not seen in 
caffeine-only studies (P = 0.11) supporting the assumption that the effects of GTE are independent of 
the caffeine content per se. In addition, a dose dependant response was observed with a 0.02 g/24 h 
increase in fat oxidation for each 1 mg increase of ingested catechins. However, due to the limited 
number of studies and the large variation in dose, the authors were unable to give a lower and upper 
dose to elicit maximal changes to fat oxidation.  
On balance, research has supported an increase in fat oxidation at rest, in response to shorter term 
GTE intake. However, not all studies showed increases in fat metabolism (or energy expenditure). The 
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effects of GTE on fat oxidation at rest may be small which are only apparent when tested in larger 
sample sizes as demonstrated from the conclusive evidence in the meta-analysis. Therefore, the 
inconsistencies in the studies reported could be related to the small sample sizes implemented, the 
exact catechin composition and the amount of caffeine present in the GTE. Therefore, further research 
is required to elucidate the most effective supplementation protocol to enhance fat oxidation during 
resting conditions. 
1.7.2 Longer term green tea intake and its effect on resting fat metabolism 
Auvichayapat et al [205], gave GTE (750 mg/d catechins + 87 mg/d caffeine) or placebo for 12 weeks 
to obese Thai men and women. Resting EE and substrate oxidation were measured at baseline, week 4, 
8, and 12. Compared to baseline, longer term GTE intake significantly lowered fasting RQ at week 8 
and elevated EE at week 8 and 12. Harada et al [206] administered either a high catechin (593 mg/d 
catechin + 22 mg/d caffeine) or a low catechin drink (78 mg/d catechin + 81 mg/d caffeine) to 12 
Asian males, over a 12 week period. Using a stable isotope method, (
13
C labelled triglycerides meal), 
13
CO2 excretion was significantly higher in the high catechin group compared to the low catechin 
group at week 12 compared to baseline. This is indicative of increased dietary fat oxidation. In 
addition diet induced thermogenesis (DIT), in the 8 h post meal, increased from baseline to week 12 
(51.4 kcal and 90.3 kcal respectively) in the high catechin group only.  These studies suggest that 
longer term GTE has the potential to increase fat oxidation and alter energy metabolism. 
Long periods of dietary restriction are associated with a suppression of resting EE [207].  Thus, long 
term GTE intake may prevent this [208]. Diepvens et al [208] investigated the effect of GTE intake 
(1125 mg/d catechins + 225 mg/d caffeine) for 83 d during dietary restriction versus a placebo in 
overweight Caucasian women. Resting EE and RQ were measured at day 4 and 32. Compared to 
placebo, there was no significant difference in fasting EE, DIT or RQ in the GTE group. However, 
participants used in this study were moderate habitual caffeine consumers (300 mg/day) which may 
have affected the results as suggested by a recent study by Westerterp-Plantenga et al [209]. The 
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authors showed that intake of encapsulated GTE (270 mg/day EGCG + 150 mg/day caffeine) or 
placebo for 12 weeks, following a 4 week low energy diet, only caused a significantly lower fasting 
RQ for those who had a low habitual caffeine intake (<300 mg/day) compared to a high habitual 
intake (<300 mg/d). This was also true for reductions in body weight and body fat.  
To date there are only a small number of studies that have investigated the effect of longer term GTE 
ingestion on fat oxidation. Taken together these studies suggest that longer term intake of GTE may 
potentially augment fat metabolism but only if habitual caffeine intake is low, potentially by 
overcoming some of the regulatory components of fat oxidation. 
1.7.3 Shorter term green tea intake and its effects on fat metabolism during exercise. 
During exercise, fat oxidation rates are up to 10-fold higher than at rest, due to the energy demand of 
the working muscles [210]. But as previously discussed in this chapter, there are numerous regulatory 
components for the capacity to oxidise fat during exercise. From the limited number of studies to date 
GTE may be a nutritional intervention that may target some of these regulatory components during 
exercise. The evidence to support this is outlined below.    
In 2008, Venables et al [188] were the first to study the effects of acute (24 h) GTE intake on fat 
oxidation rates during exercise. In this cross over double blind study, subjects consumed GTE (890 ± 
13 mg/day catechins containing 366 ± 5 mg/day EGCG) or placebo before completing a bout of 
moderate intensity cycling (30 minutes at 50% Wmax). Average fat oxidation rates during exercise were 
17% higher in the GTE condition compared to placebo (0.41 ± 0.03 g/min and 0.35 ± 0.03 g/min, 
respectively).  More recently, during 60 minute cycle at 60% VO2max, fat oxidation did not increase 
following 6 days of EGCG (270 mg/day) when compared to caffeine and [211]. Interestingly, more fat 
was oxidised following caffeine and placebo trials compared to EGCG (0.13 ± 0.05 g/min, 0.16 ± 0.06 
g/min, 0.16 ± 0.05 g/min respectively). However, at such low fat oxidation rates it makes it difficult to 
detect differences because of the variation of the measurement. This is discussed in more detail in the 
following section.  
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In conclusion there are only a limited number of studies that have investigated the effect of shorter 
term GTE intake on fat metabolism during exercise. The results to date remain equivocal. Thus, more 
research is needed before more firm conclusions can be drawn. In addition, understanding the 
metabolic differences or similarities of GTE at rest and during exercise would be of great importance. 
Herein, in order to gain new and comprehensive insights in the metabolic effects of GTE at rest but 
also during exercise, Chapter 2 of this thesis examines the metabolic response to 7 days of GTE at rest 
and during moderate intensity exercise using a metabolomics approach.  
1.7.4 Longer term green tea intake and its effects on fat metabolism during exercise. 
GTE intake, over a more prolonged duration, may result in further increases in fat oxidation rates 
during exercise. A recent study conducted a 2 hour cycling exercise test (50% Wmax) following 3 
weeks of GTE (159 mg/day catechins) and placebo ingestion, in a randomised cross over study design. 
Despite longer-term GTE intake, the authors did not observe a difference in average RER during the 
first or second hour of exercise between the groups (1 h: 0.95 ± 0.01 and 0.96 ± 0.01, 2 h: 0.91 ± 0.01 
and 0.91 ± 0.01 for placebo and GTE respectively) [212]. However, subjects only ingested a total of 
159 mg/day catechins of which 68 mg was EGCG. This is a much lower dose than that administered in 
other studies [188]. 
More promising results have been found when GTE has been ingested chronically (≥ 12 weeks) 
alongside an exercise training program. Maki et al [213] reported that overweight adults had a greater 
loss in total and subcutaneous abdominal fat area following a 12 week training program (180 
min/week) plus daily consumption of a GTE (625 mg/day catechins, 39 mg/day caffeine) compared to 
a control beverage (39 mg/day caffeine). Unfortunately fat oxidation was not measured in the study. In 
animal studies, fat oxidation has been measured following longer term GTE intake in combination 
with exercise training. Shimotoyodome et al [214] found that mice, after completing 15 weeks of 
regular exercise in combination with GTE ingestion, had significantly lower RER and increased fat 
utilisation during exercise, than the exercise only group. Furthermore, a 30% increase in running time 
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has also been found in mice fed a 0.5% GTE diet in conjunction with exercise training [215]. This 
increase in endurance capacity was accompanied with increased β oxidation rates and a lower RER, 
compared with the mice that only exercised. Similarly, more recent evidence has demonstrated that the 
age related decline in endurance capacity in senescence-accelerated prone mice was prevented when 
fed a 0.35% GTE diet combined with exercise training. These adaptations to endurance capacity were 
also paralleled with greater skeletal muscle β oxidation rates following GTE and exercise training 
[216].  
In humans, Ota et al [217] supplemented 14 healthy male subjects with a placebo or GTE beverage 
rich in catechins (570 mg/day catechins of which 218 mg was EGCG) for 2 months, during which they 
took part in regular treadmill exercise (5 km/h for 30 min 3 times a week) . It was found that subjects 
consuming the GTE test beverage had 24% higher fat oxidation rates during exercise than the placebo 
group. A similar effect was found when the supplementation and exercise training period was 
extended to 10 weeks [218]. In this study, daily consumption of a test beverage containing 573 mg of 
GTE catechins plus regular exercise (60 min cycle at 60% VO2 max 3 times a week) significantly 
lowered RER compared to placebo. These studies provide an early insight into the possibility that 
longer term GTE intake in combination with exercise training may be efficacious in elevating fat 
oxidation.  
It appears that in a small number of studies, both shorter and longer term GTE intake has the potential 
to increase fat oxidation. But this has not been consistently shown. However, no study has directly 
compared shorter and longer term GTE intake on fat oxidation during exercise. For these reasons, the 
practical relevance and use of GTE remains ambiguous. The exact mechanisms may differ dependent 
on the duration of intake.  
1.7.5 The mechanisms behind the potential effects of Green tea on substrate utilisation 
Several mechanisms have been proposed by which GTE could influence substrate utilisation. The 
majority of evidence originates from in vitro studies, which may have limited application in vivo. Such 
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studies do not consider the bioavailability of catechins in humans, reflected in the dose and form of 
catechins used in vitro. The mechanisms that explain the potential shorter term and longer term effects 
of GTE ingestion may be distinctly different. Thus, both will be discussed in the following section.  
1.7.5.1 Mechanisms behind the shorter-term effects of green tea intake on fat metabolism  
For some time now it has been proposed that shorter term intake of GTE, more specifically EGCG as 
well as caffeine, may target the sympathetic nervous system (~1-2 hours after ingestion).  
1.7.5.1.1 GTE and Catechol-O-methyltransferase inhibition  
Catechol-O- methyltransferase (COMT) is known as an intracellular enzyme and is ubiquitous 
throughout all mammalian tissues including skeletal muscle and adipose tissue [219]. COMT is a 
constitutively active enzyme which degrades catechol compounds, such as many of the 
neurotransmitters, by transferring a methyl group [219]. EGCG has been reported to directly inhibit 
catechol-O- methyltransferase (COMT) [220]. Herein, it is believed that circulatory catecholamine 
concentrations will be greater, in turn increasing the sympathetic nervous system (SNS) [221] thus 
stimulating lipolysis via adrenergic receptors and potentially increasing fat oxidation [210]. As a result 
the COMT mechanism has been extensively referenced in the literature, despite a lack of evidence in 
humans. 
The most cited study to support EGCG inhibitory effects of COMT are reported in an early in vitro 
study by Borchardt [220]. Based on this early work others [222] have reported that COMT is inhibited 
directly by certain catechins. Interestingly, no specific tea catechin was identified by Borchardt [220]. 
Therefore, it is difficult to conclude, based on this study alone, whether GTE catechins are capable of 
inhibiting COMT. More recently it has been suggested that specific tea catechins are substrates and 
inhibitors of the O-methylation of COMT in human, mice and rat liver [223-226]. It has been shown 
that those catechins that possess a galloyl-type D ring (EGCG and ECG) are 100-1000 more potent at 
inhibiting COMT in vitro [223]. Furthermore, it seems that COMT activity is highly variable within a 
population which may explain the large individual responses to GTE. This may also explain the 
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aforementioned ethnic differences in the response to GTE [186], as a higher expression and activity of 
COMT is apparent in Asian populations [227, 228]. What is currently unclear is the specific site of 
inhibition or where the accumulation of catecholamines may occur in vivo.  
To date, there is only one study to show an increase in 24 hour noradrenaline (NA) urinary excretion 
following shorter term GTE intake at rest in humans [187] with other studies showing no effect [198, 
199, 202]. Yet, it would appear that in vivo the low circulatory concentrations of catechins are unlikely 
to inhibit COMT, especially in the conjugated form. In support, the potency of catechins ability to 
inhibit COMT is lost once they are glucoronidated [223]. Therefore, the inhibitory effects of catechins 
in vivo may be lost once conjugated: methylated, glucuronidated, and sulphated which limits the 
application of the COMT mechanism in vivo. At present even if the COMT enzyme was important in 
the degradation of catecholamines the link to increasing fat oxidation is an assumption that is often 
made.  
1.7.5.1.2 Synergistic effects of GTE and Caffeine 
The metabolic effects of GTE may also be driven by the presence of caffeine in many of the studies to 
date. As previously discussed in this chapter, caffeine in vitro has been shown to affect tissues 
ubiquitously by indirectly controlling levels of intracellular cyclic adenosine monophosphate (cAMP), 
calcium and catecholamine release [229]. Caffeine has been proposed to inhibit phosphodiesterase 
(PDE) activity [229], which is responsible for degrading cAMP a secondary messenger in the 
sympathetic pathway. The increase of cAMP is thought to promote lipolysis by activating the 
phosphorylation of hormone sensitive lipase (HSL) [230] which in turn is believed to increase 
lipolysis and fat oxidation [210] . Once again, there is a wealth of in vitro evidence to support the 
potential mechanisms of caffeine, using supra physiological concentrations (100-6000 µmol/L in vitro 
compared to 20-40 µmol/L in humans) [141]. This clearly limits the application of these results to 
humans.  
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It is often hypothesised that the intake of both GTE and caffeine may result in synergistic effects by 
targeting the SNS, through COMT and PDE. In vitro, Dulloo et al [222] investigated the thermogenic 
effects of GTE and caffeine on brown adipose tissue (BAT). In isolation GTE stimulated BAT 
thermogenesis greater than caffeine. Therefore, Dulloo et al [222] argued that the combination of both 
of these ingredients would augment thermogenesis further. In theory, the argument for synergistic 
effects of GTE and caffeine is sound. However, there is no direct in vivo evidence to support it. A 
number of human studies at rest have shown that GTE and caffeine ingestion has no effect on markers 
of lipolysis (through changes in plasma FAs and glycerol [2, 208, 231]) or the SNS (represented by no 
apparent differences in plasma catecholamines [198, 199, 202]. This may be partly explained by the 
lower doses of caffeine ingested in GTE supplementation protocols (<150 mg ~ 1-2 mg/kg BM) when 
compared to previous studies that supplement caffeine alone (5-9 mg/kg BM) [119, 168]. Considering 
that there is little or no evidence that the COMT mechanism is responsible for changes in fat oxidation 
in humans following GTE (with or without caffeine), Chapter 2 of this thesis also assessed whether 7 
days of GTE supplementation was able to augment plasma catecholamine concentrations at rest or 
during exercise 
1.7.5.2 Mechanisms behind the effects of longer term green tea intake  
The mechanisms behind the effects of longer term GTE may be different than those that explain the 
shorter term effects of GTE. The reported increase in fat oxidation, following longer term GTE 
ingestion, may be explained by alterations to fat metabolism specific gene expression. At present, only 
animal and in vitro evidence is available to support the potential mechanisms following longer term 
GTE intake.  
1.7.5.2.1 Mechanisms behind the effects of longer term green tea intake at rest 
A number of animal studies have shown that longer term intake of GTE results in a decrease in 
adipogenic genes such as peroxisome proliferator-activated receptor- γ (PPAR- γ), Ccaat-enhancer 
binding protein- α (C/EBP-α), sterol regulatory element binding protein-1c (SREBP-1c), activated 
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protein 2 (aP2), lipoprotein lipase (LPL), and fatty acid synthase (FAS) [232]. In addition, others have 
illustrated that longer term GTE intake increases mRNA expression for lipolytic and β oxidation 
enzymes in the liver and adipose tissue, such as carnitine palmitoyl transporter I (CPTI), HSL and 
adipose triglyceride lipase (ATGL) [233, 234]. However, this is not  supported by all [235]. Recently, 
16 weeks of EGCG was found to elevate mRNA expression of fat metabolism enzymes (MCAD, 
NRF-1, UCP3, and PPARα) in mice skeletal muscle [236]. Alternatively, these alterations to lipolytic 
and β oxidation enzymes are not always apparent in skeletal muscle [233, 234]. More recently Sae-tan 
et al [236] was the first to show that 16 weeks of 0.32% dietary EGCG was able to alter mRNA 
expression specific to skeletal muscle fat metabolism enzymes in mice including: MCAD, NRF-1, 
UCP3, and PPARα. This demonstrates that longer term GTE intake may have direct effects on 
increasing gene expression specific to fat metabolism enzymes not only in the liver and adipose tissue 
but also in the skeletal muscle. 
It seems that the alterations to fat metabolism genes may occur in a variety of tissues following longer 
term GTE intake. What is less clear is the time course of GTE intake required to induce these 
metabolic alterations at a tissue level. Recently Friedrich et al [237] observed in mice that EGCG 
(1.0%) consumed for 4 days resulted in lower liver triglyceride and glycogen content in the post-
prandial state. These metabolic changes were also accompanied by a down regulation of lipogenic 
gene mRNA expression for acetyl CoA carboxylase (ACC), FAS and stearoyl-CoA (SCD1) in the 
liver. In a second experiment the authors showed that 7 days of EGCG (0.25-0.5%) resulted in an 
increased lipid oxidation. However, the authors did not assess changes in liver, skeletal muscle or 
adipose tissue gene expression following GTE intake. Taken together these results suggest that GTE 
ingestion, even as shorter as 4-7 days, may increase lipid oxidation due to decreased lipogenic gene 
expression.  
The precise molecular signalling mechanism by which longer term GTE intake activates fat 
metabolism gene expression is currently unclear. It is understood these adaptations to fat metabolism 
may be mediated by peroxisome proliferator receptor-γ co-activator-1-α (PGC-1α) [104] which co-
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activates peroxisome proliferator activated receptors (PPAR), both of  which are responsible for 
regulating fat metabolism adaptations [104]. However, Murase et al [238] concluded that increases in 
fat oxidation following longer term GTE intake were not attributable to changes in PGC-1 α. Further, 
GTE catechins have been shown in some [239, 240], but not all cases [241] to activate PPARs in vitro. 
Lee et al [240] showed that GTE increased the activation of PPAR- α using a transient transfection 
assay. It was reported that EGCG and EGC were shown to be most effective. The in vitro evidence is 
also supported by animal data. GTE supplementation of 4-12 weeks has been shown to lead to greater 
PPAR-α and PPAR-γ expression in the liver, adipose tissue and skeletal muscle [242-244]. However, 
Chen et al [233] reported no change in liver PPAR expression following 6 months EGCG intake in 
rats.  
At present, longer term GTE may induce changes to fat metabolism enzymes that over time would 
increase the capacity to oxidise fat. However, at this stage, it is too early to conclude whether these 
adaptations to fat metabolism are due to GTE induce changes to signalling molecules, such as PGC1- 
α and PPARs. Future human investigations are warranted.  However, what this preliminary evidence 
demonstrates that potentially up regulating fat oxidation with GTE may augment adaptations to fat 
metabolism. This has important implications for the adaptations that may occur after exercise.  
1.7.5.2.2 Mechanisms behind the effects of longer term green tea intake and exercise training 
As mentioned, endurance exercise training is highly effective at increasing fat oxidation [245]. This is 
due to skeletal muscle adaptations specific to the expression of fat metabolism enzymes and transport 
proteins following exercise training [104, 210, 246]. These specific adaptations are responsible for 
improving exercise performance. Few studies have investigated the exact signalling molecules that 
may explain the adaptations that occur following exercise training with or without longer term GTE 
intake in human and animal studies. As mentioned above, GTE in vitro and in animal models has been 
suggested to alter PGC1- α and PPAR signalling molecules which may be responsible for inducing the 
adaptations to fat metabolism. In order for these signalling molecules to be activated it has been 
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suggested that exercise is required [109]. It would therefore seem that in order for GTE to activate the 
adaptations to fat metabolism enzymes and proteins, exercise may be required.  
In support of this a number of laboratories in Japan have demonstrated that longer term GTE intake in 
mice, subjected to endurance exercise training, may improve endurance capacity. The performance 
enhancements were accompanied by increases in fat metabolism specific enzyme gene expression 
when compared to exercise only mice [238, 241]. Murase et al [238] observed that 12 weeks of GTE 
(0.1-0.5%) increased mRNA expression for sarcolemmal fatty acid transporter (FAT/CD36) and 
MCAD above that of exercise alone. These adaptations were accompanied by augmented β oxidation 
as well as exercise performance, assessed by time to exhaustion test. Similar results have been 
demonstrated by others that an increase in fat oxidation was explained by skeletal muscle adaptations 
[214, 238]. In addition these studies also showed that the highest GTE concentration caused a 
significant increase in plasma FA concentrations at the end of exhaustive exercise [215, 238, 241, 
247]. It could be suggested that the combination of exercise training and GTE intake resulted in 
greater lipolysis which, in addition to the muscle adaptations, explain the increase in β oxidation.  
At present the underlying mechanisms to explain the improvements in fat oxidation following longer 
term GTE intake are incompletely understood. Although based on animal evidence only, it seems that 
GTE, when ingested on a regular basis, may cause alterations to fat metabolism enzyme gene 
expression in the liver, adipose tissue and skeletal muscle. It is also important to note that based on 
allometric scaling the equivalent GTE doses (3-32 cups/d or ~450-4800 mL/d) given to mice may 
prove difficult to administer to humans [248].  
1.8 Nutritional support to avoid nutrient deficiency in athletes 
Despite the studies outlined above, suggesting that nutritional interventions may be effective in 
augmenting fat metabolism and exercise performance, it is rarely suggested that an athlete requires 
nutritional supports in order to prevent nutritional deficiency. However, emerging evidence over the 
past decade has alarmingly shown that vitamin D deficiency is highly prevalent worldwide [11], even 
Chapter 1   General Introduction 
 
-42- 
 
in athletes who spend significant time outdoors training and competing [249-251]. Further, it also 
appears that for many athletes, dietary vitamin D is an often ignored micronutrient, with reports 
suggesting that athletes consume well below the current RNI [252-254]. With this in mind, the extent 
of vitamin D deficiency, the sources of vitamin D in athletes and the impact it may have on exercise 
performance is largely unknown [10]. However, athletes are currently supplementing vitamin D in 
their diet from supplements in the hope of gaining an ergogenic effect. Therefore, research is required 
to explore the extent of deficiency and the effect of supplementation on exercise performance in 
athletes. Chapters 3 and 4 of this thesis explore these unknown questions.  
1.9 Vitamin D for athletic performance 
1.9.1 Photobiology and metabolism of vitamin D 
Vitamin D is a pluripotent fat-soluble secosteroid, produced in the skin via ultraviolet-B (UVB) 
radiation from sunlight, at a wavelength of 290-315 nm [255]. Sunlight penetrates the skin and 
converts 7-dehydrocholesterol in the plasma membrane of the epidermis and dermis to pre vitamin D3 
(precholecalciferol) [256]. The pre vitamin D3 is then converted to stable vitamin D3 (cholecalciferol), 
which has been shown to occur within 2 h of exposure to sunlight [257]. The stable vitamin D3 can 
either be taken up by the vitamin D binding protein (DBP) into the capillary bed or undergoes 
photoisomerization to inactive forms [256]. The process of producing inactive forms of vitamin D 
metabolites ensures vitamin D intoxication does not occur with prolonged exposure to the sun. 
Vitamin D3 is then taken up by the liver where it is converted by the enzyme vitamin D-25 
hydroxylase (25-OHase) to 25-hydroxyvitamin D (25(OH)D) (calcidiol) which is the stable clinical 
measure of  vitamin D status, with a half life of ~ 3 months [258]. It is evident that in healthy young 
individuals, who were exposed to sunlight, a significant increase in 25(OH)D occurs within 24 h of 
exposure [259]. It has been estimated that a single 30 minute exposure in the sun to the whole body 
can be equivalent to 10,000 IU (250 µg, 1 µg = 40 IU) of vitamin D [258], while exposure to the hands 
and arms for 15 minutes may provide 800-1500IU of vitamin D. The delivery of vitamin D from the 
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sun is dependent on the pigment of the skin, the age of the individual and the latitude of exposure 
[255, 256, 260].  
Vitamin D can also be provided through dietary intake as vitamin D2 (ergocalciferol) and vitamin D3 
(cholecalciferol) (Recommended Daily Allowance (RDA) United Kingdom, 200 IU). Vitamin D2 is a 
steroid found in plants, sourced from cereals and fungi products [258] whereas the major source of 
dietary vitamin D is from vitamin D3 in the form of fish (200-1000 IU/100g serving) , egg yolks (20 
IU/serving), butter and fortified foods [258]. Vitamin D can also be found in „over the counter‟ 
supplements in D2 and D3, with the majority of vitamin D supplements in the United States being D2 
and in the United Kingdom being D3. Following intake, dietary vitamin D is absorbed and transported 
to the liver by chylomicrons in the lymphatic system for hydroxylation [258]. However, vitamin D2 is 
less effective than vitamin D3 at raising 25(OH)D [261], due to the difference in affinity to bind to the 
25-OHase [261].  The 25(OH)D can be further hydroxylated in the kidney by the enzyme 25-
hydoxyvitamin D-1α-hydroxylase (1-OHase, CYP27B1) to the active form 1,25(OH)2D3 (calcitriol) 
[258].  
The traditional role of vitamin D is through calcium and phosphorus homeostasis for bone metabolism 
and neuromuscular function [9]. Vitamin D regulates intestinal absorption of dietary calcium and 
phosphorus through 1,25(OH)2D3 interacting with the vitamin D receptor-retinoic acid-x-receptor 
complex (VDR-RXR) increasing the epithelial calcium channels [258]. 1,25(OH)2D3 also regulates 
bone metabolism through VDR-RXR in osteoblasts to form mature osteoclasts which causes a release 
of calcium into the circulation [258]. This process is regulated through circulatory calcium and 
phosphorus concentrations. When vitamin D concentrations are low, intestinal absorption of calcium 
and phosphorus is impaired. In order to sustain circulatory concentrations for bone metabolism and 
neuromuscular function, an increase in the parathyroid hormone (PTH) occurs which stimulates 
calcium resorption and bone calcium mobilisation, as well as stimulating the production of 
1,25(OH)2D3 [258]. When vitamin D is sufficient, PTH is regulated directly by 1,25(OH)2D3 and the 
increase in circulatory calcium concentrations [258].   
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Vitamin D status is known to follow a biphasic pattern across the year due to the varying contribution 
of sunlight exposure throughout each season [262] (Figure 1.1) . Vitamin D is stored in circulation, 
bound to DBP [256], but also in the adipose tissue and skeletal muscle [263, 264]. The seasonal 
variation in vitamin D is explained by the cutaneous production of vitamin D which is determined by 
the zenith angle of the sun altering the amount of UVB from the sun that reaches the earth [258]. 
During the months of October to March at latitudes above 35⁰N, little or no cutaneous vitamin D 
synthesis occurs due to a high zenith angle and low UVB (Figure 1.1) [255, 258]. Apart from the 
season and latitude, other factors such as time of day, covering the skin with clothes and sun lotion, 
ageing (through a decrease in 7-dehydrocholesterol in the skin), skin pigment (melanin) are all known 
to alter cutaneous synthesis of vitamin D and thus increase the prevalence of vitamin D deficiency 
[258].  
1.9.2 Categorisation of vitamin D status 
The definition of categorising vitamin D status is complicated due to multiple recommendations 
currently available in the literature which are based on varying health outcomes. Recently, the Institute 
of Medicine (IOM) stated that sufficient vitamin D status should be set >50 nmol/L to ensure optimal 
bone health [265]. In addition, the Scientific Advisory Committee on Nutrition (SACN) and Foods 
Standard Agency (FSA) in the United Kingdom (UK) define vitamin D deficiency as < 25 nmol/L 
[266]. However, these recommendations have received a great deal of criticism from the Endocrine 
Society [267] and other experts in the field [268] with higher values (>75 nmol/L) suggested due to 
the benefits that vitamin D has on both skeletal and extra skeletal health.  
1.9.3 Vitamin D and bone health 
The profound effect of vitamin D on bone health has been recognised since the turn of the century 
[269]. In children and adolescents vitamin D is responsible for preventing the development of rickets, 
which is defined as the weakening and deformation of the bones due to poor bone mineralisation 
[258]. In adults, vitamin D is responsible for preventing the development of secondary 
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hyperparathyroidism, which is associated with the development of osteomalacia, increasing bone 
turnover and increasing the risk of osteoporosis [258]. Rickets and osteomalacia are usually present 
when plasma 25(OH)D is < 25 nmol/L [258]. A great deal of research has been conducted in order to 
establish the optimal concentration of vitamin D that is required to protect against secondary 
hyperparathyroidism, and thus minimise osteomalacia, osteoporosis and fracture. However, the 
25(OH)D concentration that results in a plateau in PTH concentrations in humans remains unclear, 
which is one of the reasons for the argued vitamin D status guidelines. The IOM states that 25(OH)D 
concentrations must be >50 nmol/L in order to minimise PTH concentrations. This is principally based 
on evidence from Preiemel et al [270] who showed that the incidence of osteomalacia in motor vehicle 
accident victims was not apparent when 25(OH)D was >50 nmol/L. Holick et al [271, 272] has 
recently provided a review of the evidence to suggest that these recommendations may be in part be 
misleading and the optimal 25(OH)D may be closer to >75 nmol/L. Further, other large scale studies 
have also reported 25(OH)D of >50 nmol/L [273] as well as >75 nmol/L [272] in order to result in a 
PTH plateau. A number of recent reviews have been highly influential in suggesting that PTH plateau 
occurs at >75 nmol/L, which has led to the general acceptance that for optimal bone health 25(OH)D 
50-75 nmol/L should be encouraged [274].  
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Figure adapted from Hypponen and Power (2007) Am J Clin Nutr 85 (3) 860-8. Reproduced with permission from AJCN.   
Figure 1.1 Proposed seasonal vitamin D status (dashed black line) based on correction to current seasonal vitamin D status observed in the UK adults 
(solid black line) to improve exercise performance.  
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It is often assumed that a reduction in PTH will lead to improved bone health. Yet in the majority of 
the aforementioned studies markers of bone health or fracture risk were not assessed. Despite this, a 
large number of population based studies have demonstrated that the risk of fractures and bone loss 
over time is greatly increased at 25(OH)D <50 nmol/L. Cauley et al [275] showed that the relative risk 
of hip fractures was greater in women with 25(OH)D < 47.5 nmol/L when compared to those with 
25(OH)D >70 nmol/L. Similar findings have also been shown in men as well as young and old 
individuals [276-280] where the risk of fracture is lower at concentrations >50 nmol/L. Collectively it 
is well established that vitamin D is vital for bone health and increasing vitamin D status with 
supplementation can reduce the risk of fractures [265, 281]. Achieving a vitamin D status of 50-75 
nmol/L would appear optimal for bone health.  
1.9.4 Vitamin D and muscle function 
The contention regarding vitamin D status guidelines is also based on well documented evidence that 
shows that vitamin D is highly important in optimal muscle function and composition. This point is 
particularly made by the Endocrine Society who argue that the IOM report does not consider the 
effects that vitamin D has on extra skeletal health.  
Muscle weakness, otherwise known as myopathy, features in those individuals with vitamin D 
deficiency (< 25 nmol/L) [282-284] but may also occur at high vitamin D concentrations 25-50 
nmol/L [285]. Myopathy is also accompanied with muscle pain and hypotonia in children and adults 
[286, 287] resulting in an impaired ability to perform simple physical tasks such as: climbing stairs as 
well as standing and sitting from a chair. In addition, neuromuscular impairments also occur with 
vitamin D deficiency [288, 289], as observed by a waddling gait, increased body sway and 
abnormalities to motor recruitment [9, 290]. The impairment to muscle function and neuromuscular 
activity may in part be explained by the depleted calcium content and uptake observed in isolated 
mitochondria and skeletal muscle from animals, respectively [291, 292]. More recently, Sinha et al 
[293] demonstrated that the skeletal muscle fatigue associated with vitamin D deficiency may be 
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explained by an attenuated mitochondrial oxidative function as measured by magnetic resonance 
spectroscopy. Thus it appears that vitamin D is crucial in the maintenance of skeletal muscle structure 
and functionality.  
Evidence exists to show that the predominant impairments to muscle function with vitamin D 
deficiency are improved with vitamin D supplementation [286, 287, 290]. Furthermore, these 
improvements are reported to occur at concentrations > 75 nmol/L [267],  with Zittermann et al [294] 
defining optimal concentrations for skeletal muscle function at 25(OH)D 100-250 nmol/L. 
Morphological changes have also been shown to be a predominant feature of vitamin D deficiency [9, 
295]. Biopsy studies have shown atrophy of type II muscle fibres associated with myopathy induced 
by vitamin D deficiency [296, 297]. Sato et al [296] demonstrated that the age related decline in type 
II muscle fibres was reversed in those supplemented with vitamin D (1000 IU/d) for 2 years, which 
correlated with 25(OH)D. Further, Visser et al [298] documented in 331 elderly men and women (>65 
y) that the age related decline in muscle mass (sarcopenia) was doubled in those who were vitamin D 
deficient (<50 nmol/L) and had greater PTH (>3.0 pmol/L) concentrations. More recently, cross 
sectional evidence in young women showed a 24% greater degree of fat infiltration in the muscle in 
those with lower 25(OH)D (<50 nmol/L) [299].  
1.9.4.1 Evidence from the elderly 
These deleterious effects of vitamin D deficiency on skeletal muscle structure and function have also 
been shown in numerous studies in the elderly to increase the risk of falls and reduce skeletal muscle 
strength and endurance.  
The association between vitamin D and risk of falls may in part be explained by an improved muscle 
function. A number of large cross sectional studies have examined this potential relationship by using 
a number of tests including hand grip dynamometer strength, leg strength, sit to stand test, walking 
speed tests and the timed up and go test. Visser et al [298] monitored 1008 elderly men and women (> 
65 y) over a 3 year period and showed that during this time a vitamin D status < 25 nmol/L reduced 
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hand grip strength twice as much when compared to those with higher vitamin D status. In a similar 
study design, Wicherts et al [300] showed that in 1234 elderly men and women (>65 y) physical 
performance (assessed using a variety of tests) was collectively poorer in individuals with vitamin D 
status < 50 nmol/L as opposed to those  with > 75 nmol/L. Furthermore, the authors observed a greater 
reduction in physical performance in individual who were severely vitamin D deficient (< 25 nmol/L).. 
In support of these findings Bischoff-Ferrari et al [301] showed that in 4100 elderly individuals had 
better physical performance test outcomes when concentrations of 25(OH)D were between 22-40 
nmol/L, with further improvements observed from 40-94 nmol/L. The study also showed that the 
benefits of vitamin D on physical performance were observed in both physical active and inactive 
individuals. Additionally, Bischoff-Ferrari et al [302] previously showed that a higher vitamin D status 
is also positively associated with improved leg extension power, which is more specific to 
performance measures that may be used in health adults or athletes. This suggests that the benefits to 
muscle function may even be observed in individuals with healthy and functional skeletal muscle and 
in tests that are more specific to athletic performance.   
However, not all studies in the elderly have found an association between vitamin D status and muscle 
function [303-307]. This inconsistency is further evident when looking at the evidence to support the 
efficacy of vitamin D supplementation to improve muscle function in the elderly. The lack of 
consistent findings when investigating the effect of vitamin D on muscle function and performance in 
the elderly is due to the highly variable study design implemented. This includes the variable dose 
(400-2000IU/d or 8400-14,000IU/wk or 100,000IU/month), composition (Calcium, D2 or D3), 
duration (3 months – 7 years), basal vitamin D status (15-115 nmol/L) and participant characteristics 
(age, gender and disability). While the evidence is mixed, there are a number of studies that show a 
significant improvement in muscle function following vitamin D supplementation [296, 308-315]. 
Lips et al [316] demonstrated that 8400 IU/wk (~1200IU/d) reduced body sway in 226 elderly men 
and women (>70 y). Gupta et al [317] showed a significant improvement in grip and calf strength in 
Asian adult men and women (32 y) when supplemented with 60,000IU/ wk of vitamin D3 and 
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1000mg calcium. However, this effect may only have been observed as the participants were severely 
deficient prior to supplementation (<25 nmol/L). In agreement other studies have shown no benefit to 
muscle function when baseline vitamin D status has been insufficient or sufficient (50- >75 nmol/L) 
[318-320]. Further, a recent meta analysis of 17 randomised controlled trials involving 5072 elderly 
participants, concluded that there was no significant effect of vitamin D supplementation (range of 
doses included 400IU/d to 60,000IU/wk) on leg or grip strength in the elderly when baseline 25(OH)D 
were >25nmol/L [321]. In addition Kenny et al [313] showed no improvement to exercise 
performance or strength in elderly individuals who were sufficient at baseline, despite a significant 
increase in 25(OH)D (~87nmol/L) following 1000IU/d for 6 months. 
1.9.4.2 Evidence from young adults and adolescents 
The effect of vitamin D on muscle function and exercise performance has been examined in 
adolescents and younger adults [307, 322, 323]. Ward et al [322] tested 99 postmenarchal girls aged 
12-14 y and showed that vitamin D status was positively correlated with two leg counter movement 
jump height, velocity, power and force. Similar findings were observed in Chinese adolescent girls (15 
y old) where a positive correlation was found between vitamin D status and hand grip strength [323]. 
Significantly lower hand grip strength was apparent in those girls who were not vitamin D deficient 
and severely deficient when compared to those with vitamin D status > 50 nmol/L. More recently, 
evidence in 200 male and female adults showed that vitamin D sufficiency may be important for 
endurance performance, as VO2 max was positively correlated with 25(OH)D [324]. Thus, vitamin D 
may play a role in muscle function and exercise performance (VO2 max) in groups of individuals 
whose muscle morphology has not deteriorated, as observed in the aforementioned elderly studies. 
Although this observation in healthy adults, let alone in athletes, has not been well defined and 
requires further investigation. However, to date, the associative evidence between vitamin D and 
muscle function has not taken into account variables that may contribute towards to positive 
association. Firstly most of the evidence to date that has found a significant association has mainly 
been a heterogeneous group. In addition back ground nutrition, such as habitual dietary intake and 
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dietary supplements, which may contribute to muscle mass growth and development are not taken into 
account. These are factors that must be considered in more detail in future investigations.  
Another variable that may also contribute to explaining the improvements to muscle function, strength 
and size with higher 25(OH)D is the relationship between vitamin D and testosterone [325, 326]. 
Testosterone, a steroid hormone from the androgen group, is important in muscle anabolism during 
growth and development [327]. In addition, serum testosterone release is reduced with age, which has 
been suggested to be linked with the sarcopenia [328]. Consequently ensuring serum testosterone 
concentrations are optimal throughout the life span is vital for growth and development.  
With this in mind, serum testosterone concentrations (both free and total) have been shown to vary 
season by season, with higher concentrations seen during the summer compared with the winter [329]. 
Other studies have failed to observe a seasonal pattern, but attributed the lack of pattern to less time 
spent outdoors during the summer [330, 331]. This data would suggest that seasonal fluctuations in 
vitamin D status could alter serum testosterone concentrations. In support, a number of studies have 
shown that 25(OH)D is associated with serum testosterone concentrations (Free and total) [332-334]. 
Nimptsch et al [334] illustrated, in 1362 men (aged 40-75 y), that a dose response between 25(OH)D 
and testosterone (Free and total) was observed, until a plateau was reached between 75-85 nmol/L. 
This data would suggest that optimal testosterone concentrations are reached when vitamin D 
sufficient (> 75 nmol/L). In further support, Pilz et al [335] has previously shown in overweight men 
(25-49 y) that 1 year vitamin D supplementation (3332 IU/d) raised 25(OH)D to sufficiency and 
significantly increased both free and total testosterone concentration when compared to placebo.  
Currently though, it is unknown whether increasing testosterone concentrations in young adults, 
especially athletes is beneficial to health, athletic performance or training adaptation. It is without 
doubt that optimal testosterone concentrations are vital for developing children and preserving quality 
of muscle mass in the elderly. In support, Bischoff-Ferrari et al [336] illustrated that those elderly men 
and women (> 65 y) with higher serum testosterone had a predicted 60% lower risk of falls, which was 
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further reduced with 3 years vitamin D (700 IU/d) plus calcium (500 mg/d) supplementation. In 
contrast, recent data from West et al [337] in young health males, showed that increasing circulatory 
testosterone during and after acute exercise and throughout a 12 week training programme, did not 
increase acute muscle protein synthesis [338] or training induced skeletal muscle adaptations [339]. 
Consequently, the effect of vitamin D and testosterone altering skeletal muscle mass and function, and 
the benefits it may bring to athletes, remains largely unknown.  
On the whole, evidence suggests that vitamin D deficiency may have deleterious effects on the skeletal 
muscle structure, size and function. Such losses within the skeletal muscle should not to be 
understated as they are critical in functionality and mobility in the elderly, but in the context of this 
thesis, may be critical in optimal exercise performance in athletes. However, to date this hypothesis in 
athletes is unclear. Consequently chapter 4 and 5 of this thesis examined the effect of vitamin D 
deficiency on muscle function and exercise performance in athletes.  
This thesis defines vitamin D status as severe deficiency, deficiency, insufficiency and sufficiency 
corresponding to 25(OH)D concentrations of <25 nmol/L, <50 nmol/L, 50-75 nmol/L and >75 
nmol/L, respectively. These cut offs for vitamin D status are in unison with the majority of guidelines 
to date [267, 340].  
1.9.5 Vitamin D and Immune function  
Performance in various athletic events is multi factorial. Besides from the physiological limitations 
(skeletal muscle mass, contractile function, oxygen kinetics, substrate metabolism), well being and 
immune function are also important in determining performance. Of late, vitamin D has been shown to 
have a role in mediating immune function [341]. It is known that exercise, especially of high intensity, 
has an immunodepressive effect which appears to increase the risk of infection, especially upper 
respiratory tract infections (URTI) [342]. There are several factors to explain the immunodepressive 
effects of high intensity exercise which are beyond the scope of this thesis chapter. For an extensive 
insight into the topic the reader is directed to the recent review by Walsh et al [342]. One factor, in 
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which vitamin D may play a critical role, is through receptors found on the cell surface membrane of 
leucocytes known as toll like receptors (TLR) [343]. In brief, TLR are trans-membrane proteins that 
are critical in detecting microbial pathogens which in turn causes an inflammatory response to initiate 
proliferation of lymphocytes. However, it has been shown that exercise can acutely reduce the 
expression of TLR on monocyte cell surface membrane [344] and thus partly explain the 
immunodepressive effect. Vitamin D has been shown to firstly interact with TLR, as leucocytes 
possess a VDR and 1-α hydroxylase [341]. In turn this causes the hydroxylation of 25(OH)D to 
1,25(OH)2D3, which initiates antibiotic activity through  antimicrobial peptide cathelicidin [345]. 
Therefore, it has been postulated that vitamin D is capable of activating an immune response 
independent of inflammation or TLR.  While the majority of this evidence has stemmed from in vitro 
work, associative evidence has shown a lower risk of infection during the summer months when 
compared to the autumn and winter in the United Kingdom [346]. More recently Aloia et al [347] 
illustrated that 3 years of vitamin D supplementation (2 years - 800 IU/d, 1 year – 1000IU/d) reduced 
incidence of colds and related symptoms during the winter in 34 African-American post-menopausal 
women. However, since no study has confirmed these findings. Based on the limited data, it could be 
suggested that vitamin D may be important in optimising immune function, at least in athletes, when 
immunosuppression maybe prevalent when undergoing training.   
1.9.6 Prevalence of vitamin D deficiency in the United Kingdom 
In the United Kingdom (UK) (50-60⁰N), a high prevalence of vitamin D deficiency and insufficiency 
has been observed. Data from the 1958 British birth cohort study showed that 2850 adults 25(OH)D 
during the winter and spring season averaged 41.1 nmol/L, of which 47% of adults were deficient (<40 
nmol/L), and 16% were clinically deficient (<25 nmol/L) (Figure 1.1) [262]. More recently, Cashman 
et al [348] showed that during the winter in 1132 men and women living in Ireland (52°N), 59% were 
vitamin D deficient (<50 nmol/L) and 84% were vitamin D insufficient (<75 nmol/L). Further, the 
authors showed that even during the summer, 22-36% and 69% of participants tested were vitamin D 
deficient and insufficient respectively. The high prevalence of vitamin D deficiency and insufficiency 
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is explained by the fact that the UK has one of the poorest sunny climates worldwide [349] with a high 
yearly cloud clover [350]. This means that over the course of the year sunlight exposure is severely 
impaired, reducing the synthesis of vitamin D. In addition, during the winter in the UK, little or no 
cutaneous vitamin D synthesis occurs due to a high zenith angle and low UVB (Figure 1.1) [255, 258]. 
Further, it appears that the current UK policy on sun exposure is primarily focused on preventing the 
development of skin cancer, with previous recommendations stating avoidance of sun exposure 
(Cancer Research UK and World Health Organisation) [268, 351]. Yet these policies and 
recommendations neglect the consideration of the health benefits of vitamin D to both bone and 
muscle [268]. It has since been suggested that 10-15 minutes of sun exposure to just the hands and 
face in the summer is sufficient to gain adequate vitamin D status [268]. This was further supported by 
SACN in 2007 who stated that individuals are able to gain enough vitamin D from time spent outdoors 
with sun bathing not being required, especially to avoid sun burn and higher risk of skin cancer [44]. 
In contention with the abovementioned statements, evidence has shown that sunlamp treatment (3/wk 
for 6 wk) to individuals during the winter mimicking the midday summer sun of UK (53.8°N), resulted 
in only 26% of individuals obtaining sufficient vitamin D status [81]. This data clearly supports the 
notion that casual sun exposure in the UK is not adequate in the winter, let alone in the summer, to 
raise and sustain sufficient vitamin D status.   
The high prevalence of vitamin D deficiency and insufficiency in the UK may also, to a lesser extent 
to sun exposure, be explained by the poor dietary intake of vitamin D. Today, very few foods are 
fortified with vitamin D in the UK and dietary intake from sources such as fish and meats is limited, 
with current food sources estimated to provide ~120IU/d [268]. Consequently, the high prevalence of 
vitamin D deficiency and insufficiency in the summer and winter in the UK demonstrates the lack of 
vitamin D intake from both dietary and sun exposure.  
With this in mind, vitamin D supplementation is therefore warranted. However, to date the vitamin D 
dose required to raise and sustain vitamin D status at sufficient concentrations is currently under 
debate. The recent IOM report [265] states that in order to achieve a vitamin D status of >50 nmol/L a 
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vitamin D intake of 600 IU/d is required. Further, the SACN and FSA state a daily recommended 
value (DRV) of 400 IU/d [266], only if sun exposure is limited. However numerous studies have 
shown that independent of sun exposure in the UK, an intake of 400-600 IU/d is inadequate to raise 
vitamin D status to >50 nmol/L [352]. In further support, Hall et al [353] demonstrated that in order to 
sustain sufficient vitamin D status across the year, summer sun exposure had to be high (90 min/d) and 
as a result vitamin D supplementation of 1300IU/d was required during the winter. Alternatively, the 
authors also showed that during low sun exposure in the summer (~20 min/d) it was estimated that 
1000IU/d was required during the summer, while during the winter 2550IU/d was required. Yet, the 
work by Hall et al [353] was conducted in California, which would suggest that far higher doses of 
vitamin D would be needed in the UK to sustain sufficient vitamin D status all year round due to the 
poor sun exposure in the UK.   
In light of the poor contribution of the sun and the diet to vitamin D status in the UK, it has been 
proposed that doses above the current RDA in the UK (200 IU/d), between 1000-4000 IU/d, may be 
required to achieve and sustain vitamin D sufficiency [267, 340]. However, with the higher suggested 
doses of vitamin D, has bought into question the safety and toxicity of such doses [265, 266, 354-356]. 
Vitamin D toxicity, categorised by hypercalcaemia, has been reported to only take effect at 25(OH)D 
concentrations >350 nmol/L which are achieved with vitamin D3 > 100,000 IU/d [354-356]. However, 
doses up to 10,000 IU/d have been shown to be efficacious at improving vitamin D status in the 
absence of toxicity, which questions the current upper limits of vitamin D set [355]. Taken together, 
vitamin D supplementation would appear to be an effective strategy to ensure vitamin D sufficiency, 
however to date a vitamin D supplement protocol (dose and duration) is yet to be determined. Herein, 
to begin establishing an effective supplementation protocol, chapter 6 of this thesis explores the dose 
response of short term (28 d) vitamin D3 supplementation, well above the current UK DRV, on 
achieving vitamin D sufficiency during the winter.  
1.9.7 Prevalence of vitamin D deficiency in athletes 
Chapter 1   General Introduction 
 
-56- 
 
Based on the aforementioned evidence, vitamin D deficiency is wide spread in the general population 
[11]. It can be assumed from large cross sectional data in adults [348, 352, 357], that those vitamin D 
deficient individuals would likely include physically active and competitive sports men or women. 
Currently there is a growing appreciation for the prevalence of vitamin D deficiency in athletic 
populations. However, the prevalence at higher latitudes such as the UK remains unclear (Table 1.4).  
Athletes who train and compete indoors, cover their skin, or compete at high latitudes may be more at 
risk of vitamin D deficiency [10, 252, 260]. In agreement, Hamilton et al [250] showed that athletes 
who lived and trained in Qatar, who regularly train indoors, cover their skin (for environmental and 
social factors), or train after sunset observed a high prevalence of vitamin D deficiency (~90%) despite 
the sunny environment. Similar results were observed in athletes residing in Israel, with 94% of 
basketball players and dancers being vitamin D insufficient [251]. Interestingly, even outdoor athletes 
have been shown to suffer from vitamin D deficiency, as demonstrated by French cyclists who train 
outdoors 16 h/wk [358].  
Even at low latitudes, where the climate is less extreme than the abovementioned studies, 33% and 
50% of Australian elite gymnasts were vitamin D deficient and insufficient at the end of autumn [359]. 
At higher latitudes, especially during the winter, a high prevalence of vitamin D deficiency and 
insufficiency has been reported in athletes [249, 360-364]. Lehtonen-Veromaa et al [362] showed that 
68% and 43% of young Finnish girls (60.5°N) competing in gymnastics and running in the winter 
were vitamin D deficient (<38 nmol/L in the study) and clinically vitamin D deficient (<30 nmol/L) 
respectively.  
However, during the summer, the authors demonstrated an improved vitamin D status, with only 2% 
of the athletes being vitamin D deficient. Vitamin D deficiency and insufficiency has also been 
reported amongst elite athletes [361, 363, 364]. Morton et al [363] reported a mean 25(OH)D of 51±19 
nmol/L during the winter in the UK elite football players, with 65% of the players being insufficient. 
Similarly, at the beginning of the football season which corresponded with the end of the summer in 
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the UK, only 10% of the players were vitamin D insufficient. This was likely due to the majority of 
the players spending the summer abroad in hot and sunny climates.  Further, a recent study in UK elite 
track and field athletes observed that over the course of the year, 19% and 29% of athletes were 
vitamin D deficient and insufficient, respectively [364]. However, the authors did not control for the 
season that the blood sample was collected, therefore little is known about the prevalence of vitamin D 
status throughout each season in this group of athletes.  
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Reference Country (⁰N) N Age  Season 25(OH)D 
(nmol/L)  
Prevalence of vitamin D status 
Hamilton et al 
[250]  
Doha, Qatar (25.3⁰N) 93 (I:20 O:73) 13-45 y Summer 58% < 25 
3% < 50  
Deficient (<50 nmol/L): 91% Sufficient (50-75 
nmol/L):9% 
 
Constantini et al 
[251]  
Jerusalem, Israel 
(31.8⁰N) 
 
98 (I:77 O:21) 10-30 y Winter 
Summer 
W-63 ± 21 
S-67 ± 43 
Deficient (<50 nmol/L): 19% Insufficient (50-75 
nmol/L): 48% Sufficient (>75 nmol/L): 27% 
Lovell et al  
[337] 
Canberra, Australia 
(35.3⁰S) 
 
18 (I:18 O:0) 10-17 y Autumn 56 (range 
29-84) 
Deficient (<50 nmol/L): 34% Insufficient (50-75 
nmol/L): 50% Sufficient (>75 nmol/L): 16% 
Lehtonen et al  
[340] 
Turku, Finland 
(60.5⁰N) 
131(I:20 O:73) 9-15 y Winter 
Summer 
W-34 ± 14 
S-63 ± 15 
W- Deficient (<37.5 nmol/L): 68%                                
S- Deficient (<37.5 nmol/L): 2% 
 
Barrack et al  
[343] 
California, USA 
(38.5⁰N) 
26 (I:0 O:26) 14-17 y  Autumn 93 ± 3 NR 
 
 
Galan et al  
[344] 
Seville, Spain 
(37.4⁰N) 
28 (I:0, O:28) 27 ± 4 y Winter 
Summer 
W- 38-111 
S- 62-163 
W- Insufficient (<75 nmol.L): 64%                                                      
S- Sufficient (>75 nmol/L): 93% 
 
Halliday et al  
[249] 
Wyoming, USA 
(41.3⁰N) 
41 (I:12, O:29) 20 ± 2 y Winter 
Spring 
Autumn 
W-76 ± 24 
Sp-105 ± 37 
A- 123 ± 42  
W-Insufficient (<80 nmol/L): 61% Deficient (<50 
nmol/L): 3% Sp- Insufficient (<80 nmol/L): 16% 
Deficient (<50 nmol/L): 4%  A- Insufficient (<80 
nmol/L): 10% Deficient (<50 nmol/L): 2%  
     
Ducher et al  
[345] 
Melbourne, Australia 
(37.8⁰S) 
16 (I:16, O: 0) 10-19 y Winter 50 (range 
21-94) 
Deficient (<50 nmol/L):56% Insufficient (50-75 
nmol/L): 25% Sufficient (>75 nmol/L): 19% 
 
Bescos et al  
[338] 
 
Barcelona, Spain 
(41.4⁰N) 
 
21 (I:21, O: 0) 25 ± 4 y Winter 48 ± 22 Deficient (<50 nmol/L):57% Insufficient 50-75 
nmol/L): 33%  Sufficient (>75 nmol/L):  10% 
 
       
Abbreviations:  I Indoor, O Outdoor, W Winter, Sp Spring, A Autumn, S Summer  NR Not reported 
 
Table 1.4 Overview of studies assessing vitamin D status in athletes across the seasons 
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Reference Country (⁰N) N Age  Season 25(OH)D 
(nmol/L)  
Prevalence of vitamin D status 
Morton et al  
[341] 
 
 
Liverpool, United 
Kingdom (53.4⁰N) 
 
20 (O: 20) 26 ± 4 y Winter 
Summer 
W-104 ± 21  
S-51 ± 19 
W- Insufficient (<50 nmol/L): 65% Sufficient 
(>50 nmol/L): 35%                 
S – Insufficient (<50 nmol/L): 10% Sufficient 
(>50 nmol/L): 90% 
 
Pollock et al 
[342] 
 
United Kingdom  
(51-54 ⁰N) 
63 (I: 20, O: 43) 25 ± 4 y Winter 
Summer 
W-63 ± 30  
S-89 ± 40 
Deficient (<50 nmol/L): 19% Insufficient (50-75 
nmol/L): 29%  
 
       
Close et al  
[339] 
 
 
Liverpool, United 
Kingdom (53.4⁰N) 
 
61(O: 61) 22 ± 2 y Winter Range 15-125  Deficient (<50 nmol/L) – 62% Insufficient (50-75 
nmol/L)– 38%  
Close et al  
[346] 
 
 
Liverpool, United 
Kingdom (53.4⁰N) 
 
30 (O: 30) 21 ± 2 y Winter/Spring 51 ± 26  Severely deficient (<30 nmol/L) – 20% Deficient 
(<50 nmol/L) – 57%  
Wilson et al  
[347] 
 
 
Liverpool, United 
Kingdom (53.4⁰N) 
 
36 (F:19, J: 18) F 27 ± 5 y 
J 25 ± 5 y 
Winter F 38  ± 28 
J 35  ± 14 
Severely deficient (<30 nmol/L) – 37% Deficient 
(<50 nmol/L)  – 31% 
Abbreviations:  I Indoor, O Outdoor, W Winter, Sp Spring, A Autumn, S Summer NR Not reported F Flat horse riders J Jump horse riders 
 
Table 1.4 continued 
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The most comprehensive study to date investigated vitamin D status, dietary intake of vitamin D and 
sun exposure habits in 41 athletes, living at latitude of 41.3⁰N, from a number of indoor and outdoor 
sports across a season [249]. The authors observed a biphasic response in vitamin D status across the 
seasons, with a higher prevalence of vitamin D insufficiency in the winter compared to the spring and 
autumn, 61%, 16% and 12% respectively. It appeared that vitamin D status was higher in outdoor 
athletes at the end of autumn. Additionally, very few athletes reported consuming the RDA of vitamin 
D set in the US (<7% in all seasons) or consuming a vitamin D supplement (24-54% of athletes across 
the season). Yet, multivitamin intake was frequently used by athletes and correlated with vitamin D 
status in the winter. In agreement, a growing number of studies have illustrated that athletes consume 
vitamin D well below the DRI and is often an ignored micronutrient by athletes and nutritionists [252-
254].  
Therefore, vitamin D status in athletes is ultimately determined by a number of risk factors that 
regulate the cutaneous synthesis of vitamin D from the sun and dietary intake. Nevertheless, despite 
the work by Halliday et al [249], there is very limited information on the prevalence of vitamin D 
deficiency in athletes, especially those living and training at high latitudes (>50⁰N), for example in the 
UK [361, 363, 364]. Secondly, very little is known about the extent that risk factors are associated 
with developing vitamin D deficiency in athletes. However, it would appear that the high prevalence 
of vitamin D deficiency and insufficiency in the winter and autumn months combined with the low 
dietary vitamin D intake, as previously discussed, warrants the use of vitamin D supplementation by 
athletes. In light of this discussion, chapters 5 and 6 in this thesis detail studies that explore the 
prevalence of vitamin D deficiency in a variety of UK athletes, during the winter, while establishing 
the association that lifestyle, training and dietary factors have with vitamin D status.  
1.9.8 Vitamin D and athletic performance 
Early evidence from German and Russian athletes suggested the potential benefits and importance of 
vitamin D for optimal exercise performance [10]. In 1930, reports from Germany stated that exercise 
Chapter 1   General Introduction 
 
-61- 
 
performance could be improved when ultraviolet irradiation from sun lamps was given to athletes, 
with some athletic associations arguing it provided an unfair athletic advantage [10]. The improvement 
to performance was observed through the manipulation of vitamin D status by using 8-10 weeks of 
ultraviolet irradiation. The performance improvements included strength, speed, endurance, 
cardiovascular fitness and reaction time. However, the reported magnitude of performance 
improvements was large (8-60%) when compared to placebo, which was paralleled with the fact that 
many of the studies were often poorly controlled. Coinciding with the early ergogenic effects of 
vitamin D, consistent literature indicates physical and athletic performance is seasonal; which may be 
related to the concentration of vitamin D found within the body [10] (Figure 1.1). In support, long 
distance runners performance and VO2 max has been shown to improve during the summer compared 
with winter seasons [370]. Interestingly, Hettinger et al 1956 [371], reported that daily training of the 
wrist flexor muscles for 7-10 months significantly improved strength gains during the summer and a 
decline in the winter months. Yet, it is difficult to conclude that the ergogenic effects are solely due to 
vitamin D due to the lack of control implemented throughout the abovementioned studies [10]. 
Nevertheless, sustaining sufficient vitamin D status throughout the year, specifically by preventing 
vitamin D deficiency in the winter and autumn, may be advantageous to an athlete‟s training and 
exercise performance (Figure 1.1). Within the past year, this paradigm has undergone preliminary 
investigation. Barker et al [372] observed that participants who received 200IU/d or 4000IU/d for 28 
days did not improve muscle strength when compared to placebo during the winter. However, the lack 
of finding was likely due to the low latitude of the test site (40°N), which was accompanied by a high 
prevalence of vitamin D sufficiency prior to supplementation. More recently, a pilot study conducted 
in a small number of soccer players (n=10) found that 8 weeks of 5000IU/d during the winter in the 
UK (53°N) significantly improved 10 m sprint times and vertical jump when compared to placebo 
[361]. The work conducted by Close et al [361] provides early insight into the potential benefits of 
achieving and sustaining vitamin D sufficiency for athletic performance. However, due to the small 
subject number recruited and the poor control implemented throughout the study (training regime, diet 
and supplement compliance) the benefits of vitamin D supplementation in athletes remain unclear. In 
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addition, the current supplementation protocol (dose and duration) that is necessary to achieve vitamin 
D sufficiency and consequently provide benefits to exercise performance is also yet to be determined. 
With this in mind, Close et al [368] recently examined the effect of 20,000 IU/wk and 40,000 IU/wk 
compared to a placebo control for 12 weeks on muscle function (1-RM bench press, leg press, 20-m 
sprint and vertical jump height) in rugby and football players. The authors found that 57% of the 
athletes were vitamin D deficient prior to supplementation which increased to sufficiency in both 
supplementation groups. Following 12 weeks of supplementation, no difference in vitamin D status 
was observed between the two doses. However, despite the sufficient concentrations following 
supplementation, no differences in any muscle function test was observed in the athletes. However, 
interestingly the authors did demonstrate that high weekly doses of vitamin D (20,000 IU/wk ~ 
2800IU/d) are highly effective at increasing vitamin D status in 6 weeks. Therefore, this early data in 
athletes suggests that high doses of vitamin D, above the RDA, are efficacious at correcting the high 
prevalence of vitamin D deficiency. However, it is firstly yet to be determined whether or not high 
daily doses above the vitamin D DRI, which is a more realistic nutritional regime that may be used by 
many athletes, are effective at increasing vitamin D status. Secondly, it remains unclear if increasing 
vitamin D status with this supplementation strategy may improve exercise performance. Herein 
chapter 6 of the thesis focuses on elucidating the optimal dose response with vitamin D 
supplementation on improving status and whether achieving sufficiency improves exercise 
performance in UK athletes.   
1.9.9 Mechanisms to describe the effects of vitamin D in skeletal muscle 
The improvement in skeletal muscle function and structure with vitamin D suggests that it is capable 
of directly binding and inducing effects within the skeletal muscle. This is firmly supported by the 
presence of the vitamin D receptor (VDR) within the skeletal muscle which is required to induce the 
physiological of vitamin D. [373, 374]. In addition, the enzyme 1-OHase has also recently been 
identified in skeletal muscle [375] allowing 25(OH)D to convert to 1,25(OH)2D3. The interaction and 
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activation of the VDR in the skeletal muscle is understood to induce genomic (slow) and non-genomic 
(fast) signalling pathways through the presence of nuclear and non-nuclear VDR [376].  
The genomic effects of vitamin D occur by the VDR interacting with a nuclear retinioc acid-x-receptor 
(RXR) to form a complex which then induces DNA transcription and de novo protein synthesis [9]. 
Vitamin D is capable of targeting more than 1000 vitamin D responsive human genes [377], 
specifically relating to skeletal muscle calcium handling, proliferation and differentiation [378-382]. 
Secondly, VDR knockout mice display abnormal skeletal muscle developmental growth, resulting in 
severely atrophied muscles, impaired functional performance and motor co-ordination [383, 384]. 
Additionally, these knockout mice have also been shown to have impaired swimming ability and 
motor co-ordination [383, 385]. Thirdly, vitamin D has also been shown to mediate the synthesis 
proteins that are vital for skeletal muscle physiology and contractile function including: ATP 
accumulation [386], increased troponin C [387], as well as actin and sarcoplasmic reticulum 
expression [388]. Collectively this mechanistic data from animal in vitro and in vivo studies proposes 
that vitamin D has pro-anabolic effects within the skeletal muscle. However, the direct examination of 
these effects within human skeletal muscle is yet to be conducted.  
Alternatively, 1,25(OH)2D3 is capable of inducing non-genomic (fast) responses within the skeletal 
muscle via the VDR by formation of secondary signalling messengers or phosphorylation of 
intracellular proteins. These signals are thought to occur through manipulations of caveolae 
microdomains on the plasma membrane of the skeletal muscle which are important in signal 
transduction [389]. Those characterised signalling pathways include p38 mitogen activated protein 
kinase (p38 MAPK) [389, 390] phospoinositol-3-kinase (PI3-K)/Akt [391] and extracellular regulated 
kinase1/2 (ERK 1/2) [392]. All of these signalling proteins are known to be implicated in the upstream 
regulation of mammalian target of rapamycin (mTOR) complex 1 (mTORC1), which is well 
documented to be critical in the regulation of skeletal muscle mass [393, 394]. However, the direct 
interaction between vitamin D, mTORC1 and the regulation of skeletal muscle mass and function in 
humans is unknown. Interestingly, the benefits to skeletal muscle growth and strength following 
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amino acid treatment in the elderly were shown to be reduced in those participants who were vitamin 
D deficient and insufficient [395]. This in part may be explained by reduced non-genomic signalling 
and blunted mTORC1 activity. But it also may be explained by early evidence which showed greater 
muscle protein degradation [396] and reduced incorporation of the amino acid leucine, which is 
known to stimulate mTORC1 [397], in vitamin D deficient rat skeletal muscle [386]. This provides 
even more evidence for vitamin D possessing a pro anabolic effect within the skeletal muscle.  
The effects of vitamin D on muscle function and strength have also been shown to be independent of 
changes to muscle mass [297, 398]. Early evidence in vitamin D depleted chicks showed the calcium 
content and uptake by the SR was low [291, 292]. Furthermore, in vitro studies have shown that 
treatment of vitamin D depleted animal myotubes with 1,25(OH)2D3 results in a rapid uptake of 
calcium [381, 399]. This is due to 1,25(OH)2D3 being able to induce the initiation of calcium 
mobilisation from the SR, as well as influx from extracellular compartments through voltage gated and 
store-operated calcium channels [400, 401]. Through the increase in calcium mobilisation, calmodulin 
and calmodulin-dependent protein kinase II (CAMK II) are also activated [380, 389, 391, 392, 402, 
403]. These calmodulin signals are known to be important in skeletal muscle mitochondrial biogenesis 
[87, 104] which may provide evidence for the improvements to fatigue with correction of vitamin D 
deficiency [282, 293, 301].  
Collectively, the genomic and non-genomic mechanisms of vitamin D illustrate that the importance of 
vitamin D in skeletal muscle structure and function. It would appear that through the mechanisms, 
vitamin D is highly important in preventing the development of peripheral fatigue, which is highly 
important in ageing functionality but also in athletic performance. Additionally, vitamin D may also be 
critical in optimising the adaptations to exercise training, which is essential in preventing the 
development of sarcopenia in the elderly but may also be important for athletes. Yet these speculative 
viewpoints remain to be elucidated critically in human skeletal muscle, both in vitro and in vivo, in the 
elderly let alone in athletes.  
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1.10 Aims of the thesis 
This thesis investigates a number of diverse nutritional interventions and supports that may optimise 
fat metabolism during exercise and improve endurance exercise performance. These interventions and 
supports include green tea, coffee and vitamin D. 
Chapter 2 describes a study where the metabolic effects of short term green tea supplementation were 
investigated both at rest and during exercise using a metabolomic approach. In addition Chapter 2 
investigates the catecholamine response at rest and during exercise in order to test the hypothesis that 
green tea is capable of inducing alterations to substrate metabolism through the often cited COMT 
mechanism, which to date has not been comprehensively investigated in humans. Chapter 3 describes 
a study where the metabolic and performance effects of caffeine were compared with coffee, in order 
to establish whether coffee may be used as a nutritional support by athletes to gain the same benefits to 
performance as previously observed with caffeine.  
Based on the recent evidence that has demonstrated a high prevalence of vitamin D deficiency in the 
general population, there is concern for the extent of deficiency in athletes. Chapter 4 describes a 
study whereby a variety of athletes living and training at high latitude were tested to assess the 
prevalence of vitamin D deficiency while also identifying the potential sources and limitations to 
vitamin D status. Chapter 4 also identifies whether vitamin D status is associated with exercise 
performance in athletes. The current vitamin D requirements to prevent deficiency are mixed and 
under current debate. Chapter 5 describes a study that explored the effect that a variety of doses of 
vitamin D had on improving vitamin D status as well as the implications that improving vitamin D 
status would have on exercise performance. 
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2.1 Abstract 
Background: Green tea catechins have been hypothesized to increase energy expenditure and fat 
oxidation by inhibiting catechol-O-methyltransferase (COMT) and thus promoting more sustained 
adrenergic stimulation. Metabolomics may help to clarify the mechanisms underlying their putative 
physiological effects. The study investigated the effects of seven days ingestion of green tea extract 
(GTE) on the plasma metabolite profile at rest and during exercise. Methods: In a placebo-controlled, 
double-blind, randomized, parallel study, 27 healthy physically active males consumed either GTE (n= 
13, 1200mg catechins, 240 mg caffeine / day) or placebo (n= 14, PLA) drinks for seven days. After 
consuming a final drink (day 8) participants rested for two hours and then completed 60 minutes 
moderate intensity cycling exercise (56±4% VO2max). Blood samples were collected before and 
during exercise. Plasma was analyzed using untargeted 4-phase metabolite profiling and targeted 
profiling of catecholamines. Results: Using the metabolomic approach we observed that GTE did not 
enhance adrenergic stimulation (adrenaline and noradrenaline) during rest or exercise. At rest, GTE 
lead to changes in metabolite concentrations related to fat metabolism (β-hydroxybutyrate), lipolysis 
(glycerol) and TCA cycle intermediates (citrate) when compared to PLA. GTE during exercise caused 
reductions in β-hydroxybutyrate concentrations as well as increases in pyruvate, lactate and alanine 
concentrations when compared to PLA. Conclusions: GTE supplementation resulted in marked 
metabolic differences during rest and exercise. These metabolic differences were not related to the 
adrenergic system, which questions the in vivo relevance of the COMT inhibition mechanism of action 
for GTE.  
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2.2 Introduction 
The concept of “challenging homeostasis” has been proposed as a novel approach to define 
biomarkers for nutritional related health [1]. It is thought that responses to a challenge of homeostasis 
will affect multiple pathways and provide information other than static homeostatic and disease 
relevant end-point measures. These dynamic responses may be appropriate means to assess effects and 
mechanisms of nutritional interventions that may remain hidden under the large variation within a 
healthy population. Exercise is a physiological challenge to homeostasis of the human body. 
Metabolomics based on gas- or liquid chromatography – mass spectrometry (GC/MS, LC/MS) is 
capable of measuring the multi-factorial, integrative metabolic responses  to  an exercise challenge 
and/or a nutritional intervention or supplement [2-6].  
Green tea has been reported to have a number of health promoting effects, including anti-obesity 
properties [7-10]. These health benefits are generally attributed to its polyphenol content, particularly 
to catechins that are often enriched in GTE (green tea extract). These are comprised of 
epigallocatechin gallate (EGCG), epicatechin gallate, and gallocatechin gallate, among others. EGCG 
is thought to be the most pharmacologically active of the catechins. GTE also contains caffeine. The 
anti-obesity properties of GTE are attributed to both acute [11] and chronic [7,12] GTE 
supplementation augmenting energy expenditure (EE) and fat oxidation under resting conditions. 
However, this has not been consistently reported [13,14]. During moderate intensity exercise, EE is 
elevated several times when compared to rest, and absolute rates of lipolysis and fat oxidation are 3-10 
fold higher. The administration of GTE could at least in theory have an additive effect on fat 
metabolism above and beyond what is seen with exercise alone. Indeed, it has been observed that fat 
metabolism is up regulated during exercise following both acute [15] and chronic [16] GTE 
supplementation. So far, differences in the metabolic effects of GTE between rest and exercise have 
not been investigated in a single study. It is also currently unknown, whether the effects of GTE on fat 
metabolism or any other related metabolic effects are more prominent following acute or chronic GTE 
supplementation. 
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It has previously been observed that certain catechins in GTE target specific control points of the 
sympathetic nervous system [17]. EGCG has been suggested to directly inhibit catechol-O-
methyltransferase (COMT) an enzyme that is responsible for degrading catecholamines (noradrenaline 
(NA) and adrenaline (A)) [18]. Inhibiting the degrading action of COMT would lead to elevated 
catecholamine concentrations resulting in greater sympathetic nerve stimulation and thus higher rates 
of lipolysis. This is thought to elevate fat oxidation and EE at  rest and during exercise [10]. The 
COMT pathway is likely to take effect following acute GTE supplementation. Alternatively, it has 
been suggested that chronic GTE supplementation may lead to an up- or down-regulation of various 
proteins and enzymes involved in fat metabolism [19,20]. However, there is no convincing evidence to 
support the acute or chronic mechanisms of GTE in vivo.  
Based on the mixed study outcomes on fat metabolism following GTE supplementation, and the lack 
of mechanistic evidence in vivo, the aim of the present study was to examine the effects of 7 days GTE 
supplementation (1200 mg total catechins and 240 mg caffeine/day) on  human metabolism at rest and 
during moderate intensity exercise (56±4% VO2(max)). These effects were assessed in human plasma 
using GC-MS- and LC-MS/MS-based 4-phases metabolite profiling [21]. This comprehensive 
metabolite profiling approach provided an unbiased and systemic investigation into the multi-factorial 
metabolic response following GTE supplementation at rest and during exercise. We hypothesized that 
GTE ingestion for 7 days would induce metabolic changes consistent with increased lipolysis and that 
these changes could be maintained or enhanced during exercise after a single bolus intake of GTE. In 
addition, we tested the hypothesis that GTE stimulates the adrenergic system by measuring targeted 
profiles including various catecholamines.  
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2.3 Methods and Materials 
2.3.1 Study design 
2.3.1.1 Participants 
27 healthy physically active male participants were recruited for the purposes of the study. Inclusion 
criteria were: < 4 cups of tea or coffee / day (thus less than ~ 400 mg caffeine / day), exercise 3-5 
times / week, 30-90 min / session. In addition, participants had to be 18-55 y and BMI < 30 kg.m
-2 
to 
be included in the study. Participants were randomly allocated into either a GTE group (n=13, age 22 
± 5 y, weight 77.6 ± 12.0 kg, BMI 24.3 ± 3.0 kg/m
2
) or a placebo (PLA) group (n=14, age 22 ± 8 y, 
weight 78.8 ± 10.2 kg, BMI 24.7 ± 2.7 kg/m
2
). All participants gave written informed consent to 
participate in the study. The study was approved by the University of Birmingham Ethics Committee. 
2.3.1.2 Preliminary Testing 
One week prior to the first experimental trial, all participants visited the human performance lab for 
familiarisation, assessment of health and an incremental exercise test using an electronically braked 
cycle ergometer (Lode Excalibur Sport, Groningen, Netherlands) to volitional exhaustion [22]. 
Participants started by cycling at 95 W for 3 minutes and work rate was increased by 35 W (Winc) 
every 3 minutes (tinc) until they reached exhaustion. The Wmax was calculated by using the following 
equation [23]:  
Wmax = Wout + (t/tinc) Winc 
Wout is the power output of the last completed stage (in W), and t is the time (in minutes) spent in the 
final stage. Wmax values were used to determine the workload of 50% Wmax (~55% VO2(max)) used in 
the experimental trials. Respiratory measures of oxygen consumption ( 2OV
 ) and carbon dioxide 
production ( 2COV
 ) were assessed using an online gas analysis system (Oxycon Pro, Jaeger). Heart 
rate (HR) was measured continuously (Polar S625X; Polar Electro Oy, Kempele, Finland). 2OV
 was 
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considered to be maximal if 2 of the 3 following conditions were met: 1) a levelling off of ( 2OV
 ) with 
further increasing workloads; 2) a HR within 10 beats/minutes of the age predicted maximum (220 
bpm - age); and 3) a respiratory exchange ratio of >1. 
2.3.1.3 Experimental Design 
The study was designed as a  placebo-controlled, double-blind, randomized, parallel study. Subjects in 
the assigned groups consumed either a GTE drink (1200 mg catechins, 240 mg caffeine) or a PLA 
drink for seven days (Figure 2.1). On day 0 (D0), all participants arrived at the Human Performance 
Lab between 0600 and 0800 following a 10 hour overnight fast and 24 hour controlled diet on D0. 
Upon arrival a flexible 20-gauge Teflon catheter (Venflon; Becton Dickinson, Plymouth, United 
Kingdom) was then inserted into an antecubital vein. A 3-way stopcock (PVB Medizintechnik, 
Kirchseean, Germany) was attached to the catheter to allow repeated blood sampling during the trial. 
A resting blood sample (5 mL) was taken (t=0 min). Participants then rested for 2 hours in a seated 
position. At the end of the rest period a second resting blood sample (5 mL) was taken (t=120 min). 
Following this, participants began cycling at 50% Wmax for 60 minutes. Throughout the exercise blood 
samples (5 mL) were taken at t=140, 150, 160, 180 minutes (Figure 2.1). The catheter was kept patent 
by flushing it with 3-4 mL isotonic saline (0.9%; Baxter, Norfolk, United Kingdom) after each blood 
sample. The experimental trial was then repeated 8 days later. The only difference in the trials on D0 
and D8 was the consumption of a single bolus of GTE (600 mg catechins, 120 mg caffeine) or PLA 
after the collection of the resting blood sample and prior to the resting period. 
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Figure. 2.1. Study design schematic 
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2.3.1.4 Diet and Supplement 
 After the initial trial, participants were randomly assigned to either ingest GTE or PLA for 7 days 
(Figure 2.1). The GTE and PLA supplements were provided in the form of a drink. Each drink was 
provided in a 330 mL can. The GTE (Taiyo International, Japan) and PLA compositions are displayed 
in Table 2.1. 
Table 2.1. Content of the GTE and PLA drink   
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: GC, gallocatechin; EGC, epigallocatechin; C, catechin; EC, epicatechin; EGCG, 
epigallocatechin gallate; GCG, gallocatechingallate; ECG, epicatechingallate; GC, gallocatechin.  
 
 
  Treatment GTE PLA 
mg /  
330 mL can 
Caffeine 120.4 10 
GC 55.1 0 
EGC 5.5 0 
C 181.1 0 
EC 47 0 
EGCG 207.5 0 
GCG 31 0 
ECG 25.6 0 
GC 0 0 
Total mg / 330 
mL can 
Catechins 559 0 
Caffeine 120.4 10 
Total mg   
/ day 
Catechins 1119 0 
Caffeine 240.8 20 
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Participants were instructed to consume two drinks per day, one drink an hour prior to breakfast and 
another drink an hour prior to dinner. The supplementation period started on the day following the pre-
supplementation trial. Subjects received daily reminders in the form of text messages in the morning 
and the evening to ensure compliance. Participants returned to the human performance lab on D8 
having consumed the drinks for 7 days. The 24 hour period prior to D0 trial participants were asked to 
record a food diary which was replicated prior to D8 trial.  
2.3.1.5 Sample collection 
All blood samples were stored on ice for no longer than 35 minutes. Subsequently, plasma was 
separated by centrifugation (1500xg, 10 minutes, 4°C), aliquoted in 1 mL samples and stored at -80°C. 
2.3.2 Data acquisition  
2.3.2.1 Metabolite Profiling  
Four-phase metabolite profiling and quantification of catecholamines (Figure 2.2) were performed on 
human plasma samples at Metanomics Health GmbH, Berlin, Germany. Three types of mass 
spectrometry analyses were applied. GC-MS (gas chromatography-mass spectrometry; Agilent 6890 
GC coupled to an Agilent 5973 MS-System, Agilent, Waldbronn, Germany) and LC-MS/MS (liquid 
chromatography-MS/MS; Agilent 1100 HPLC-System (Agilent, Waldbronn, Germany) coupled to an 
Applied Biosystems API4000 MS/MS-System (Applied Biosystems, Darmstadt, Germany)) were used 
for broad profiling, as described by van Ravenzwaay et al. [24]. SPE-LC-MS/MS (solid phase 
extraction-LC-MS/MS; Symbiosis Pharma (Spark, Emmen, Netherlands) coupled to an Applied 
Biosystems API4000 MS/MS-System (Applied Biosystems, Darmstadt, Germany)) was used for the 
determination of catecholamine concentrations. 228 metabolites fulfilled the quality criteria for 
relative quantification, and absolute quantification was performed for an additional 10 metabolites. 
From a total of 238 metabolites, 163 were known metabolites and 75 were not chemically identified 
with sufficient certainty (i.e. thus considered in the present study to be unknown analytes).  
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Technical reference samples were measured in parallel with the study samples in order to allow the 
relative quantification of metabolites in the study samples. These technical reference samples were 
generated by pooling aliquots of plasma from all study samples. A relative quantification for each 
metabolite was obtained by normalizing peak intensity in the study samples to the median peak 
intensity of the corresponding metabolite in the technical reference samples measured in the same 
batch. The relative quantification were log-transformed before ANOVA analysis and were back 
transformed (10^x) to obtain the ratios that are presented in the tables below.   
Figure 2.2. Sample workflow: 4 phases profiling and platform of catecholamines  
 
 
2.3.3 Metabolite Profiling by GC-MS and LC-MS/MS  
Proteins were removed from plasma samples (60 µl) by precipitation. Subsequently polar and non-
polar plasma fractions were separated for both GC-MS and LC-MS/MS analysis by adding water and 
a mixture of ethanol and dichloromethane. For GC-MS analyses, the non-polar fraction was treated 
with methanol under acidic conditions to yield the fatty acid methyl esters derived from both free fatty 
acids and hydrolyzed complex lipids. The polar and non-polar fractions were further derivatized with 
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O-methyl-hydroxyamine hydrochloride (20 mg/mL in pyridine, 50 µL) to convert oxo-groups to O-
methyloximes and subsequently with a silylating agent (MSTFA, 50 µl) before GC-MS analysis [25]. 
For LC-MS/MS analyses, both fractions were reconstituted in appropriate solvent mixtures. High 
performance LC (HPLC) was performed by gradient elution using methanol/water/formic acid on 
reversed phase separation columns. Mass spectrometric detection technology was applied as described 
in the patent US 7196323, which allows targeted and high sensitivity “Multiple Reaction Monitoring” 
profiling in parallel to a full screen analysis. 
For the lipid phase, the broad profiling technology determines e.g. fatty acid concentrations after 
acid/methanol treatment which is essential for derivatization preceding GC-MS analysis. As a 
consequence, complex lipids are hydrolyzed to components of the lipid backbone (i.e. glycerol) and 
fatty acids. Hence, the concentration of a fatty acid determined by this procedure represents the sum of 
its occurrence in free and in lipid-bound form. Components of the backbone can be recognized by the 
term (“lipid fraction “) added to the metabolite name. As an example “glycerol, lipid fraction” 
represents glycerol liberated from complex lipids – in contrast, “glycerol, polar fraction” represents 
glycerol which had been present originally in the biological sample. The use of “additional” indicates 
that quantification can be affected by the co-occurrence of metabolites exhibiting identical 
characteristics in the analytical methods. Literature data and/or comparison with alternative methods 
(e.g. LC-MS/MS, GC-MS) suggest that such metabolites are present at minor concentrations only. 
Quantification of catecholamines  
Catecholamines and their related metabolites were measured by online SPE-LC-MS/MS, as described 
by Yamada et al. [26]. Quantification was performed using stable isotope-labelled standards.  
2.3.4 Data analysis 
The data set comprised profiles from 318 plasma samples that were analyzed both using multivariate 
and univariate statistical methods. (Six samples were not considered due to labelling errors.) 
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Multivariate analysis 
Multivariate analysis including PCA [principal component analysis] and PLS-DA [partial least 
squares/projection to latent structures-discriminant analysis] was performed using SIMCA P+ version 
12 software (Umetrics, Umea, Sweden). One subject was completely excluded from the analysis due 
to abnormal metabolite profiles. For another subject, one specific time point (D0, t=160 min) was 
discarded. All metabolite data were log-transformed to better match normal distribution. Data were 
further centred and scaled to unit variance. Scaling to unit variance introduces a common scale for all 
metabolites independent on their absolute amount of variance. Thereby, the resulting models obtain 
robustness, i.e., they cannot be dominated by a single or few high-variance metabolites. The 
explorative unsupervised multivariate analysis method PCA was used for the detection of trends, 
patterns and groupings among samples and variables. The supervised projection method PLS-DA was 
used to display the maximum co-variance of metabolic data with a defined Y variable (class, 
categorical) in the dataset. The cross-validated cumulative Q
2
 value was used as a measure of the 
predictive value of the PLS-DA model. A Q
2
 value of 1 indicates maximum predictive power, whereas 
Q
2
 values close to or below 0 indicate a lack of predictive power. As a rule of thumb, models with 
Q
2
cum > 50% are considered to be of good predictive power in this context. To account for the fact that 
several samples for each subject were analyzed, cross-validation was performed by the leave-on-
subject out method. This ensured that cross-validation was not inappropriately facilitated by the 
presence of related samples (here: different time point from the same subject) in the test dataset given 
the usually lower intra-individual variability compared to inter-individual variability.  
Univariate analysis 
ANOVA analysis was performed using R-software package nlme [27,28]. Treatment factors “UNT” 
comprised all samples on D0, “GTE” all samples collected on D8 from subjects consuming GTE, and 
“PLA” all samples collected on D8 from subjects consuming placebo, respectively. The ANOVA 
mixed-effects model included the categorical fixed effects factors “treatment” (UNT, PLA, GTE) and 
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“time” (0, 120, 140, 150, 160, 180) and their interaction and random intercept effects for “day” and 
“subject”. The combination of the binary factors “day” (0, 8) and the ternary factor “treatment” (UNT, 
GTE, PLA) allowed for setting up the following mixed-effects model without third-order interactions. 
The model specification (in R notation) was: 
Fixed effects:  metabolite ~ (treatment + time)^2, 
Random effects:  metabolite ~1 | day / subject. 
The correlation between samples of the same subject at different times was handled by a model of type 
AR(p=1) = ARMA(p=1,q=0) with equidistant time steps time.int (1,2,…6). All study-relevant 
contrasts were readout in the form of treatment contrasts by selecting different factor reference levels. 
The t-statistics results of the ANOVA models comprised estimates, standard deviations, t-values, and 
p-values. Model diagnostics were conducted in four ways to ensure adequateness of model structure: 
(a) Residuals were inspected visually by scatter plots of standardized residuals versus fitted values: 
generally, residuals did not correlate with fitted values and showed homogenous variance. (b) Random 
subject intercepts were tested by t-Test comparing the two study arms GTE and PLA on D0. The 
number of significant metabolites was on false positive level. (c) Random day effects were negligible 
relative to other variance components. Accordingly, they do not influence other effect estimates. (Note 
that the random day effect was introduced only due to technical/algorithmic reasons.) (d) The AR(1) 
correlation coefficient (“phi”) was found to vary in a reasonable range with mean 0,14 and 
interquartile range from P25%=0.03 to P75%=0.24. The t-statistics results of significantly changed 
metabolites are summarized in a colour coded format in the tables. The resulting numbers of 
significantly changed metabolites were evaluated by binominial test to account for false positives due 
to multiple hypotheses testing (data not shown). 
2.4 Results 
The 4-phases metabolite profiling using both GC-MS and LC-MS/MS (Figure 2.2) comprised in total 
of 238 metabolites including 32 amino acids and amino acid derivatives, 11 carbohydrates and related 
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metabolites, 10 metabolites related to energy metabolism, 3 nucleobases and related metabolites, 10 
vitamin cofactors and related metabolites, 12 miscellaneous metabolites, 73 complex lipids, fatty acids 
and related metabolites, and 75 unknown analytes. In addition, 10 catecholamines and other 
monoamines were in most instances quantitatively measured using a targeted profiling method.  
Initially, multivariate statistics (PCA and PLS-DA) was performed to identify outliers and to get a 
general idea on the variability of the data. PLS-DA clearly discriminated between exercise and resting 
conditions (Q
2
cum=80.5%). Furthermore, a clear separation was observed between pre- and post–GTE-
supplementation. (Q
2
cum=51.5% including all time points; Q
2
cum=49.2% including time points 140-180 
min and subjects of the GTE study arm). Other models discriminating between the GTE and the PLA 
interventions under resting and exercise conditions, respectively, were not significant indicating that 
inter-individual differences might dominate the discrimination over treatment and/or exercise. Based 
on this overall impression, a univariate ANOVA mixed-effects model was calculated and clearly 
identified statistically significant changes in individual metabolites that could be attributed to the 
effect induced by exercise or the GTE supplement. 
2.4.1 Effect of exercise on human metabolism 
Table 2.2 illustrates the metabolite changes induced by moderate intensity exercise in all subjects pre-
supplementation (UNT). The changes during exercise (140, 150, 160, 180 min) were compared to 
resting conditions at the end of the two hour rest period (120 min). They comprised of increases in 
indicators of glycolysis (lactate and pyruvate), indicators of lipolysis (glycerol), TCA cycle 
intermediates (citrate, fumarate, malate, succinate), indicators of adenine catabolism (uric acid), 
accelerated protein synthesis (uridine, pseudouridine), indicators of hormonal acitivity (cortisol, 
dehyroepinandrosterone sulfate), catecholamines (DOPAC, DOPA, DOPEG, HMPG, 5-HIAA, HVA, 
noradrenaline), vitamins and related metabolites (4-pyridoxic acid, panthenic acid, cryptoxanthin), 
certain fatty acids (e.g. arachidonic acid, linoleic acid), certain phospholidids (e.g. choline 
plasmalogen, lysophosphatidylcholine (C18:0)), certain sphingolipids (e.g. ceramide (C18:1,C24:0),  
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Table 2.2. ANOVA estimate for effect of exercise on metabolome derived from data from pre-
supplementation (UNT).  
 
Data presented here is the relative concentration expressed as ratios. This data was log transformed prior to ANOVA statistical analysis.  
Colour coding: ratio > 1 & p-value < 0.01 () ratio > 1 & 0.01 ≤ p-value < 0.05 () ratio > 1 & 0.05 ≤ p-value < 0.10 () ratio < 1 & 0.05 ≤ 
p-value < 0.10 () ratio < 1 &  0.01 ≤ p-value < 0.05 () ratio < 1 & p-value < 0.01 () Font coding: black & bold: ( ratio < 0.5 ) or ( ratio 
>2) black & normal: ( 0.5 ≤ ratio <  0.9 ) or ( 1.1 < ratio ≤ 2 ) black & italic: 0.9 ≤ ratio ≤ 1.1. 
 
  
                                                           time / min
METABOLITE
140 
vs 
120
150 
vs 
120
160 
vs 
120
180 
vs 
120
Alanine 1.30 1.33 1.37 1.33
Cysteine (additional: Cystine) 1.07 1.06 1.10 1.11
Methionine 1.05 1.03 1.08 1.12
Phenylalanine 1.05 1.06 1.07 1.11
Tyrosine 1.04 1.05 1.07 1.13
4-Hydroxyphenylpyruvate 1.15 1.20 1.27 1.30
Ketoleucine 1.27 1.23 1.18 1.18
trans-4-Hydroxyproline 0.91 0.89 0.89 0.87
Urea 0.99 1.07 1.02 1.08
Erythrol 1.09 1.08 1.12 1.16
Glucosamine 1.16 1.12 1.12 1.18
Glucose 1.04 1.02 1.04 1.02
Mannosamine 1.14 1.12 1.17 1.17
Mannose 0.94 0.82 0.77 0.70
myo-Inositol 1.04 1.03 1.08 1.12
Sucrose 0.90 0.72 0.87 0.81
Cholestenol No 02 1.04 1.06 1.04 1.00
Cholesterol, total 1.06 1.07 1.05 1.04
Cholesterylester C16:0 1.10 0.97 1.01 1.00
Cholesterylester C18:1 1.02 1.10 1.10 1.09
Cholesterylester C18:2 1.03 1.09 1.07 1.12
Cholesterylester C20:4 1.02 1.04 1.02 1.08
Glycerol, lipid fraction 1.00 0.96 0.94 0.93
Pentadecanol 1.02 1.02 1.13 1.13
Taurochenodeoxycholic acid  
(additional: Taurodeoxycholic acid) 1.25 1.67 1.14 0.96
Arachidonic acid (C20:cis[5,8,11,14]4) 1.08 1.05 1.04 1.04
Behenic acid (C22:0) 1.08 1.04 1.05 1.02
conjugated Linoleic acid (C18:trans[9,11]2) 
(add.: conjugated Linoleic acid (C18:cis[9]trans[11]2)) 1.06 1.07 1.08 1.07
dihomo-gamma-Linolenic acid 1.09 1.07 1.08 1.04
Docosahexaenoic acid (C22:cis[4,7,10,13,16,19]6) 1.09 1.05 1.04 1.05
Eicosapentaenoic acid (C20:cis[5,8,11,14,17]5) 1.08 1.04 1.01 1.01
gamma-Linolenic acid (C18:cis[6,9,12]3) 1.08 1.04 1.06 1.03
Isopalmitic acid (C16:0) 1.06 1.05 1.04 1.03
Lignoceric acid (C24:0) 1.05 1.01 1.03 1.03
Linoleic acid (C18:cis[9,12]2) 1.06 1.04 1.04 1.02
Myristic acid (C14:0) 1.05 1.06 1.09 1.17
Nervonic acid (C24:cis[15]1) 1.09 1.03 1.06 1.04
Palmitic acid (C16:0) 1.04 1.03 1.04 1.04
Palmitoleic acid (C16:cis[9]1) 1.06 1.06 1.07 1.10
Stearic acid (C18:0) 1.03 1.02 1.01 1.02
Tricosanoic acid (C23:0) 1.10 1.06 1.05 1.03
DAG (C18:1,C18:2) 1.09 1.09 1.10 1.12
TAG (C16:0,C16:1) 0.98 0.89 0.88 0.89
TAG (C16:0,C18:2) 0.97 0.91 0.93 0.93
TAG (C18:1,C18:2) 0.95 0.89 0.93 0.90
TAG (C18:2,C18:2) 0.98 0.97 0.97 0.93
Galactose, lipid fraction 1.09 1.04 1.07 1.05
Glucose, lipid fraction 1.20 1.15 1.26 1.10
myo-Inositol, lipid fraction 1.05 1.06 1.05 1.05
Cortisol 1.11 1.11 1.06 1.10
Dehydroepiandrosterone sulfate
(additional:Testosterone-17-sulfate ) 1.18 1.10 1.14 1.20
Pseudouridine 1.02 1.05 1.03 1.08
Uric acid 1.03 1.03 1.07 1.07
Uridine 1.04 1.04 1.09 1.10
                                                           time / min
METABOLITE
140 
vs 
120
150 
vs 
120
160 
vs 
120
180 
vs 
120
Choline plasmalogen (C18,C20:4) 1.05 1.03 1.05 1.03
Glycerol phosphate, lipid fraction 1.11 1.08 1.06 1.01
Lysophosphatidylcholine (C18:0) 1.13 1.07 1.02 1.02
Lysophosphatidylcholine (C18:1) 0.98 0.95 0.99 0.90
Lysophosphatidylcholine (C18:2) 1.02 1.00 1.03 0.92
Lysophosphatidylcholine (C20:4) 0.99 0.97 0.94 0.91
Phosphatidylcholine (C16:0,C16:0) 1.04 1.04 1.02 1.03
Phosphatidylcholine (C16:1,C18:2) 1.01 1.03 1.06 1.03
Phosphatidylcholine (C18:0,C18:1) 1.02 1.02 1.01 1.00
Phosphatidylcholine (C18:0,C18:2) 0.99 1.00 0.99 1.00
Phosphatidylcholine (C18:0,C20:4) 1.00 1.00 1.01 1.01
Phosphatidylcholine (C18:0,C22:6) 1.04 1.03 1.02 1.03
Phosphatidylcholine (C18:2,C20:4)
(additional: Phosphatidylcholine (C16:0,C22:6)) 1.00 1.00 1.01 1.00
1-Hydroxy-2-amino-(cis,trans)-3,5-
octadecadiene (from sphingolipids) 1.11 1.08 1.03 1.06
3-O-Methylsphingosine (add.: Sphingolipids, 
erythro-Sphingosine, threo-Sphingosine) 1.13 1.09 1.03 1.06
5-O-Methylsphingosine  (add.: Sphingolipids, 
erythro-Sphingosine, threo-Sphingosine) 1.12 1.07 1.03 1.09
Ceramide (d18:1,C24:0) 1.11 1.07 1.05 1.05
Ceramide (d18:1,C24:1) 
(additional: Ceramide (d18:2,C24:0)) 1.14 1.06 1.11 1.07
erythro-C16-Sphingosine 1.09 1.07 0.96 1.03
erythro-Dihydrosphingosine 1.10 1.06 1.02 1.05
erythro-Sphingosine
(additional: Sphingolipids) 1.10 1.07 1.03 1.06
Sphingomyelin (d18:1,C16:0) 1.06 1.05 1.08 1.11
Sphingomyelin (d18:1,C24:0) 1.05 1.02 1.04 0.99
threo-Sphingosine (additional: Sphingolipids) 1.11 1.07 1.04 1.07
2-Hydroxybutyrate 0.81 0.75 0.72 0.74
3-Hydroxybutyrate 0.84 0.95 1.14 1.54
Citrate (additional: Isocitrate) 0.98 1.02 1.09 1.14
Fumarate 1.17 1.20 1.17 1.14
Lactate 2.73 2.52 2.46 2.06
Malate 1.85 1.89 1.84 1.79
Pyruvate (additional: Phosphoenolpyruvate (PEP)) 2.29 2.22 2.32 2.24
Succinate 2.08 2.16 2.33 2.32
3,4-Dihydroxyphenylacetic acid (DOPAC) 1.10 1.21 1.24 1.40
3,4-Dihydroxyphenylalanine (DOPA) 1.05 1.11 1.12 1.14
3,4-Dihydroxyphenylglycol (DOPEG) 1.32 1.53 1.61 1.81
4-Hydroxy-3-methoxyphenylglycol (HMPG) 1.05 1.17 1.26 1.49
5-Hydroxy-3-indoleacetic acid (5-HIAA) 1.05 1.09 1.11 1.16
Homovanillic acid (HVA) 1.09 1.17 1.25 1.43
Noradrenaline (Norepinephrine) 2.61 2.81 2.82 3.09
Serotonin (5-HT) 1.16 0.96 1.20 1.49
Canthaxanthin 1.03 1.11 1.11 1.29
Creatine 1.08 1.12 1.17 1.26
Cryptoxanthin 1.13 1.07 1.09 1.06
Glycerol, polar fraction 1.44 1.62 1.79 2.24
Hippuric acid 1.17 1.21 1.30 1.28
Phosphocreatine 0.86 0.92 0.77 0.87
Taurine 1.04 1.04 1.13 1.20
4-Pyridoxic acid 1.11 1.11 1.18 1.20
alpha-Tocopherol 1.06 1.00 0.98 1.02
Coenzyme Q10 1.07 0.99 1.01 0.99
Nicotinamide 0.78 0.77 0.77 0.81
Pantothenic acid 1.31 1.27 1.35 1.37
Threonic acid 1.07 1.06 1.05 1.14
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erthro-sphingosine), certain cholesterylester (e.g. cholesterylester C18:2), several amino acids 
(alanine, cysteine, methionine, phenylalanine, tyrosine), and miscellaneous metabolites (creatine, 
taurine, hippuric acid). Only a small number of these metabolites increased considerably during  
exercise with a ratio > 2 (Table 2.2). These included lactate, pyruvate, succinate, noradrenaline, and 
glycerol. On the other hand, some metabolites were reduced during exercise, such as 2-
hydroxybutyrate, trans-4-hydroxyproline, mannose, certain triacylglycerides (TG) and nicotinamide. 
The onset of exercise caused a significant reduction in 3-hydroxybutyrate, followed by a subsequent 
increase towards the end of exercise indicating an initial increase in fat oxidation at the onset of 
exercise with a delay in fatty acid mobilisation and availability late throughout exercise. The onset of 
exercise also increased the levels of certain fatty acids and sphingolipids. Other metabolites such as 
pseudourine, uric acid, uridine, taurine, serotonin, and certain cholesterylesters only showed changes 
towards the end of exercise. 
2.4.2 Effect of GTE under resting condition  
The effect of GTE under resting conditions was assessed by comparing the metabolite profiles from 
post-GTE-supplementation (GTE–D8) versus pre-supplementation (UNT– D0) and from post-GTE-
supplementation (GTE –D8) versus post-PLA-supplementation (PLA–D8). As a control, the profiles 
from post-PLA-supplementation (PLA–D8) were compared to pre-supplementation (UNT–D0) (Table 
2.3). To assess the impact of 7-days supplementation of GTE under resting fasted conditions only the 
profiles recorded at time point 0 on each intervention day were taken into account.  
Caffeine, hippuric acid, homovanillic acid and 3,4-dihydroxyphenylacetate were elevated post-GTE-
supplementation. Caffeine was present in the GTE supplement and hence the presence of caffeine in 
plasma on D8 was considered as a measure of compliance. The relative concentrations of caffeine are 
displayed in Figure 2.3. The appearance of hippuric acid, homovanillic acid and 3,4-
dihydroxyphenylacetate are known metabolites from gut-microbial degradation of polyphenols [29]. 
Besides these exogenous effects, GTE induced reductions in di- and triacylglycerides (DAG, TAG), 
certain fatty acids, certain phosphatidylcholines, alanine, tryptophan, creatine, urea, serotonin, and 5-
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hydroxy-3-indoleactetic acid (5-HIAA). Higher concentrations were observed for certain 
cholesterylesters, 3-hydyroxybutyrate, citrate, lactaldehyde, and glycerol (Figure 2.4). 
Table 2.3. ANOVA estimate for effect of GTE on metabolome under fasting and resting 
condition.  
 
Data presented here is the relative concentration expressed as ratios. This data was log transformed prior to ANOVA statistical analysis.  
Colour coding: ratio > 1 & p-value < 0.01 () ratio > 1 & 0.01 ≤ p-value < 0.05 () ratio > 1 & 0.05 ≤ p-value < 0.10 () ratio < 1 & 0.05 ≤ 
p-value < 0.10 () ratio < 1 &  0.01 ≤ p-value < 0.05 () ratio < 1 & p-value < 0.01 () Font coding: black & bold: ( ratio < 0.5 ) or ( ratio 
>2) black & normal: ( 0.5 ≤ ratio <  0.9 ) or ( 1.1 < ratio ≤ 2 ) black & italic: 0.9 ≤ ratio ≤ 1.1. 
 
 
METABOLITE
PLA-D8     
vs      
UNT-D0
GTE-D8     
vs        
UNT-D0
GTE-D8      
vs           
PLA-D8
Alanine 1.10 0.93 0.85
Asparagine 1.10 1.01 0.91
Threonine 1.09 1.00 0.92
Tryptophan 1.04 0.93 0.89
Ketoleucine 0.88 0.97 1.11
Urea 1.00 0.82 0.81
Cholesterylester C18:1 0.93 1.13 1.22
Cholesterylester C18:2 0.91 1.13 1.24
Cholesterylester C20:4 0.95 1.11 1.17
Glycerol, lipid fraction 1.15 0.87 0.76
Pentadecanol 1.06 0.88 0.84
Docosahexaenoic acid (C22:cis[4,7,10,13,16,19]6) 1.14 0.83 0.73
Eicosapentaenoic acid (C20:cis[5,8,11,14,17]5) 1.31 0.84 0.64
Isopalmitic acid (C16:0) 1.13 0.92 0.81
Myristic acid (C14:0) 1.23 1.04 0.85
DAG (C18:1,C18:2) 1.06 0.88 0.83
TAG (C16:0,C16:1) 1.27 0.87 0.69
TAG (C16:0,C18:2) 1.13 0.88 0.78
TAG (C18:2,C18:2) 1.09 0.82 0.75
TAG (C18:2,C18:3) 1.26 0.68 0.54
Phosphatidylcholine (C18:0,C22:6) 1.05 0.87 0.82
Phosphatidylcholine No 02 1.06 0.94 0.88
Sphingomyelin (d18:1,C16:0) 0.91 1.07 1.18
3-Hydroxybutyrate 0.74 1.63 2.21
Citrate (additional: Isocitrate) 1.02 1.22 1.20
Lactaldehyde 0.93 1.13 1.22
3,4-Dihydroxyphenylacetic acid (DOPAC) 1.20 1.61 1.34
5-Hydroxy-3-indoleacetic acid (5-HIAA) 1.09 0.95 0.87
Homovanillic acid (HVA) 1.07 1.50 1.41
Serotonin (5-HT) 1.39 0.73 0.52
Caffeine 1.45 5.64 3.88
Creatine 1.12 0.86 0.77
Glycerol, polar fraction 0.82 1.11 1.36
Hippuric acid 0.80 1.64 2.04
Ascorbic acid (additional: Glucose) 1.13 1.03 0.91
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2.4.3 Effect of GTE during exercise 
The ANOVA mixed-effects model segregated the effects induced by GTE or PLA during exercise from those 
induced by exercise alone. Table 2.4 lists the metabolite changes solely caused by GTE or PLA during exercise. 
The following comparisons were made: Post-GTE-supplementation (GTE–D8) versus pre-supplementation 
(UNT–D0), post-GTE-supplementation (GTE–D8) versus post-PLA- supplementation (PLA–D8), and - as a 
control - post-PLA-supplementation (PLA–D8) versus pre-supplementation (UNT–D0) The effects of GTE or 
PLA during exercise were assessed after 20, 30, 40 and 60 minutes of exercise. The data were normalized to the 
end of the 2 hour rest period (t= 120 min) (Figure 2.1) to focus on the effects induced during exercise and to 
eliminate any effects that accounted for resting conditions and were apparent in shifts in baseline levels at time 
points 0 and 120 min. Our study design included the 7 days (chronic) supplementation as well as the single bolus 
(acute) intake of either GTE or PLA on D8. It is thought that 7 days GTE supplementation would mostly affect 
plasma metabolites that were measured under resting conditions at time point 0, whereas the single bolus intake 
prior to the trial on D8 would determine the effects during exercise. The reason for this is that the main 
components of GTE would have accumulated in plasma after the two hours of rest [29]. Thus, by normalizing 
the metabolite changes to the end of the 2 hour rest period (120 min), the effects during exercise may at first 
instance be ascribed to the main components in GTE boosted by the single bolus intake. Overall, the metabolite 
changes induced by GTE during exercise were weaker than the effects induced by exercise itself. Nevertheless, 
significant metabolite changes were observed both when comparing the effect of GTE – D8 versus UNT – D0 
and the effect of GTE – D8  versus PLA – D8 (Table 2.4). These changes comprised of the increase in alanine, 
cysteine, histidine, certain cholesterylesters, lactate, malate, pyruvate, hippurate, and phosphocreatine. In 
addition, reductions in 3-hydroxybutyrate, certain fatty acids, certain TAGs, and DOPEG were 
apparent during exercise (Figure 2.4). Other changes could not fully be attributed to the GTE 
supplementation. These may be due to day-to-day variations or the PLA supplementation. For 
example, glycerol, glutamate, TAG (C16:0,C16:1), noradrenaline, serotonin and taurine were reduced 
in GTE – D8 when compared to PLA – D8. However, these changes were not seen when comparing 
GTE - D8 versus UNT – D0. On the other hand, these changes were increased when comparing the 
effect of PLA – D8 versus UNT – D0.  
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Figure 2.3 Relative concentrations of caffeine 
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                                                          time / min
METABOLITE
140 
vs 
120
150 
vs 
120 
160 
vs 
120 
180 
vs 
120
140 
vs 
120
150 
vs 
120
160 
vs 
120
180 
vs 
120
140 
vs 
120
150 
vs 
120
160 
vs 
120
180 
vs 
120 
Alanine 0.97 1.00 0.94 0.97 1.12 1.14 1.11 1.18 1.16 1.14 1.19 1.22
Aspartate 1.15 1.18 1.26 1.36 1.17 1.13 1.44 1.22 1.02 0.96 1.14 0.90
Cysteine (additional: Cystine) 1.00 1.00 0.95 0.94 1.16 1.13 1.07 1.10 1.16 1.14 1.13 1.17
Glutamate 1.13 1.26 1.08 1.21 0.94 1.02 0.85 0.93 0.83 0.81 0.79 0.77
Histidine 0.95 0.99 0.98 0.97 1.08 1.07 1.08 1.09 1.14 1.09 1.10 1.12
Urea 0.97 0.86 0.89 0.86 1.02 0.88 0.95 0.88 1.05 1.03 1.07 1.02
Sucrose 1.71 1.36 1.48 1.75 1.51 1.75 1.24 1.12 0.88 1.29 0.84 0.64
Cholesterylester C18:2 1.00 1.04 1.00 0.93 1.06 1.04 1.06 1.05 1.05 1.00 1.07 1.13
Cholesterylester C20:4 0.96 0.97 0.98 0.95 1.00 1.00 1.06 1.03 1.03 1.03 1.08 1.09
conjugated Linoleic acid (C18:trans[9,11]2) 
(add.: conjugated Linoleic acid (C18:cis[9]trans[11]2)) 0.93 0.97 0.98 0.95 0.91 0.93 0.91 0.96 0.98 0.96 0.93 1.01
dihomo-gamma-Linolenic acid (C20:cis[8,11,14]3) 0.93 0.97 0.96 0.98 0.95 0.98 0.94 0.99 1.03 1.01 0.99 1.01
Eicosanoic acid (C20:0) 1.02 1.09 1.07 1.09 1.01 1.06 0.98 1.08 0.99 0.97 0.92 0.99
gamma-Linolenic acid (C18:cis[6,9,12]3) 0.89 0.91 0.92 0.88 0.94 0.98 0.91 0.98 1.05 1.09 0.99 1.11
Heptadecanoic acid (C17:0) 0.98 1.08 1.10 1.03 0.96 0.97 0.99 0.92 0.99 0.90 0.90 0.89
Linoleic acid (C18:cis[9,12]2) 0.98 0.98 1.01 1.01 0.95 0.95 0.93 0.99 0.97 0.97 0.92 0.98
Myristic acid (C14:0) 0.95 0.99 1.02 0.93 0.89 0.95 0.91 0.93 0.94 0.96 0.89 1.00
Oleic acid (C18:cis[9]1) 0.99 1.01 1.04 1.02 0.92 0.93 0.92 0.98 0.93 0.93 0.89 0.97
Palmitic acid (C16:0) 0.98 0.99 1.02 1.01 0.94 0.96 0.93 0.99 0.96 0.97 0.91 0.98
Palmitoleic acid (C16:cis[9]1) 0.99 1.02 1.06 1.04 0.87 0.91 0.88 0.95 0.88 0.89 0.84 0.91
TAG (C16:0,C16:1) 1.09 1.19 1.14 1.15 0.98 1.02 0.96 0.97 0.90 0.86 0.84 0.85
TAG (C16:0,C18:2) 1.09 1.09 1.06 1.06 0.99 0.97 0.96 0.94 0.91 0.90 0.90 0.89
TAG (C18:2,C18:2) 1.01 1.04 1.07 1.02 0.96 0.91 0.92 0.94 0.95 0.88 0.86 0.91
TAG (C18:2,C18:3) 1.11 1.12 0.96 1.07 0.91 0.93 0.79 0.92 0.82 0.83 0.82 0.86
myo-Inositol, lipid fraction 0.96 0.96 0.95 0.94 0.94 0.95 0.91 0.92 0.99 0.99 0.96 0.98
Choline plasmalogen (C18,C20:4) 1.02 1.03 0.99 1.01 0.95 0.98 0.95 0.99 0.94 0.95 0.96 0.98
Lysophosphatidylcholine (C18:2) 0.98 0.95 0.87 0.95 0.96 0.91 0.87 0.88 0.98 0.96 1.00 0.93
Phosphatidylcholine (C16:0,C20:4)
(additional: Phosphatidylcholine (C18:2,C18:2)) 0.99 1.00 0.99 0.99 1.00 1.01 1.01 1.01 1.01 1.01 1.02 1.02
Phosphatidylcholine (C18:0,C20:4) 0.99 1.00 0.99 0.99 1.01 1.02 0.98 1.03 1.02 1.03 1.00 1.04
Phosphatidylcholine (C18:0,C22:6) 1.00 1.02 1.00 0.99 0.98 0.96 0.99 0.97 0.98 0.95 0.99 0.98
Phosphatidylcholine (C18:2,C20:4) 
(additional: Phosphatidylcholine (C16:0,C22:6)) 1.01 1.02 1.01 1.01 0.99 1.00 0.99 1.00 0.97 0.98 0.99 1.00
Phosphatidylcholine No 02 1.02 0.99 1.01 1.05 1.10 1.05 1.13 1.10 1.08 1.05 1.11 1.05
Ceramide (d18:1,C24:1)   
(additional: Ceramide (d18:2,C24:0)) 1.04 1.14 1.02 1.06 0.91 0.99 0.95 1.01 0.88 0.87 0.93 0.95
Sphingomyelin (d18:1,C16:0) 1.00 0.98 0.98 0.83 0.92 0.95 0.98 0.99 0.92 0.96 1.00 1.19
3-Hydroxybutyrate 1.08 1.18 1.11 1.06 0.77 0.73 0.73 0.69 0.71 0.62 0.66 0.65
Lactaldehyde 1.09 1.03 1.06 1.14 1.04 0.87 1.03 1.24 0.96 0.85 0.97 1.09
Lactate 1.03 1.11 1.03 1.10 1.38 1.54 1.45 1.39 1.34 1.39 1.41 1.26
Malate 1.02 1.07 1.11 1.21 1.15 1.21 1.40 1.26 1.12 1.12 1.26 1.04
Pyruvate (add.: Phosphoenolpyruvate (PEP)) 1.03 1.10 1.00 1.07 1.31 1.42 1.34 1.32 1.27 1.30 1.34 1.24
Succinate 0.93 1.03 0.90 0.99 1.15 1.12 1.07 1.03 1.23 1.09 1.18 1.03
3,4-Dihydroxyphenylglycol (DOPEG) 1.08 1.02 1.09 1.05 0.94 0.92 0.88 0.90 0.87 0.90 0.81 0.86
Noradrenaline (Norepinephrine) 1.09 1.16 1.27 1.31 1.02 1.06 1.12 1.00 0.93 0.92 0.88 0.77
Serotonin (5-HT) 1.11 2.12 1.42 2.86 0.75 0.86 0.88 0.83 0.67 0.41 0.62 0.29
Cortisol 1.16 1.22 1.14 1.08 0.94 0.94 0.96 1.03 0.81 0.77 0.84 0.96
Dehydroepiandrosterone sulfate 
(additional: Testosterone-17-sulfate) 0.99 1.04 1.05 1.05 0.85 0.87 0.81 0.97 0.85 0.84 0.78 0.93
Canthaxanthin 1.08 1.22 1.09 1.20 0.95 0.90 0.87 0.88 0.88 0.73 0.80 0.73
Glycerol, polar fraction 1.18 1.27 1.21 1.24 0.96 0.99 1.00 1.03 0.81 0.78 0.83 0.83
Hippuric acid 1.03 1.24 1.06 1.00 1.27 1.37 1.32 1.57 1.23 1.10 1.24 1.57
Phosphocreatine 0.85 0.71 1.17 0.93 1.43 1.24 1.51 1.34 1.68 1.75 1.29 1.44
Taurine 1.07 1.13 1.06 1.22 0.96 0.98 0.95 0.99 0.90 0.87 0.90 0.81
4-Pyridoxic acid 0.86 0.90 0.81 0.82 1.05 1.10 0.98 1.00 1.22 1.22 1.21 1.21
beta-Carotene 1.03 1.10 1.03 0.98 0.89 1.06 1.07 1.14 0.86 0.96 1.04 1.17
PLA-D8 vs UNT-D0 GTE-D8 vs UNT-D0 GTE-D8 vs PLA-D8
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Table 2.4. ANOVA estimate for effect of GTE on metabolome during exercise. 
Data presented here is the relative concentration expressed as ratios. This data was log transformed prior to ANOVA statistical analysis.  
Colour coding: ratio > 1 & p-value < 0.01 () ratio > 1 & 0.01 ≤ p-value < 0.05 () ratio > 1 & 0.05 ≤ p-value < 0.10 () ratio < 1 & 0.05 ≤ 
p-value < 0.10 () ratio < 1 &  0.01 ≤ p-value < 0.05 () ratio < 1 & p-value < 0.01 () Font coding: black & bold: ( ratio < 0.5 ) or ( ratio 
>2) black & normal: ( 0.5 ≤ ratio <  0.9 ) or ( 1.1 < ratio ≤ 2 ) black & italic: 0.9 ≤ ratio ≤ 1.1. 
 
2.5 Discussion 
By applying untargeted GC-MS- and LC-MS-based metabolite profiling to human plasma, we have 
been able to comprehensively investigate the metabolic responses following GTE supplementation at 
rest and during moderate intensity exercise. The main finding of the current study was that 7 days 
GTE supplementation resulted in different metabolic effects during rest and exercise when compared 
to PLA and UNT. In particular, GTE altered metabolite concentrations involved in the intermediary 
metabolism (Figure 2.4). At rest GTE induced metabolite changes indicative of enhanced lipolysis 
(increase in glycerol, reduction in TAGs, increased fat oxidation (increase in 3-hydroxybutyrate), 
activated TCA cycle (increase in citrate), reduced amino acid catabolism (reduction in urea and 
creatine), reduced Cori-cycle (reduction in alanine), and enhanced glycolysis (increase in 
lactaldehyde). These metabolite changes suggest that GTE has the potential to enhance aerobic energy 
and fat metabolism at rest. Metabolic effects related to oxidative energy metabolism have previously 
been observed using a 
1
H-NMR metabolic profiling in human urine following 2 days of GTE 
supplementation [30]. Our results are also in line with a number of studies that have demonstrated  
increases in whole body EE and fat oxidation during resting conditions following GTE 
supplementation [7,11,12]. However, a number of studies have reported no difference in FFA or 
glycerol concentrations despite changes in whole body measures of fat oxidation [13,31,32]. In the 
current study fat oxidation rates were not measured during the rest period. Therefore, it cannot finally 
be concluded whether the metabolite changes related to fat metabolism (glycerol or 3-
hydroxybutyrate) would have induced changes in fat oxidation.  
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Figure 2.4 Plasma metabolite concentrations of GTE versus PLA during rest (bar graph) and during exercise (line graph) illustrated as part of the 
intermediary metabolism.  Black circles and white circles represent GTE and PLA respectively. Data are means ± SD. The x-axis of the line graphs 
indicate time in minutes 
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In comparison, GTE supplementation resulted in contrasting effects during exercise. GTE caused 
metabolite changes that are associated with enhanced glycolysis (increase in pyruvate, lactate), 
enhanced Cori-cycle (increase in alanine), and decreased fat oxidation (reduction in 3-
hydyroxybutyrate) when compared to PLA and UNT. These changes suggest an enhancement in 
anaerobic energy metabolism. This result is somewhat unexpected, since several previous studies have 
reported that acute [15] and chronic [16] GTE supplementation have the ability to induce greater fat 
oxidation rates over and above that of exercise alone, potentially through stimulating lipolysis as 
illustrated by higher concentrations of glycerol [15]. In the current study no change in lipolytic 
metabolites (glycerol) were observed during exercise. This may be explained in part by the increase in 
lactate concentration considering that lactate is known to inhibit lipolysis and limit fat oxidation rates 
during exercise [33]. The high lactate concentrations were unexpected due to the moderate exercise 
intensity implemented in the study. The accumulation of pyruvate and lactate and the reduction in 3-
hydroxybutyrate indicate a lower pyruvate oxidation through acetyl-CoA (Figure 2.4). It is notable 
that we observed no difference in fat oxidation rates during exercise following GTE supplementation 
when compared to PLA and UNT (data not shown) suggesting that these metabolite changes were too 
weak to cause changes in physiological parameters.  
In the current study, we also used targeted profiling of catecholamines in order to elucidate whether 
GTE supplementation is able to stimulate the adrenergic system. Fat metabolism can be activated by 
stimulating the adrenergic response. Not surprisingly, in the present study exercise alone induced 
significant changes of 14 metabolites involved in the catecholamine metabolism. EGCG, a major 
catechin in GTE, has been suggested to directly inhibit COMT (catechol-O-methyltransferase) [18] an 
enzyme that is responsible for degrading catecholamines (NA and A). The current hypothesis is that 
degrading these catecholamines leads to attenuation of sympathetic nervous system (SNS) activity. 
The inhibition of COMT and thus reduced degradation of NA would result in an increase in EE, 
lipolysis and potentially an increase in fat oxidation [10]. A limited number of studies have shown that 
GTE supplementation increases catecholamine concentrations following acute GTE supplementation 
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[14,34,35]. However, the actual contribution of this mechanism to reported effects of GTE in humans 
remains unclear. In our study GTE did not increase NA and directly related metabolites either at rest 
or during exercise. This result suggests that GTE supplementation may not alter the activity of COMT 
and thus questions the efficacy of the widely referenced COMT mechanism in humans. Interestingly 
during the resting condition metabolites indicative of lipolysis were elevated, which may occur 
through a cascade of events activated by catecholamines of the adrenergic system [33]. However, 
since no differences in NA and A were observed also during resting conditions, this could suggest that 
GTE stimulated lipolysis via non-adrenergic mechanisms. The non-adrenergic mechanisms could 
include the up-regulation of lipid-metabolizing enzymes by NF-ĸB (29). Alternatively, augmented 
lipolysis may be explained by the action of caffeine rather than the effects of green tea catechins. 
Caffeine has been shown to stimulate lipolysis independent of changes in catecholamines [36] via 
antagonizing  adenosine receptors directly on adipocytes [37]. However, it is not known whether green 
tea catechins are able to elicit direct effects on adipose tissue similar to that of caffeine. 
This is the first study to directly compare the metabolic responses to GTE supplementation between 
resting and during moderate intensity exercise conditions. Significant differences in metabolic 
responses at rest and during exercise following GTE supplementation were observed. Similar results 
were observed in a previous study showing that the ingestion of capsinoids - which are non-pungent 
analogues of capsaicin (8-methyl-N-vanillyl-6-nonenamide) naturally present in sweet pepper - 
increased adrenergic activity and energy expenditure at rest but had little effect during exercise [38]. It 
could be argued that during exercise GTE was not potent enough to further enhance an already 
stimulated environment. In comparison, GTE may offer stimulatory effects to human metabolism 
under resting conditions. The apparent difference in the metabolic response at rest and during exercise 
may be rooted in differences between chronic and acute GTE supplementation. In the current study, 
the metabolic effects observed during rest can be largely attributed to the chronic effects of GTE (7 
days). In comparison the metabolic effects observed during exercise could be argued to be induced by 
the acute effects (single dose) post GTE supplementation. Thus, an increase in EE and fat oxidation 
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and their related metabolic effects may only be present after chronic GTE supplementation. Chronic 
supplementation may induce a progressive regulation of various proteins and enzymes at certain sites 
in the body resulting in a systemic shift on the endogenous metabolism after long-term 
supplementation. For example, chronic GTE supplementation (8-24 wk) has been demonstrated to 
alter the gene expression related to energy metabolism and lipid homeostasis in an animal model [39]. 
However, the authors acknowledge that while the study design is capable of detecting chronic effects 
(7 days) at rest, the metabolic effects during exercise are induced both by acute and chronic GTE 
supplementation combined. Therefore, future research is required to tease out the differential 
metabolic effects between acute and chronic GTE supplementation both at rest and during exercise.  
Alternatively, the apparent difference in the metabolic effects at rest and during exercise may be 
attributed to different bioactive components in GTE and/or the presence of caffeine known to be 
crucial factors ultimately influencing the rates of fat or carbohydrate oxidation [40]. The single dose of 
GTE or PLA consumed two hours before the exercise test during the post- supplementation trial 
increased the concentrations of directly absorbed components in GTE such as catechins, in particular 
EGCG, and caffeine (Figure 2.3) and may be responsible for the effects observed during exercise. In 
comparison, phenolic metabolites originating from gut microbial degradation of polyphenols usually 
only appear in circulation 3-4 hours after polyphenol consumption [29] and are unlikely to be 
responsible for  the effect during exercise. However, they could have contributed to the chronic effects 
observed at rest. Following 7-days GTE supplementation, some phenolic acids such as hippuric acid, 
homovanillic acid and 3,4-dihydroxyphenylacetic acid were increased in plasma at rest  due to the 
slow bioconversion of polyphenols by gut microbiota. Nutrient – gut microbiota interactions have 
previously been discussed to play an important role in polyphenol bioavailability, human obesity, and 
insulin resistance [41]. Further investigations are needed to assign acute and chronic effects to certain 
bioactive species in GTE and to specify the role of gut microbiota. 
The current study also illustrated novel metabolic responses of GTE at rest and during exercise. GTE 
induced reductions in metabolites from the tryptophan pathway (tryptophan, serotonin and 5-HIAA) at 
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rest and in 3,4-dihydroxyphenylglycol (DOPEG), serotonin and NA during exercise. DOPEG is 
known to inhibit the enzyme monoamine oxidase (MAO) causing the oxidative deamination of NA, 
serotonin, and other amines. Inhibition of this enzyme would lead to increasing concentrations of NA 
and serotonin. Yet these two metabolites were reduced at the end of the exercise period suggesting a 
complex relationship between DOPEG, NA and serotonin as observed in plasma. This data provides 
evidence that GTE is capable of altering activity of certain catecholamines. However, the underlying 
mechanisms as well as their relation to physiological outcomes remain to be elucidated.   
Finally, changes in certain TAG‟s and fatty acids were observed post-GTE- supplementation under 
resting and exercise conditions. This may suggest that GTE affects the response of exogenous and 
endogenous lipids. Manipulating lipids could be an interesting target for protecting against insulin 
resistance. Elevation in circulating lipids (DAG, TAG, FFA) has commonly been associated with 
impaired insulin-mediated glucose uptake [42,43] and elevated insulin resistance [44] usually 
coexisting with obesity and type 2 diabetes [45]. Exercise is one way of providing protection by 
having beneficial effects on glycaemic control [46] and by increasing utilisation of intramuscular 
lipids by reducing DAG and ceramides [47]. Recent evidence has shown that chronic GTE 
supplementation suppresses insulin resistance mainly in animal models [39,48] and improves insulin 
sensitivity in young physically active males [15]. However, the protective effects against insulin 
resistance with GTE in humans is currently not conclusive [49]. It is interesting to consider the 
possibility that GTE may provide additive protection against insulin resistance when combined with 
exercise, by increasing the turnover of intramuscular lipids rather than increasing storage of lipids 
associated with the metabolic syndrome.  
In summary, our comprehensive metabolite profiling approach broadened our understanding on the 
mode of action of exercise and GTE beyond the physiological outcomes. Moderate intensity exercise 
stimulated multiple metabolic pathways including lipolysis, glycolysis, as well as the activation of the 
TCA cycle and the adrenergic system. The metabolite changes induced by GTE were more subtle and 
affected fewer pathways when compared to those induced by exercise alone. In agreement with 
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previous studies, we illustrated that 7-days GTE supplementation mainly enhanced metabolites 
indicative of lipolysis and fat oxidation under resting conditions, when compared to PLA. This effect 
was not enhanced during exercise. This suggests that a single dose of GTE may not be potent enough 
to stimulate further the metabolism that was already up-regulated by exercise. Furthermore, GTE did 
not stimulate the adrenergic system during rest and exercise since no increase in NA and related 
catecholamines were observed. This challenges COMT inhibition as the putative mechanism of action 
of GTE in vivo. Yet GTE stimulated lipolysis under resting conditions suggesting non-adrenergic 
mechanisms. It is clear, that the effects observed in plasma only provide limited information on the 
underlying mechanisms of action, since the metabolite concentrations in plasma reflect spill-over 
effects that may occur in several tissues including brain, skeletal muscle, liver, gut and adipose tissue. 
Further investigations are required to elucidate the potential targets, interactions and bioactivity of 
green tea catechins to understand the exact mechanisms of GTE and the physiological outcomes in the 
human body.  
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3.1 Abstract 
Background: There is consistent evidence supporting the ergogenic effects of caffeine for endurance 
based exercise. However, whether caffeine ingested through coffee has the same effects is still subject 
to debate. The primary aim of the study was to investigate the performance enhancing effects of 
caffeine and coffee using a time trial performance test, while also investigating the metabolic effects 
of caffeine and coffee. Methods: In a single-blind, crossover, randomised counter-balanced study 
design, eight trained male cyclists/triathletes (Mean ± SD: Age 41±7y, Height 1.80±0.04m, Weight 
78.9±4.1kg, VO2 max 58±3 mL•kg
-1•min-1) completed 30 min of steady-state (SS) cycling at 
approximately 55% VO2max followed by a 45 min energy based target time trial (TT). One hour prior 
to exercise each athlete consumed drinks consisting of caffeine (5 mg/kg BM), instant coffee (5 mg/kg 
BM), instant decaffeinated coffee or placebo. The set workloads produced similar relative exercise 
intensities during the SS for all drinks, with no observed difference in carbohydrate or fat oxidation. 
Results: Performance times during the TT were significantly faster (~5.0%) for both caffeine and 
coffee when compared to placebo and decaf (38.35±1.53, 38.27±1.80, 40.23±1.98, 40.31±1.22 min 
respectively, p<0.05). The significantly faster performance times were similar for both caffeine and 
coffee. Average power for caffeine and coffee during the TT was significantly greater when compared 
to placebo and decaf (294±21W, 291±22W, 277±14W, 276±23W respectively, p<0.05).  No 
significant differences were observed between placebo and decaf during the TT. Conclusions: The 
present study illustrates that both caffeine (5 mg/kg BM) and coffee (5 mg/kg BM) consumed 1 h prior 
to exercise can improve endurance exercise performance.  
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3.2 Introduction 
Numerous studies to date have shown that caffeine ingested prior to [1-7] and during [8] prolonged 
sub-maximal and high intensity exercise can improve performance. Since the seminal work by Costill 
and colleagues [9] it is often cited that caffeine induces its ergogenic effects by an increase in fat 
oxidation through the sympathetic nervous system, and a subsequent sparing of muscle glycogen [2]. 
However, there is very little support for an increase in fat oxidation [10,11] or an enhancement to the 
sympathetic nervous system [12] being the principal mechanism of caffeine‟s ergogenic effect. Since, 
recent investigations have elucidated that the principal mechanism of caffeine‟s ergogenic effects is 
through its ability to act as an adenosine receptor antagonist to induce effects on both central and 
peripheral nervous system [13] to reduce pain and exertion perception [14], improve motor 
recruitment [13]  and excitation-contraction coupling [15-17].  
In the literature to date, the ergogenic effects are well documented with the time to exhaustion test at a 
fixed power output being the predominant performance measure used [1,2,9-11]. It was questioned 
whether assessing endurance capacity in this way would have sufficient ecological validity to translate 
results to real life events [18]. However, since then a number of studies have confirmed the ergogenic 
effects of caffeine using time trial protocols [3-5,7,8], which involves completing an energy based 
target or set distance in as fast as time possible, thus simulating variable intensities that are likely to 
occur during competitive events. In most of these studies pure (anhydrous) caffeine was ingested 
through capsules or dissolved in water. Based on this research it is often assumed that ingesting 
caffeine in a variety of dietary sources, such as coffee, will result in the same ergogenic effect.  
Very few studies, however, have shown a positive effect of coffee on exercise performance. Coffee 
improved performance in some [9,19-21], but not all studies [22-24]. This may seem surprising as 
reports have shown that coffee is the most concentrated dietary source of caffeine as well as being one 
of the largest sources of caffeine used by athletes prior to competition [25]. Amongst the current 
studies, only two investigations have actually used coffee rather than decaffeinated coffee plus 
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anhydrous caffeine [21,22], with only one of these studies showing an ergogenic effect of the coffee 
[21]. This further identifies the equivocal evidence surrounding the performance effects of coffee. The 
most cited study is perhaps a study by Graham et al [22], who showed that running time to exhaustion 
(85% VO2 max) was only improved when runners ingested pure caffeine (4.5mg/kg BM), prior to 
exercise, but not when they ingested either regular coffee (4.5mg/kg BM), decaffeinated coffee plus 
caffeine (4.5 mg/kg BM), decaffeinated coffee and a placebo control. The authors reported that the 
difference in performance could not be explained by the caffeine or methylxanthine plasma 
concentrations 1h following intake or at end of exercise, as no difference was observed between trials 
that contained caffeine.  
Graham et al [22] suggested that other components in coffee known as chlorogenic acids, may have 
antagonised the physiological responses of caffeine. However, in this study [22] chlorogenic acids in 
the coffee or in the plasma were not measured. Chlorogenic acids are a group of phenolic compounds 
that possess a quinic acid ester of hydroxycinnamic acid [26]. The consumption of chlorogenic acids 
varies significantly in coffee ranging from 20-675mg per serving [26]. It has previously been shown in 
vitro that chlorogenic acids antagonize adenosine receptor binding of caffeine [27] and causes blunting 
to heart rate and blood pressure in rats [28]. For this reason, it is unclear what role chlorogenic acids, 
found in coffee, will have on the physiological and metabolic effects of coffee and caffeine during 
exercise in humans. Therefore, due to the large variation of chlorogenic acids between coffee 
beverages and the unclear performance effects of coffee to date, it is yet to be determined if coffee 
causes differences in the performance and metabolic effects during exercise when compared to 
caffeine alone.  
Therefore, the primary aim of the present study was to investigate whether acute intake of instant 
coffee (5 mg/kg BM) and anhydrous caffeine (5 mg/kg BM) are ergogenic to cycling performance 
compared to decaffeinated coffee or placebo beverages when using a validated 45-minute  time trial 
performance test.. In addition, completing a steady state exercise bout prior to the time trial 
performance test is a routine protocol used in our laboratory [18,29]. For this reason it provided an 
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opportunity to also investigate the effect of acute anhydrous caffeine or coffee intake on substrate 
oxidation and plasma metabolite responses during 30-min steady state exercise (55% VO2 max). The 
study hypothesis was  that despite the previous work by Graham et al [22], 5 mg/kg BM regardless of 
the form of administration (anhydrous or coffee) would be ergogenic to performance similarly when 
compared to decaffeinated coffee or placebo, but this effect would not be mediated through changes in 
fat metabolism.  
3.3 Materials and Methods 
3.3.1 Participants 
Eight trained cyclists/triathletes (Mean ± SD: Age 41±7y, Height 1.80±0.04m, Weight 78.9±4.1kg, 
2OV
 max 58±3 mL•kg-1•min-1) were recruited from local Birmingham cycling and triathlon clubs. 
Inclusion criteria included participants who trained 3 or more times per week (>90-min/session), had 
been training for >2 years, and had a low habitual caffeine intake of ≤ 300mg/d (approximately ≤ 3 
cups coffee/d). All participants were fully informed of the experimental trials and all risks and 
discomforts associated before providing written informed consent to participate in the study. All 
procedures and protocols were approved by the Life and Environmental Sciences Ethical Review 
Committee at the University of Birmingham. 
3.3.2 General Study design  
The study design was a cross over, randomised and single blinded. Maximal oxygen uptake ( 2OV
 max) 
and power (Wmax) was assessed during a preliminary trial. Following this each participant completed 
4 experimental trials, each separated by 7 days. Each trial consisted of consuming: caffeine (5mg/kg 
BM) (CAF), instant coffee (5mg/kg BM) (COF), instant decaffeinated coffee (DECAF) or placebo 
(PLA, Quinine Sulphate) in the overnight fasted state (8hrs) 1 h before completing a 30 min steady 
state cycle exercise bout (SS) (55% 2OV
  max). Following this each participant was instructed to 
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complete a time trial lasting approximately 45-min. Each participant returned to the lab 7 days later to 
repeat the trial, with a different supplement.  
3.3.3 Preliminary Trial 
Before the experimental trial, participants visited the Human Performance Laboratory at the 
University of Birmingham on two separate occasions separated by 7 days. During the first visit 
participants completed an incremental exercise test on an electronically braked cycle ergometer (Lode 
Excalibur Sport, Groningen, Netherlands) to volitional exhaustion ( 2OV
 max test). Prior to beginning 
the test participants firstly had weight (OHaus, Champ II scales, USA) and height (Seca stadiometer, 
UK) recorded. Participants mounted the cycle ergometer, which was followed by a 5-min warm up at 
75 W, participants then started the test at 95 W for 3-min. The resistance was increased every 3-min, 
in incremental steps of 35W, until they reached voluntary exhaustion. Wmax was calculated using the 
following equation: 
Wmax = Wout + [(t/180) X 35] 
Where Wout is the power output of the last stage completed during the test, and t is the time spent, in 
seconds, in the final stage. Throughout the test respiratory gas measurements ( 2OV
  and 2COV
 ) were 
collected continuously using an Online Gas Analyser (Oxycon Pro, Jaeger). 2OV
  was considered 
maximal if 2 out of the 4 following criteria were met: 1) if 2OV
  levelled off even when workload 
increased 2) a respiratory exchange ratio (RER) of >1.05 3) a heart rate within 10 beats/min of age 
predicted maximal heart rate 4) a cadence of 50 rpm could not be maintained. Heart rate (HR) was 
recorded during each stage of the test using a HR monitor (Polar, Warwick, UK). Wmax was used to 
determine the work load for the steady state exercise bouts throughout all subsequent experimental 
trials (50% Wmax). Wmax was also used to calculate the total amount of work to be completed during 
the 45-min time trial and the linear factor, both calculated according to the formula derived by 
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Jeukendrup et al [18]. The bike position was recorded following the test to be replicated in all other 
trials.  
Approximately 7 days later participants reported back to the lab, for the second preliminary trial, 
between 0600 and 0800 having undergone an 8 hr fast. The purpose of the trial was to familiarise each 
subject to the experimental trial and time trial protocol. All participants completed 30 min SS at 50% 
Wmax (55% 2OV
 max). Expired breath samples were collected every 10-min for measures of 2OV

,
 
2COV

, 
and RER (Oxycon Pro, Jaeger). Immediately following all participants completed a time trial 
lasting ~45 min. The data collected during the familiarisation trial was not used for any of the final 
analysis.  
3.3.4 Experimental Trial 
All participants reported to the Human Performance Lab between 0600 and 0800 having completed an 
8 h overnight fast. On arrival weight was recorded (Seca Alpha, Hamburg, Germany) and a flexible 
20-gauge Teflon catheter (Venflon; Becton Dickinson, Plymouth, United Kingdom) was inserted into 
an antecubital vein. A 3-way stopcock (Connecta; Becton Dickinson) was attached to the catheter to 
allow for repeated blood sampling during the experimental period. An initial 15 mL fasting blood 
sample was collected (EDTA-containing tubes, BD vacutainers). Following this all participants 
consumed one of the treatment beverages and rested for 1h, with further samples taken at 30 min and 
60 min (10 mL EDTA). After the rest period, participants then mounted the cycle ergometer, in an 
identical bike position as recorded during the preliminary trial, and began a 30 min SS at 50% Wmax 
(55% 2OV
 max). Blood samples (15 mL) and 4 min respiratory breath samples, VO2, VCO2 and RER, 
(Oxycon Pro, Jaeger) were collected every 10 min during the exercise.  The catheter was kept patent 
during both the rest and exercise period by flushing it with 5 mL isotonic saline (0.9% w/v; B Braun) 
after every blood sample. In addition, heart rate (HR) was recorded (Polar RS800CX) every 15 min at 
rest and every 10 min during SS.  Ratings of Perceived Exertion (RPE) scale were recorded every 10 
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min during SS using the 6-20 Borg scale [425]. Upon completion of the SS, the subject was instructed 
to stop exercising for ~1 min, and the cycle ergometer was set in the linear mode. The participants 
were instructed to complete an energy-based target amount of work at 70% Wmax in the quickest time 
possible. The total amount of work (650 ± 37KJ) was calculated for the 45 min time trial. A linear 
factor, 70% Wmax divided by (90rpm)
2
 was entered into the cycle ergometer. Participants received a 
countdown prior to starting the time trial and received no verbal or visual feedback regarding 
performance time or physiological measures throughout the test. No additional measures, blood or 
respiratory, were taken through the test. Participants received no feedback about their performance 
until they had completed all 4 experimental trials. Following the completion of the TT, each 
participant completed a questionnaire to guess the test beverage consumed prior to the commencement 
of the trial, as well as report any GI distress experienced during the trial.  
3.3.5 Treatment Beverages 
During each visit to the lab, participants ingested one of four treatment beverages. This included 
caffeine (5 mg/kg BM), regular coffee (5 mg/kg BM), decaffeinated coffee and placebo. Therefore, 
decaffeinated coffee and placebo acted as controls to both of the caffeinated trials.  Caffeine 
(Anhydrous caffeine, 99.8% pure, Blackburn Distributions Ltd, Nelson, United Kingdom) was 
weighed (394.4±7.0 mg) prior to the trial, and was immediately dissolved and vortexed for 15 min in 
600 mL of water prior to consumption and served in an opaque sports drinks bottle. Coffee was 
prepared using instant coffee (Nescafe Original). In order to select the correct weight of coffee to 
equal 5 mg/kg BM, Nescafe states that Nescafe Original instant coffee provides 3.4g caffeine/100 g of 
instant coffee. This information was confirmed using a HPLC method (see below), and based on the 
analysis it was calculated that 0.15 g coffee/kg BM equalled 5 mg/kg BM.  Therefore, prior to each 
trial, coffee was weighed (11.8±1.0 g) and dissolved in 600 mL hot water (94±2 ⁰C) and served in a 
mug. Both coffee and decaffeinated coffee were served hot, while caffeine and placebo were served 
cold.  
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DECAF (Nescafe Original Decaffeinated coffee, <97% caffeine free) was prepared in an identical 
fashion, with the same amount of decaffeinated coffee as the COF beverage. Using a HPLC method, 
decaffeinated coffee provided minimal caffeine throughout each of the prepared beverages (0.17 
mg/kg BM or mean intake of 13.41±0.70mg). In order to blind the participants from the taste of the 
caffeine trial, the placebo trial consisted of 8mg of Quinine sulphate (Sigma, UK). Quinine sulphate is 
a food ingredient found in tonic water to give a bitter taste. The quinine sulphate was dissolved in 600 
mL of water, vortexed for 15 min, and served in an opaque sports drinks bottle. The exact dose of 
quinine sulphate was preliminary tested in our lab. A dose of 8 mg was sufficient to prevent the 
blinded researchers from distinguishing between the placebo and caffeine trial. 
The coffee and decaffeinated coffee samples were further analysed externally for chlorogenic acids (5-
CQA) (Eurofins Scientific, Italy). Based on the analysis, total 5-CQA was 33.91 mg/g and 28.29 mg/g 
for COF and DECAF respectively. This was then used to calculate the average concentration of total 
5-CQA and related isomers for each participants drinks, based on the weight of instant COF and 
DECAF. The average chlorogenic acid intake in COF and DECAF are presented in Table 3.1.  
All of the beverages were prepared in 600 mL of water. This was firstly to avoid any difference in 
uptake and bioavailability of each of the ingested ingredients, as well as replicating the format of 
coffee consumption from everyday life. Secondly 600 mL of coffee dissolved in water was not only 
considered tolerable, based on taste testing by researchers within our laboratory, but also matched 
similar volumes as used by Graham et al [216]. Once participants received each of the beverages at the 
beginning of the trial, they had 15 min to consume the entire 600 mL.  
3.3.6 Diet and Exercise Control 
Participants were instructed to record their food intake the day prior to the preliminary familiarisation 
trial. Participants had to replicate this diet in the 24 h prior to each experimental trial, as well as 
refraining from any exercise, consume no alcohol and withdraw from any caffeinated products.  
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3.3.7 Calculations 
Substrate metabolism was measured during the SS. From the respiratory output measurements of 2OV

and 2COV
  (L/min), carbohydrate [1] (CHO) and fat oxidation [2] was calculated every 10 min during 
the SS. In order to calculate CHO and fat oxidation stoichiometric equations [31] were used, which 
assume that each of the participants were exercising at a steady state and that protein oxidation was 
negligible  
[1] Carbohydrate oxidation = 4.210 2COV
 – 2.962 2OV

 
[2] Fat Oxidation = 1.65 2OV

 – 1.701 2COV

 
3.3.8 Blood Analysis 
Following collection, all tubes were placed in ice until the end of the experimental trial. Following this 
each tube was centrifuged at 3500 rpm for 15 min at 4°C. Aliquots of plasma were immediately frozen 
in liquid nitrogen and stored at -80°C for later analysis. Each blood sample taken throughout each 
experimental trial were analysed for plasma glucose (Glucose Oxidase; Instrumentation Laboratories, 
England), fatty acids (FA) [NEFA-C; Randox, England], glycerol (Glycerol; Randox, England) and 
lactate [Lactate, Randox, England] using an ILAB 650 (Instrumentation Laboratory, Cheshire, United 
Kingdom).  
3.3.9 Plasma Caffeine and Chlorogenic Acid analysis 
Plasma caffeine were analysed externally (City Hospital, Dudley, Birmingham) using a reversed-
HPLC-UV method. The sample preparation included: 200 µL of plasma were added to 100 µL internal 
standard (Proxyphylline, Sigma, United Kingdom) before mixing, heating and adding 500 µL of acetic 
acid. The supernatant was the injected (5 µL) onto a Phenomenex Prodigy 150 x 4.60mm 5 µ 
Octadecyl Silane (ODS) column using an auto sampler and detected at a UV of 273 nm. 
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Table 3.1: Mean caffeine and chlorogenic acid (Total 5-QCA) concentration in each treatment beverage serving.  
 
Treatment 
beverage  
Serving 
Volume 
(mL)  
Caffeine 
content 
(mg/serving)  
Total 5-CQA 
(mg/serving)  
% of Total 5-CQA  
CQA 5-CQA 4-QCA 5-FQA  4-FQA 
3,5-
diCQA 
3,4-
diCQA 
4,5-
diCQA 
4,5-
CFQA 
  
CAF  600  394.4±7.0  -  
- -  -  -  -  -  -  -  -  
COF  600  394.4±7.0  393.3±7.3  21%  32%  22%  8%  7%  3%  2%  3%  2%  
DECAF  600  13.4±0.2  328.1±6.1  23%  33%  24%  7%  7%  3%  1%  2%  1%  
PLA 600  -  -  -  -  -  -  -  -  -  -  -  
 
 
Means ± SE n=8   Abbreviations: CQA Caffeoylquinic acid, 5-QCA 5-O-Caffeoylquinic acid, 4-QCA 4-O-Caffeoylquinic acid, 5-FQA 5-O-
Feruloylquinic acid, 4-FQA 4-O-Feruloylquinic acid, 3,5-diCQA 3,5-O-Dicaffeoylquinic acid, 3,4-diCQA 3,4-O-Dicaffeoylquinic acid, 4,5-diCQA 
4,5-O-Dicaffeoylquinic acid, 4,5-CFQA 4,5-O-Dicaffeoylquinic acid 
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Caffeine concentrations were quantified using one point calibration from a calibrator that had 
previously been internally validated against a 9 point calibration curve (City Hospital, Dudley, 
Birmingham). With each batch two QC (High and Low) were run, with reference to the internal 
standard to account for any loses.  
The caffeine content of coffee and decaffeinated coffee were confirmed at the School of Sport and 
Exercise Sciences. In brief, coffee and decaf coffee samples were prepared (identical to preparation 
described above) and cooled before 5µL of each sample were injected onto a Phenomenex Luna 10 µ 
C18 (2) column using an auto sampler (WPS 3000, Dionex, United Kingdom). The mobile phase 
consisted of 0.1 M acetic acid in water and 0.1M acetic acid in acetonitrile. Caffeine concentrations 
were quantified using a 10-point caffeine calibration curve in water.  
Coffee and Decaf coffee were analysed for chlorogenic acids. The analysis was conducted externally 
(Eurofins Scientific, Italy) using a reverse HPLC methodology at 325 nm (Water Symmetry C18, 250 
x 4.6 mm, 5 um) with external 5-QCA standards for quantification on a 3 point calibration (10-250 
mg/kg). The mobile phase consisted of aqueous 0.5 % formic acid and acetonitrile.  
3.3.10 Statistical Analysis 
Data analysis was performed using SPSS for WINDOWS software (version 17; SPSS Inc, Chicago, 
IL). Data are expressed as means ± SEMs, unless otherwise stated. A repeated measure ANOVA was 
used to assess differences in respiratory, substrate metabolism, plasma metabolite and caffeine 
concentration as well as time trial performance measurements during each trial. In order to detect 
differences across time and between treatments a Fisher protected least significant differences post hoc 
test was used. Significance was set at P <0.05. 
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3.4 Results 
3.4.1 Steady State Exercise 
3.4.1.1 Whole body respiratory measures, HR and RPE.  
The selected workload of 50% Wmax during the SS (171±7W) resulted in similar oxygen uptake (
2OV
 ) (2590±79, 2595±89, 2465±79, 2522±71 mL/min for CAF, COF, DECAF and PLA respectively 
P=0.278). As a result the relative exercise intensity during the SS was similar throughout each trial 
(58±2%, 58±2%, 55±1% and 55±1% for CAF, COF, DECAF and PLA respectively P=0.337). Energy 
expended during SS was also shown to be similar (1607±49KJ, 1611±54KJ, 1531±50 KJ, 1565±43) 
for CAF, COF, DECAF and PLA respectively P=0.248). In addition no significant difference was 
observed in average HR during exercise (119±4, 119±4, 119±4, 120±5 bpm for CAF, COF, DECAF 
and PLA respectively P=0.281) or RPE values (10±0, 10±0, 11±0 and 11±0 for CAF, COF, DECAF 
and PLA respectively P=0.091) during SS between trials.  
3.4.1.2 Carbohydrate and Fat oxidation 
Carbohydrate oxidation rates during SS significantly reduced in all treatments across time (P=0.001). 
However, there was no significant difference in carbohydrate oxidation between each of the treatments 
(Figure 3.1A P=0.288). Similarly, fat oxidation rates significantly increased during SS in all 
treatments (P=0.001). No significant difference in fat oxidation was observed between each of the 
treatments (Figure 3.1B P=0.445). Accordingly the contribution of carbohydrate and fat to total energy 
expenditure during SS was not significantly different between any of the treatments (P=0.463). 
3.4.1.3 Plasma metabolite concentrations 
Plasma metabolite responses at rest and exercise are displayed in Figure 3.2 A-D. Plasma glucose 
concentrations (Figure 3.2A) were significantly elevated at the end of rest compared to the beginning 
of rest following CAF and COF (p<0.05 for both), while no significant difference occurred following 
DECAF or PLA (P=0.676 and 0.188 respectively). The elevation in glucose concentrations with CAF 
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following the rest period was significantly higher compared to DECAF only (P<0.05). During 
exercise, plasma glucose increased over time following CAF and COF, however only COF reached 
statistical significance (P<0.05). DECAF and PLA glucose concentrations fell during the onset of 
exercise with a significant increase in both treatments later in exercise (T=10-30 P<0.05 for both). As 
a result, CAF had significantly higher glucose concentrations within the first 20 minutes of exercise 
compared to DECAF and PLA (P<0.05 for both), while at end of exercise CAF and COF had 
significantly higher glucose concentrations compared to PLA only (P<0.05 for both). Plasma FAs 
concentration (Figure 3.2B) were significantly elevated at the end of rest compared to beginning of 
rest following CAF (P=0.010), while DECAF and PLA had reduced FA concentration, with only 
DECAF reaching statistical significance (P=0.007 and P=0.072 respectively). Therefore, CAF had 
significantly higher FAs concentration compared to DECAF and PLA at end of rest period (P<0.05 for 
both). During the beginning of exercise, CAF continued to have significantly elevated FAs 
concentration compared to DECAF only (P=0.037). FA concentration significantly increased during 
exercise (T=10-30 P=0.030) with no significant differences observed between treatments (P=0.231).  
Plasma glycerol concentrations (Figure 3.2C) did not  significantly change at rest for CAF (P=0.066), 
COF (P=0.392) and DECAF (P=0.104) but PLA significantly fell (P=0.022). DECAF was 
significantly lower at end of rest compared to CAF, COF and PLA  (P<0.05 for all), with no 
significant differences observed between any other beverage. During exercise there was a significant 
increase in glycerol concentrations for all treatments over time (P=0.001), with significantly higher 
concentrations observed for CAF (P=0.027) and COF (P=0.003) at beginning of exercise compared to 
DECAF only. 
Plasma lactate concentrations (Figure 3.2D), were significantly increased following the consumption 
of CAF and COF only during the rest period compared to DECAF (P=0.050 and P=0.003 respectively) 
and PLA (P=0.002 and P=0.001 respectively). In addition DECAF had significantly elevated lactate 
compared to PLA at end of rest period (P=0.012).   
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Figure 3.1: Carbohydrate oxidation (g/min) (A) and fat oxidation (g/min) (B) rates during 30 min steady state exercise (55% VO2 max) 1 hour 
following ingestion of caffeine, coffee, decaf or placebo beverages 
 
Data represented seen as Closed circles – Caffeine Open circles – Caffeinated Coffee Closed triangles – Decaffeinated coffee Open triangles – Placebo. 
Means ± SE n = 8 
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All treatments lactate concentrations significantly increased at the onset of exercise (P=0.004) with CAF and 
COF being significantly higher compared to PLA (P=0.037 and P=0.010 respectively). CAF and COF had 
sustained lactate concentrations at the end of exercise, with significantly higher concentrations compared to 
DECAF (P=0.008 and P=0.028 respectively) and PLA (P=0.050 and P=0.005 respectively). 
3.4.2 Plasma caffeine concentrations 
The plasma caffeine concentrations following each beverage are displayed in Figure 3.3. At baseline 
plasma caffeine concentrations were very low for all treatments (<3 µM), with no significant 
differences observed (P=0.478). Plasma caffeine significantly increased following CAF and COF 
when compared to DECAF (P=0.000 and P=0.009 respectively) and PLA (P=0.000 and P= 0.010 
respectively), with peak concentrations observed 60 min after intake (38.2±2.8 µM and 33.5±5.0 µM 
respectively). No significant difference was observed in the plasma caffeine concentrations between 
CAF or COF (P=0.156) and DECAF or PLA (P=0.558) throughout the trials 
3.4.3 Time trial performance  
CAF and COF significantly improved TT finishing times when compared to both DECAF and PLA 
(Figure 3.4). As a result mean power output during the TT was significantly greater for both CAF and 
COF compared to DECAF and PLA (294±6, 291±7, 276±7, 277±4 W, respectively). However, no 
significant differences were seen in average heart rate during the TT (170±3, 167±4, 164±3, 165±4 
BPM, respectively).  CAF significantly improved TT performance by 4.9 % (95% confidence interval 
(CI) = 2.3-6.8 %) and 4.5 % (95% confidence interval (CI) = 2.3-6.2 %) compared to PLA and 
DECAF respectively (p<0.05). Equally, COF significantly improved TT performance by 4.7% (95% 
confidence interval (CI) = 2.3-6.7 %) and 4.3 % (95 % confidence interval (CI) = 2.5-7.1 %) compared 
to PLA and DECAF respectively (p<0.05) (Table 3.2). In addition there were no significant 
differences in TT performance between CAF and COF or PLA and DECAF.  
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Figure 3.2: Plasma metabolite responses at rest (t=-60-0) and during 30 min steady state exercise (55 % VO2 max) (t=0-30) following ingestion 
of caffeine, coffee, decaf or placebo beverages.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A Glucose. B Fatty acids (FA). C Glycerol. D Lactate. Data represented seen as Closed circles – Caffeine Open circles – Caffeinated Coffee Closed 
triangles – Decaffeinated coffee Open triangles – Placebo. a Sig. different between CAF and DECAF (p<0.05) b Sig. different between CAF and PLA 
(p<0.05)  c Sig. different between COF and DECAF (p<0.05)  d Sig. different between COF and PLA (p<0.05). Means ± SE n = 7 
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. 
Figure 3.3: Plasma caffeine concentrations following ingestion of caffeine, coffee, decaf or placebo beverages. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 a CAF significantly different to DECAF and PLA (p<0.001) b COF significantly different to DECAF and PLA (p<0.001). Data represented seen as 
Closed circles – Caffeine Open circles – Caffeinated Coffee Closed triangles – Decaffeinated coffee Open triangles – Placebo Means ± SE n = 7. 
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Following the completion of the TT, 3/8 participants were able to successfully guess the correct order 
of test beverages consumed prior to the trial.  The correct guesses were more consistent for detecting 
CAF compared to the other drinks, with 6/8 of the participants guessing correctly. None of the 
participants reported any serious symptoms of GI distress at the end of any of the trials.  
 
Table 3.2: Time trial performance data for each treatment. Means ± SE n = 8 a significantly 
different to DECAF and PLA (p<0.05) b significantly different to DECAF and PLA (p<0.05)  
 
 
3.5 Discussion  
The present study examined the effects of acute intake of coffee (5 mg/kg BM) and caffeine (5 mg/kg 
BM) on time trial cycling performance, as well as substrate utilisation during SS exercise. Numerous 
studies to date have shown the efficacy of acute caffeine ingestion for improving prolonged endurance 
exercise performance [1-7]. The effects of caffeine on time trial endurance performance (>5 min) have 
recently been reviewed in a well conducted meta-analysis [7]. The authors concluded that of the 12 
studies that investigated caffeine intake (1-6 mg/kg BM), performance was improved by ~3%. Fewer 
studies have investigated the ergogenic effects of coffee, with results being mixed thus far. In 
agreement with the literature, the current study found an improvement in performance following 
caffeine intake of 4.9% and 4.5% when compared to decaf coffee and placebo, respectively (Table 
3.2).  
Treatment  TT finish time 
(min)  
Improvement 
compared to PLA % 
(95 % confidence 
intervals) 
P value  Improvement compared 
to DECAF %  
(95 % confidence 
intervals) 
P value  
CAF  38.35±0.48
a
 4.9 (2.3-6.8)  0.001  4.5 (2.3-6.2)  0.002  
COF  38.27±0.57
b
  4.7 (2.3-6.7)  0.002  4.3 (2.5-7.1)  0.002  
DECAF  40.23±0.63  -0.4 (-4.0-3.1)  0.784  -  -  
PLA  40.06±0.39  -  -  0.3(-0.3-3.9)  0.784  
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Figure 3.4: Time trial finishing time (min) for caffeine, coffee, decaf or placebo beverages  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 a CAF significantly different to DECAF and PLA (p<0.05) b COF significantly different to DECAF and PLA (p<0.05). Data represented seen as 
Closed bar– Caffeine Open bar – Caffeinated Coffee Dark grey bar– Decaffeinated coffee Light grey bar– Placebo. Means ± SE n = 8. 
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Interestingly, the current study also showed that coffee improved performance to the same extent as 
caffeine when compared to decaf coffee and placebo, 4.7 % and 4.3 % respectively.  Thus, this is the 
first study to date to demonstrate that coffee consumed 1 h prior to exercise, at a high caffeine dose (5 
mg/kg BM), is equally as effective as caffeine at improving endurance exercise performance. Our 
findings are in line with a number of studies that have shown improvements to performance following 
coffee intake [9,19-21]. Costill et al [9] were the first to show that decaf coffee plus caffeine (330 mg), 
improved exercise time to exhaustion (80 % VO2 max) compared with decaffeinated coffee (~18 %). 
More recently, Wiles et al [19] showed that coffee was able to improve 1500 m treadmill running 
performance when compared to decaffeinated coffee (~3 %). However, the current study results are in 
contrast to a number of other studies [22-24]. For example, the work conducted by Graham et al [22] 
showed that coffee (4.5 mg/kg BM), regardless of the format of intake (regular coffee or decaffeinated 
coffee plus caffeine) did not result in an improvement to running time to exhaustion (75 % VO2 max), 
where as caffeine (4.5 mg/kg BM) significantly improved performance. Therefore, it was concluded 
by Graham et al [22] that the performance effects of coffee may be inferior to caffeine. Despite this 
evidence, the current study clearly demonstrates that coffee is as effective as caffeine at improving 
endurance exercise performance.  
The discrepancy in the performance effects of caffeine and coffee between the present study and 
Graham et al [22] might be explained by the type of performance test implemented. Time to 
exhaustion tests have been shown to be highly variable from day to day, with a coefficient of variation 
(CV) ~27 % in one study [18]. It is possible that this large variability may have contributed to the lack 
of performance effects found by Graham et al [22]. Whereas using a time trial performance measure, 
as used in the current study, has previously been shown to be highly reproducible (CV ~ 3 %) and 
could detect smaller differences in performance [18]. Also the number of comparisons in the study by 
Graham et al [22] was greater than in the present study with a similar subject number, indicating that 
their statistical power was smaller. Perhaps for these reasons, the current study was able to detect 
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similar changes in performance following caffeine and coffee intake (~5 %) (Table 3.2), whereas 
Graham et al [22] did not. 
The composition and preparation of coffee in each of the studies [9,19-24] may also explain the 
discrepancies in the ergogenic effects of coffee.  Coffee is ~2% caffeine, with the remainder composed 
of chlorogenic acids, ferulic acid, caffeic acid, nicotinic acid as well as other unidentifiable 
compounds [26]. It is evident that the source of coffee beans, roasting, storage and preparation 
(brewing and filtering) dramatically alters the caffeine and chlorogenic acid content of the coffee [26]. 
In accordance, recent evidence has shown that the chlorogenic acid content of commercially available 
espresso coffees range from 24-422 mg/serving [26]. In support, the current study observes  a high 
chlorogenic acid content in both coffee and decaffeinated coffee samples (Table 3.1). Graham et al 
[22] speculated that chlorogenic acids found in coffee may have blunted the physiological effects of 
caffeine, preventing an improvement in exercise performance. However, the authors did not report 
measurements of chlorogenic acids in coffee or in plasma to support this speculation. Despite the 
compounds present in coffee, the authors reported that the bioavailability of plasma caffeine and 
paraxanthines did not differ to caffeine [22], which is in line with the present study (Figure 3.4). 
Further, in vitro studies suggest that chlorogenic acids antagonize adenosine receptor binding of 
caffeine [27] and cause blunting to heart rate and blood pressure in rats [28]. Yet, in vivo there is no 
evidence to suggest that chlorogenic acids, especially at the low nanomolar concentration typically 
observed [32], impact on the mechanisms of action of caffeine that lead to the ergogenic effects. In 
support of this notion, and in agreement with the current study, regular coffee (1.1 mg/kg BM) 
consumed prior to the ingestion of different doses of caffeine (3-7 mg/kg BM) has been shown not to 
affect the ergogenic effects of caffeine [21]. 
The improvement in performance in the current study is unlikely to be explained by alterations to fat 
oxidation, as no difference during the SS exercise bout was observed (Figure 3.1B). This is in 
agreement with a number of investigations that do not support the thesis that caffeine improves 
exercise performance by augmenting fat metabolism [33,34]. In addition these effects are apparent 
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despite consistent increases in adrenaline though activation of the SNS [33,34] and a subsequent 
elevation in FA appearance in the circulation following caffeine intake [33,34]. It is evident that the 
improvement in performance is likely through caffeine‟s direct antagonism of adenosine receptors (A1 
and A2A) on the skeletal muscle membrane to improve excitation-contraction coupling [13] via a 
greater release of Ca
2+
 from the SR [16] and/or improved Na
+
/K
+
 ATPase pump activity [15]. In 
support of this notion, Mohr et al [12] observed that tetrapelegic patients, who have an impaired 
sympathoadrenal response [35], showed that caffeine improved exercise performance, while RER did 
not change during an electrically stimulated cycling test. Further, the authors also observed a 
significant increase in FA and glycerol at rest and during exercise following caffeine intake, despite a 
lack of an adrenaline response. This is due to the fact that adenosine has been shown to inhibit 
lipolysis [36] and enhance insulin stimulated glucose uptake in contracting skeletal muscle in vitro 
[37]. In support, the current study observed a significant increase in plasma glucose, FA and glycerol 
concentrations following caffeine (Figure 3.2 A, B, C). In addition, the consistently reported elevation 
in adrenaline concentrations [33] combined with adenosine receptor antagonism following caffeine 
intake during exercise may work synergistically to activate glycogenolysis in exercising and non-
exercising tissues [34] as well as adipose tissue/skeletal muscle lipolysis [33]. This supports the fact 
that the current study (Figure 3.2 D) and others have shown that caffeine increases plasma lactate 
concentrations at rest and during exercise [33,34]. Though to date there is little supporting evidence 
that caffeine stimulates exercising skeletal muscle glycogenolysis [33,38], with early studies showing 
a paradoxical glycogen sparing effect with caffeine [2]. The elevated lactate concentrations are more 
likely due to a reduced clearance by the exercising muscle and a greater release by non exercising 
tissues [33]. Consequently, due to the healthy participants tested in the current study it is likely that the 
adenosine receptor antagonism by caffeine plays a crucial role in inducing the ergogenic effects of 
caffeine while regulating the metabolite response synergistically with the SNS.  
Interestingly, despite coffee producing similar ergogenic effects as caffeine, the metabolite responses 
were not identical (Figure 3.2). The current study observed that the significant increase in plasma 
 -136- 
 
glucose, FA and glycerol with caffeine was paralleled with an attenuated response for coffee, and a 
significantly blunted response with decaf coffee when compared to placebo (Figure 3.2 A, B, C). This 
is likely due to the compounds in coffee [39] inducing subtle effects on antagonism of adenosine 
receptors (A1 and A2A) in a variety of exercising and non exercising tissues. In accordance, Graham et 
al [22] previously showed that coffee resulted in a blunted adrenaline response when compared to 
caffeine at rest in humans, which was attributed to chlorogenic acids antagonizing adenosine receptor 
binding of caffeine [27]. In addition nicotinic acid, a fatty acid ester found in coffee known to inhibit 
lipolysis, has been shown to lower FA concentrations in patients suffering from hyperlipidemia [40]. 
Chlorogenic acids are also believed to improve glucose uptake at the skeletal muscle when compared 
to caffeine [41], also by altering the antagonism of adenosine receptors. More recently, caffeic acid 
has been found to stimulate skeletal muscle glucose transport, independent of insulin, when 
accompanied with an elevation in AMPK in vitro [42]. Despite the aforementioned evidence, it 
remains unclear why compounds in coffee appear to modulate the metabolite response but not the 
ergogenic effects of coffee in the current study. 
The current study provided a large bolus of caffeine in the form of anhydrous caffeine or coffee one 
hour prior to exercise (5 mg/kg BM). The chlorogenic acid content of the coffee beverages was 
different, which is worth highlighting as a potential limitation of the current study. Previous studies 
have failed to make comparisons between coffee and decaf coffee and instead have used decaf plus 
anhydrous caffeine [9,19-21,23,43]. In addition these studies did not examine the chlorogenic acid 
content of the test beverages. Thus, the novelty of the current study was that the performance effects 
were investigated between caffeine and coffee, independent of the combined effects of decaffeinated 
coffee plus caffeine. Adding a decaf plus caffeine trial would have been successful in controlling for 
chlorogenic acid content of the beverage. However, firstly, investigating the effect of chlorogenic 
acids on the metabolic and performance effects of caffeine was not the primary aim of the current 
study. Secondly, and more importantly, the low nanomolar concentration of chlorogenic acids in vivo 
[32] is unlikely to impact on the mechanisms of action of caffeine when compared to the physiological 
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effects observed in vitro from supra physiological concentrations of chlorogenic acids [27,28]. Yet, as 
differences in the metabolic effects of caffeine compared to coffee were observed in the current study, 
it may be important for future studies to control for chlorogenic acid content in coffee beverages or 
additionally increase the dose of chlorogenic acids to raise the bioavailability in vivo. In turn this will 
provide further insights into the metabolic differences between caffeine and coffee. In conclusion, the 
present study showed that caffeine and coffee (5 mg/kg BM) were both able to improve exercise 
performance to the same extent, when compared to both decaffeinated coffee and placebo. Our data 
does not support the notion that chlorogenic acids found in coffee impair the ergogenic effects of 
caffeine. However, the compounds found in coffee may alter the metabolic effects, as the current study 
observed differences between caffeine and coffee at rest and during exercise. It is yet to be determined 
if lower doses of caffeine, when ingested as coffee, offer the same ergogenic effects. This would offer 
a more applicable and realistic nutritional strategy for athletes.  
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4.1 Abstract 
Background: The current study aims were threefold: 1) investigate vitamin D status in athletes living 
in the United Kingdom (52.4-52.5°N), 2) identify the potential sources and limitations of vitamin D 
status in athletes and 3) examine the effect vitamin D status may have on muscle function. Methods: 
Forty-eight indoor and outdoor athletes from a variety of sports were recruited during the winter. 
Vitamin D status (25(OH)D) was assessed from a single blood sample, followed by completion of a 
questionnaire pack that assessed sun exposure and vitamin D intake. In addition muscle function was 
assessed using a mechanography vertical jump and hand grip maximum voluntary contraction. 
Results: Mean 25(OH)D was 51±24 nmol/L with 10%, 44%, 29% and 17% of athletes being severely 
vitamin D deficient (<25 nmol/L), deficient (<50 nmol/L), insufficient (50-75 nmol/L) and sufficient 
(>75 nmol/L), respectively. No significant differences in 25(OH)D were observed between gender or 
indoor and outdoor athletes. No correlation was found between 25(OH)D and time spent outdoors 
during training or leisure time, while a positive association was found between 25(OH)D and vitamin 
D supplement intake (r=0.353 p<0.005) but not dietary intake. Further, vitamin D status had no 
association with muscle function performance. Conclusions: The current study illustrates a high 
prevalence of vitamin D deficiency in UK athletes during the winter. Reported seasonal sun exposure 
and dietary vitamin D intake had little effect on winter vitamin D status. Future work should explore 
the efficacy of vitamin D supplements as an effective nutritional intervention to correct vitamin D 
deficiency during the winter. 
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4.2 Introduction 
Vitamin D is a secosteroid traditionally involved in optimal bone health which is obtained through 
endogenous cutaneous synthesis from ultraviolet radiation (UVB) as well as from dietary sources (oily 
fish, eggs, butter and fortified foods) [1]. Vitamin D is also critical in the maintenance of optimal 
skeletal muscle function, whereby myopathy [2] and neuromuscular impairments [3] are prominent 
features in children and adults with severe vitamin D deficiency (clinical measure of vitamin D, 25-
hydroxyvitamin D (25(OH)D) < 25nmol/L). The role of vitamin D in the skeletal muscle is confirmed 
by the vitamin D receptor (VDR) being abundantly expressed in the skeletal muscle [4], allowing the 
active form of vitamin D (1,25(OH)2D3) to regulate over 1000 vitamin D responsive human genes [5].  
Alarmingly, accumulating evidence has shown a high prevalence of worldwide vitamin D deficiency 
[6] especially at high latitudes, such as in the United Kingdom (UK) [7]. This suggests that the 
deleterious effects of vitamin D deficiency on skeletal muscle function are possibly prominent in our 
population today. In support of this notion, numerous studies to date have shown that vitamin D 
deficiency (< 50 nmol/L) in elderly men and women are associated with a greater risk of falls [8], 
development of fatigue [9], and reduced skeletal muscle strength [10]. In addition, skeletal muscle 
strength and function has also been shown to be negatively associated with vitamin D status in healthy 
adolescent girls [11]. Moreover, vitamin D supplementation has shown promise as a nutritional 
support in the correction of vitamin D deficiency [12] and the observed impairment to skeletal muscle 
function in the elderly.  
A growing number of studies have begun to assess the vitamin D status in athletes worldwide. 
Collectively these studies show a high prevalence of vitamin D deficiency in athletes worldwide [13-
17]. Hamilton et al 2010 reported that athletes who live and train in Qatar had a high prevalence of 
vitamin D deficiency (~90%) despite the sunny environment and low latitude. Close et al [14] has 
recently shown that outdoor athletes from a variety of sports residing from Liverpool, UK (53.4⁰N) 
display a high prevalence of vitamin D deficiency (~60%). However, to date a complete understanding 
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of the extent of the prevalence of vitamin D deficiency in UK athletes remains unclear. Despite this, 
these findings are of great concern and relevance for optimal athletic performance. 
The factors that compromise vitamin D intake include poor dietary sources as well as factors that limit 
endogenous cutaneous synthesis from the sun. These include: poor UVB at high latitudes and in 
cloudy climates, dark skin pigmentation, use of sun lotion, clothing, time of day, and time spent 
outdoors [1]. For these reasons, the high prevalence of vitamin D deficiency in athletes is likely 
explained by those who live and train indoors as well as at high latitudes and poor climates, as 
observed in the UK (50-60⁰N) [18]. Yet while athletes have been shown to consume sufficient 
quantities of many micronutrients (based on reference nutrient intake (RNI)), it appears that athletes 
consume vitamin D well below the RNI (200 IU/d in the UK, 5 µg/d) [19]. This would suggest that 
athletes may benefit from vitamin D supplementation to avoid deficiency. However, the estimation of 
vitamin D intake (sun, food and supplements) in athletes is largely unknown.   
Interestingly, despite the importance of vitamin D in the human body, the categorisation of an optimal 
25(OH)D concentrations remains under continued debate. The recent Institute of Medicine (IOM) 
report states that inadequate vitamin D status is defined at 25(OH)D <50 nmol/L [20], while the 
Scientific Advisory Committee on Nutrition (SACN) in the UK define vitamin D deficiency as 
25(OH)D <25 nmol/L [21]. These guidelines are solely based on the benefits of vitamin D on bone 
health [22]. However, they have received a great deal of criticism, with other experts defining 
sufficient vitamin D status as >75 nmol/L [23] which include the benefits to skeletal muscle function 
and not just bone health. In contrast, the Endocrinology Society [24] state that vitamin D status is 
deficient, insufficient and sufficient when 25(OH)D concentrations are <50 nmol/L, 50-75 nmol/L and 
> 75 nmol/L respectively. In support, benefits to skeletal muscle strength and performance in the 
elderly have been observed at 25(OH)D concentrations >100 nmol/L [25] whereas in athletes benefits 
to exercise performance have recently been observed when 25(OH)D was increased >75 nmol/L 
(range 75-139 nmol/L) following vitamin D supplementation [14]. Currently, the majority of evidence 
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has been documented in the elderly with an optimal vitamin D status required to elicit benefits to 
skeletal muscle function still being unknown.  
Hence, the aim of the current study was three fold. Firstly, to assess whether or not a high prevalence 
of  vitamin D deficiency in university UK athletes, at the current test site (high latitude 52.4-52.5°N) 
during the winter (December-March), was comparable to the current trends in athletes to date. In an 
attempt to account for the differing vitamin D status guidelines, the current study categorised severe 
vitamin D deficiency, deficiency, insufficiency and sufficiency as serum total 25(OH)D of <25 
nmol/L, <50 nmol/L, 50-75 nmol/L and >75 nmol/L, respectively. Secondly, the study also aimed to 
estimate vitamin D intake (sun, food and supplements) and assess the contribution of intake to  
vitamin D status. Finally the current study aimed to provide preliminary insight into the association 
between 25(OH)D and skeletal muscle function in a small number of athletes, when using basic 
assessments of skeletal muscle function.  
4.3 Method 
4.3.1 Study Participants 
Fifty male and female athletes (Mean ± SD, age: 25 ± 8 y, height: 1.75 ± 0.08 m, weight: 73.8 ± 13.6 
kg, body mass index (BMI) 27.3 ± 3.8 kg/m
2
) were recruited from the University of Birmingham, 
Birmingham in the UK (52.4-52.5°N) between December and March. To be eligible to participate, 
participants were required to have trained in a specific sport for at least 2 years and train at least twice 
per week, for 60-90 minutes per session. The study was approved by the University of Birmingham‟s 
Science, technology engineering and mathematics ethical review committee.  
4.3.2 Experimental trial 
4.3.2.1 Vitamin D status  
Participants arrived at the laboratory following a 3 h fast between 0800 and 1600 where height (Seca 
stadiometer, UK) and weight (OHaus, Champ II scales, USA) were recorded. A resting venous blood 
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sample (Venisystem Butterfly, NU Care, UK) was taken from each participant, which was 
immediately placed into silica-polymer gel tubes (Vacutainer, BD, USA) and left at room temperature 
for 1 h to clot. Samples were then centrifuged at 3500rpm and 4°C for 15 min, before serum was 
extracted and stored at -80°C. Serum total 25(OH)D was later analysed using a 25-OH vit D 
enzymeimmunoassay (Immunodiagnostik Systems) which measures both 25(OH)D2 and 25(OH)D3 
together. The intra and inter assay coefficient of variation (%CV) was 4.7 %CV and 8.4 %CV across a 
working range of 6.8-380 nmol/L. This assay has been shown to be comparable to other 
methodologies as approved by the Vitamin D External Quality Assessment Scheme (DEQAS 
www.deqas.org [26]. 
Following this, each participant completed a questionnaire pack which estimated sources and 
limitations of vitamin D. Sun exposure was estimated by asking each participant whether they were an 
indoor or outdoor athlete as well as estimating sun exposure by the amount of time they spent outdoors 
in each season across the previous year for training/competing and in leisure time (h/wk). This was 
estimated from the frequency (d/wk), duration (<30 min, 1 h, 1-3 h, 3-5 h or > 5 h) and time of day 
(early morning, mid morning, lunchtime, afternoon or evening) spent outdoors for each season.  
Dietary vitamin D intake was estimated using an adapted food frequency questionnaire [27]. A list of 
common vitamin D rich foods found in the UK diet and other less common foods were listed. 
Participants were asked to state how often they consumed each of the foods as 100g servings, unless 
otherwise stated for more conventional serving sizes for juices, milks and spreads (never or <1 /month, 
1-3 /month, 1 /wk, 2-4 /wk, 5-6 /wk, 1 /d and 2-3 /d, 4-5 /d or >6 /d). The vitamin D concentration of 
each food was gathered from the McCance and Widdowson's Composition of Foods Integrated dataset 
(CoF IDS) from the Department of Health [28]. Vitamin D content in each food item, multiplied by 
the median of the frequency selected, provided an estimation of the vitamin D content consumed per 
day (IU/d). Vitamin D supplement use was estimated by the frequency of intake of multivitamins 
and/or vitamin D only supplements (never or <1 /month, 1-3 /month, 1 /wk, 2-4 /wk, 5-6 /wk, 1 /d and 
2-3 /d, 4-5 /d or >6 /d). Participants were asked to provide the brand and product details for the 
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multivitamin and vitamin D supplement. The dose of vitamin D intake from the supplement was 
multiplied by the median of the frequency of use to give an estimation of intake (IU/d).  
4.3.2.2 Skeletal muscle function tests 
Two skeletal muscle function performance tests were completed. Vertical jump height and force was 
assessed for each participant on a multi-component force platform (Kistler, 9281CA, Winterthur, 
Switzerland) with integrated Bioware software (Kistler, version 3.2.6, Winterthur, Switzerland). 
Participants were instructed to perform a total of three maximal countermovement jumps with hands 
on hips. Between each repeat each participant rested for 60 seconds. Jump height was calculated by 
taking the velocity of each jump (calculated using the flight time method [29]) squared and dividing it 
by gravitational forces [29]. Jump force was measured by the integrated force platform in Newtons 
(N), which was normalised for weight. The maximal jump height of the three attempts was used for 
analysis.  
In addition participants completed a hand grip maximal voluntary contraction (MVC). In brief, a 
bespoke dynometer integrated with a computer system (Spike version 2.0, Cambridge Electronic 
Design Ltd., Cambridge, UK) measured MVC in Newtons (N). Participants performed four maximal 
contractions (MVC) each followed by 60s rest. MVC was classified as the largest of the four repeated 
contractions. The protocol was repeated for both the dominant and non-dominant hand.  
4.3.3 Statistical Analysis 
Data analysis was performed using SPSS for WINDOWS software (version 17; SPSS Inc, Chicago, 
IL). All data is expressed as Mean ± SD, unless stated otherwise. Prior to statistical analysis all data 
was tested for normality using the Kolmogorov-Smirnov test. Data that deviated from normality was 
log transformed. In order to detect differences in serum 25(OH)D, hours spent outdoors 
training/competing and during leisure time, dietary and supplement vitamin D intake between groups a 
one way ANOVA was used. A Bonferroni post hoc test was used to correct for multiple comparisons. 
Pearson correlations assessed associations between serum 25(OH)D and body weight, BMI, vitamin D 
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intake and performance data. All Pearson correlations were controlled for by body weight and sex. 
Whereas Spearman correlations assessed associations between serum 25(OH)D and specific vitamin D 
rich foods, vitamin D supplement intake, training time outdoors and tanning bed use. Significance was 
set at P <0.05. 
4.4 Results 
4.4.1 Participant characteristics 
Fifty participants were recruited to take part in the study, with two participants choosing to withdraw 
from the study with no specific reason. Forty eight participants (45 Caucasian and 3 Indian) were 
therefore tested, of which 28 were men (Mean ± SD, age: 26 ± 10 y, height: 1.79 ± 0.06 m, weight: 
80.2 ± 11.7 kg, body mass index (BMI) 27.7 ± 3.4 kg/m
2
) and 20 were women (Mean ± SD, age: 22 ± 
4 y, height: 1.69 ± 0.06 m, weight: 64.8 ± 10.8 kg, body mass index (BMI) 26.6 ± 4.3 kg/m
2
). The 
participants performed in a variety of sports (Table 4.1). Based on these sports, twenty one of the 
participants were classed as indoor athletes, and twenty seven were classed as outdoor athletes. 
Table 4.1: List of sports included in the study (I, Indoor, O, Outdoor) 
  
Sport Number of 
athletes 
Football (O) 2 
Rugby (O) 5 
Field Hockey (O) 2 
Netball (I)  1 
Badminton (I) 2 
Basketball (I) 3 
Gymnastics (I) 2 
Weight lifters (I) 10 
Athletics (O) 2 
Triathlon (O) 9 
Cricket (O) 1 
Squash (I) 1 
Running (O) 4 
Volleyball (I) 1 
Dancing (I) 2 
Golf (O) 1 
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4.4.2 Vitamin D status 
Mean serum total 25(OH)D was 51±24 nmol/L (range 18 - 112 nmol/L) with 10% (5/48), 44% 
(21/48), 29% (14/48) and 17% (8/48) of athletes being severely vitamin D deficient (<25 nmol/L), 
deficient (<50 nmol/L), insufficient (50-75 nmol/L) and sufficient (>75 nmol/L), respectively. 
Moreover, only 4% (2/48) of the athletes tested had 25(OH)D >100nmol/L. (Figure 4.1). No 
significant differences were observed between men and women (P=0.089) or indoor and outdoor 
(P=0.339) athletes despite total serum 25(OH)D appearing higher for women and outdoor sports 
(Table 4.2). Men had a higher prevalence of vitamin D deficiency than women, especially at 25(OH)D 
concentrations that are categorised as severely vitamin D deficient (<25nmol/L). On the other hand 
women had a higher prevalence of insufficiency than men. Further, the prevalence of deficiency, 
insufficiency and sufficiency were similar between indoor and outdoor athletes (Table 4.2).  
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Figure 4.1: Winter serum 25(OH)D concentrations from a variety of indoor and outdoor athletes living and training at high latitude in the 
United Kingdom. (Mean±SD) 
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4.4.3 Sun exposure during training and leisure time  
Outdoor athletes reported spending significantly more time outdoors training/competing in all seasons 
compared to indoor athletes (p<0.001) (Figure 4.2). However, no differences were found between men 
and women in any season. The majority of participants reported training/competing outdoors early in 
the morning during the autumn (47%) and winter (50%), whereas during the spring (41%) and summer 
(47%) the majority of participants trained outdoors at lunchtime/early afternoon. Time spent 
training/competing outdoors did not correlate with serum 25(OH)D in autumn (r=0.061 P=0.686), 
spring (r=0.128 P=0.391) or summer (r=-0.027 P=0.856). However, time spent training/competing 
outdoors in winter positively correlated with serum 25(OH)D  (r=0.344 p=0.017). 
Table 4.2: Mean serum total 25(OH)D (nmol/L) for each group and prevalence (% within each 
group) of each vitamin D status group. Mean ± SD. 
 
  Prevalence of each vitamin D status group  
 
Group 
Serum 
Total25(OH)D 
(nmol/L) 
Severely 
deficient  
(<25nmol/L) 
Deficient 
(<50nmol/L) 
Insufficient 
(50-75nmol/L) 
Sufficient 
(>75nmol/L) 
Men (n=28) 47±23 18% 50% 18% 14% 
Women (n=20) 58±24 0% 35% 45% 20% 
Indoor (n=21) 48±24 9% 48% 29% 14% 
Outdoor (n=27) 55±24 10% 41% 30% 19% 
 
 
In addition participants reported spending 3.4 ± 2.5 h/wk, 3.2 ± 2.6 h/wk, 5.0 ± 2.7 h/wk and 6.1 ± 2.3 
h/wk outdoors during leisure time in the autumn, winter, spring and summer respectively. No 
correlations were found between serum 25(OH)D and leisure time spent outdoors in autumn (r=0.107 
P=0.475), winter (r=-0.105 P=0.484), spring (r=-0.152 P=0.308) and summer (r=-0.104 P=0.489).  
4.4.4 Other sources and limitations to sun exposure 
No participant reported ever using sun beds. In total, 42% of participants reported using sun lotion in 
the summer, with only 4% reporting using sun lotion in the spring. The average sun protection factor 
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(SPF) used by participants was 18 ± 9 (range 5-50) with no correlation between the SPF and serum 
25(OH)D (r=0.080 p=0.598). Only 17% of participants reported wearing no shirt outdoors in the 
summer. For each season, the total amount of clothes worn was calculated by adding the responses to 
each individual piece of clothing. No significant differences were observed for total clothes worn in 
each season when comparing between indoor and outdoor athletes, or men and women.  
4.4.5 Vitamin D intake 
Total vitamin D intake (diet and supplements) was estimated at 317 ± 647 IU/d (max: 3040 IU/d). 
Only 11/48 (23%) participants consumed vitamin D greater than prescribed reference nutrient intake 
(RNI) [30]. Total vitamin D intake was positively correlated with serum 25(OH)D but failed to reach 
significance (r=0.275 P=0.064). Dietary vitamin D intake was estimated to be 106 ± 131 IU/d (max: 
633 IU/d). However, only 3/48 (6%) of the participants actually met the RNI. No correlation was 
found between dietary vitamin D intake and serum 25(OH)D (r=0.081 P=0.594).  
Vitamin D supplements were used by 2/48 (4%) participants, while 10/48 (21%) participants 
consumed a multivitamin containing vitamin D. The average vitamin D supplement (including 
multivitamin supplements) was 694 ± 1008 IU/d (max: 3000IU/d), with only 3 participants consuming 
a supplement that was above 400 IU/d, of which all were men. Vitamin D supplement dose was 
positively correlated with serum 25(OH)D (r=0.353 P<0.005). 
4.4.5.1 Muscle function performance tests and vitamin D status 
No significant correlation was observed between jump force (r= 0.048 P=0.755), jump height (r= -
0.275 P=0.071), dominant hand grip (r= -0.088 P=0.570) or dominant hand grip force (r= 0.12 
P=0.939) and serum 25(OH)D. 
 
 
 -153- 
 
Figure 4.2: Seasonal differences in estimation of time spent outdoors (h/wk) training/competing for indoor and outdoor athletes  
(Mean±SD) * Significantly different to indoor athletes (P<0.05).  
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4.5 Discussion 
The current study demonstrates a high prevalence of vitamin D deficiency and insufficiency during the 
winter in UK athletes, with 10% (5/48) 44% (21/48) and 29% (14/48) of the athletes tested being 
severely vitamin D deficient, deficient and insufficient, respectively. These findings are in line with 
previous studies conducted in athletes, at both high [13-15, 17] and low latitudes [16]. Morton et al 
2012 reported that 65% of elite football players were vitamin D deficient (< 50 nmol/L) during the 
winter in the UK (53°N). More recently, the same research group recruited 61 outdoor athletes from a 
variety of sports who were living and training at high latitude (53°N). It was reported that during the 
winter, 64% of a variety of outdoor athletes were vitamin D deficient [14]. Similar findings have also 
been found in athletes living and training at higher latitudes to the current study test site (60.5°N) [17]. 
Hence this data firstly brings to light the potential negative implications to athletic performance, 
considering that vitamin D deficiency is closely associated with sub-optimal skeletal muscle function 
and structure [2, 9, 10]. Secondly the data also highlights the opportunity for continued research into 
the physiological consequences of vitamin D deficiency at the current test site. 
The high prevalence of vitamin D deficiency and insufficiency observed in the current study is not 
surprising. This is because during the winter, at high latitudes, cutaneous vitamin D synthesis reaches 
nadir [1]. In addition the high cloud cover that the UK experiences most of the year also limits 
cutaneous vitamin D synthesis [31]. These factors are also likely to explain why no significant 
differences were observed between indoor and outdoor athletes vitamin D status (Table 4.2), which is 
in agreement with others [27]. This was evident despite outdoor athletes reporting spending more time 
outdoors training/competing during the summer and spring when compared to indoor athletes (Figure 
4.2). Yet the current study is unable to comment on the vitamin D status of the participants during the 
other seasons. However, [32] calculated that in California, summer sun exposure had to be high (90 
min/d) followed by vitamin D supplementation of 1300IU/d during the winter to sustain sufficient 
vitamin D status across the year. Consequently, in order for UK athletes to sustain vitamin D 
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sufficiency it may be that sun exposure should be encouraged during the summer in combination with 
vitamin D supplementation.   
In contrast to this suggestion, the current study illustrates that very few participants reported spending 
time outdoors with no top on (17%) during the summer with a high proportion of athletes frequently 
using sun lotion in the summer. Collectively these factors are known to impair cutaneous synthesis of 
vitamin D [1]. As little as 30 minutes in the midday sun wearing minimal clothing (to achieve a whole 
body minimal erythemal dose) has been shown to be equivalent to 10,000IU of vitamin D which will 
raise 25(OH)D considerably [1]. However, the current recommendations for sun exposure and sun 
protection are undefined in the UK [30]. This is mainly due to the difficulty of accurately measuring 
sun exposure, the incomplete knowledge of the suns contribution to vitamin D status and the risk of 
developing skin cancer [21]. Collectively, the poor climate of the UK combined with the low reported 
time spent outdoors during the summer would suggest that athletes require a greater dietary intake of 
vitamin D to sustain sufficient vitamin D status.  
The estimated vitamin D intake in the current study (106 ± 131 IU/d) was below the RNI (400IU) for 
the UK [30]. These estimations are in agreement with previous investigations in UK adults [7] and in 
athletes worldwide [17, 27].  However, it is argued that dietary vitamin D intake at the current RNI is 
inadequate to sustain a sufficient vitamin D status when in the absence of sunlight [1]. Despite this, 
these are the current recommendations for vitamin D intake in the UK [30]. In support, recent 
evidence from UK and Ireland (50-60⁰N) has shown that 400 IU/d of dietary vitamin D was only able 
to sustain 25(OH)D at 25 nmol/L across the year [7] and unable to maintain summer 25(OH)D during 
the winter [33]. Hall et al [32] also showed that during low sun exposure in the Californian summer 
(~20 min/d) it was estimated that an additional 1000IU/d was required to sustain sufficient vitamin D 
status. More strikingly, during the winter the authors calculated that 2550IU/d was required to sustain 
sufficient vitamin D status. Considering that sun exposure is severely reduced in the UK during the 
summer when compared to California, combining this data with the current study findings clearly 
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suggests that higher doses (1000-2500IU/d) of dietary vitamin D are essential to achieve vitamin D 
sufficiency.   
Increasing vitamin D intake in the diet is often difficult from food sources alone. Vitamin D 
supplements have been shown to be effective tools to improve the vitamin D content in the diet while 
also raising vitamin D status. However, the current study shows that very few athletes (25%) reported 
using a supplement containing vitamin D. Others have also shown a poor use of vitamin D 
supplements amongst athletes [19], even though athletes frequently use an array of dietary 
supplements [34]. Furthermore, the estimated vitamin D supplement intake in the current study was 
correlated with 25(OH)D (r=0.353 P<0.005) supporting the use of high doses of vitamin D 
supplements to increase vitamin D status. However, the current guidelines for vitamin D supplement 
use is unclear and currently under debate [20, 24]. It is generally well accepted that in order to raise 
25(OH)D to sufficient concentrations, doses above the RNI in the UK and RDA (600IU/d) in the 
United States doses are required (1000-4000IU/d) [23, 24]. In support, Close et al [13, 14] has recently 
demonstrated in two separate studies that daily vitamin D intake at 5000IU/d for 8 weeks [14] or 
larger weekly doses (20,000IU and 40,000IU) for 8 weeks [13] are both highly effective at improving 
vitamin D status to sufficient concentrations. Taken together vitamin D supplements would be an 
effective nutritional strategy for UK athletes to ensure vitamin D sufficiency can be achieved during 
the winter. Yet to date the optimal vitamin D supplementation protocol (dose, duration, and frequency) 
has not been established. Therefore, future dose response intervention studies are required to elucidate 
this further.  
It is important to highlight that the current studies estimations for vitamin D intake, from both sun 
exposure and dietary vitamin D intake, are not without its limitations. The current study implemented 
food frequency questionnaire based quantification of vitamin D intake. This was primarily due to the 
ease of gaining an insight into the dietary habits of the athletes tested. The authors however 
acknowledge that using this approach may result in an underestimation of vitamin D intake due to 
athletes under reported serving sizes, frequency and dose of supplement use or the declared use of 
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fortified foods. Future studies should aim to use more accurate measurements of vitamin D intake 
through the use of diet diaries, diet recalls and UV dosimeters.  
Despite vitamin D deficiency being shown in the elderly to have deleterious effects on skeletal muscle 
function and structures [2, 9, 10], the current study showed that vitamin D status was not significantly 
associated with skeletal muscle function (vertical jump and hand grip MVC). This data suggests that 
vitamin D status may not be important in determining skeletal muscle function in athletes. In 
contention, Ward et al [11] showed that in young adolescent girls vitamin D status was positively 
correlated with jump height, velocity, power and force. Recently, Close et al [14]showed that soccer 
players significantly improved 10 m sprint times and vertical jump following 8 weeks of 5000IU/d 
during the winter in the UK (53°N) when compared to placebo. The improvements in performance 
were observed when vitamin D status was improved to sufficiency. However, these findings have not 
been replicated by the same research group [13]. Therefore, it remains unclear what role vitamin D has 
on skeletal muscle function in athletes and thus requires further investigation.  
The lack of association between vitamin D status and muscle function in the current study may be due 
to the small number of participants as well as the heterogeneous group tested. Previous associative 
studies have observed small to medium effect sizes (r = 0.22-0.32) for the association between 
25(OH)D and skeletal muscle function and performance in larger sample sizes (99- >300 participants). 
It is also important to point out that in trained athletes skeletal muscle function and structure may be 
superior when compared to untrained adults, adolescents and the elderly. Thus, it may be speculated 
that the effect of vitamin D may have smaller effects in athletes when compared to those previously 
researched groups. Consequently, in order to effectively address the current research question large 
sample sizes (>300) may be necessary to pick up the small effect sizes potentially observed in athletes.  
In summary, we have demonstrated that the prevalence of vitamin D deficiency and insufficiency is 
high in a variety of indoor and outdoor athletes living in the UK during the winter. In addition we 
observed that athletes from the UK had a low estimated dietary intake of vitamin D, well below the 
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current RNI. However, the significant positive correlation between vitamin D supplement intake and 
25(OH)D support the use of vitamin D supplements as an effective strategy to improve vitamin D 
status in athletes. Yet, it remains unclear whether improving vitamin D status in athletes has any 
beneficial effects on performance or other determinants of performance (immunity, illness, recovery). 
Therefore, further investigations using vitamin D supplements are required to test the currently 
speculative benefits of vitamin D in athletes. 
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This thesis investigated three commonly used nutritional interventions and supports by athletes that 
are often cited to optimise fat metabolism during exercise and improve endurance exercise 
performance. These interventions and supports included green tea, coffee and vitamin D. 
More specifically the purpose of this thesis was four fold:  
1. To describe the metabolic effects of green tea at rest and during moderate intensity 
exercise.  
2. To compare the metabolic and performance effects of caffeine and coffee during 
endurance exercise. 
3. To provide insight into the prevalence of vitamin D deficiency in athletes and the 
potential impact on exercise performance.  
4. To determine the influence of vitamin D supplementation on improving vitamin D status 
and exercise performance in athletes.  
 
6.1 Part A. Green Tea and Caffeine 
Chapter 2 examined the metabolic effects of green tea extract (GTE) on human metabolism at rest 
and during moderate intensity exercise. These effects were assessed in plasma using a metabolomics 
approach, which can be used to systematically assess patterns and changes in plasma metabolites 
following exercise and dietary interventions. This approach allowed a comprehensive unbiased and 
systemic investigation into the diverse metabolic responses of GTE. This is the first study to directly 
compare the metabolic responses to GTE supplementation at rest and during moderate intensity 
exercise. GTE resulted in different metabolic effects during rest and exercise when compared to 
placebo: At rest GTE induced metabolite changes indicative of enhanced lipolysis (increase in 
glycerol, reduction in TAGs, increased fat oxidation (increase in 3-hydroxybutyrate), and activated 
TCA cycle (increase in citrate). These metabolic changes suggest that GTE has the potential to 
augment fat metabolism at rest, potentially by increasing lipolysis, which is in agreement with studies 
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that have shown increases in whole body fat oxidation at rest in humans [1-4]. However, previous 
studies have also shown no change in fat oxidation at rest following GTE in humans [5-8]. During 
exercise, GTE caused metabolite changes that were associated with enhanced glycolysis (increase in 
pyruvate, lactate) and decreased fat oxidation (reduction in 3-hydyroxybutyrate). These findings were 
somewhat unexpected as previous evidence has demonstrated that short [9] and long term [10, 11] 
GTE intake increases fat oxidation during exercise in humans. Although the reasons for these 
differential effects remain unclear, these data suggest that GTE has little effect on fat metabolism 
during exercise, which may limit its use as a nutritional support in that occasion. This is further 
supported by the fact that whole body fat oxidation was not altered in the same study following 7 days 
GTE, which has been reported in a separate manuscript [12].  
It is often cited in the literature that the short term metabolic effects of GTE are induced through a 
stimulatory effect on the SNS through the enzyme catechol-O- methyltransferase (COMT) [13]. 
COMT is a constitutively active enzyme, ubiquitous throughout all mammalian tissues including 
skeletal muscle and adipose tissue [14]. EGCG has been reported to directly inhibit catechol-O- 
methyltransferase (COMT) [15]. Herein, it is believed that circulatory catecholamine concentrations 
will be greater thus stimulating lipolysis via adrenergic receptors and potentially increasing fat 
oxidation [16]. However, the evidence to support the COMT mechanism is limited to a small number 
of in vitro studies [15, 17]. In order to investigate this mechanism in vivo, Chapter 2 used a targeted 
metabolomics approach to assess catecholamine response, specifically including adrenaline and 
noradrenaline. Not surprisingly, Chapter 2 showed that moderate intensity exercise alone induced 
significant changes of 14 metabolites involved in the catecholamine metabolism. However, in 
Chapter 2 we found no change in plasma catecholamines at rest or during moderate intensity exercise 
for GTE compared to PLA.  
Therefore, the metabolic effects that were observed at rest and during exercise in Chapter 2 appear to 
be independent of any significant changes in catecholamine concentration. As a result, this questions 
the efficacy of the widely referenced COMT mechanism to explain changes in substrate metabolism in 
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humans. Chapter 2 is supported by a small number of investigations that shows no change in plasma 
catecholamines following GTE when compared to PLA [5-7]. Thus, the mechanisms to describe the 
increase in fat oxidation at rest and during exercise following short term GTE intake remain unclear. 
Previous investigations in animals have shown that the improvements to fat oxidation following GTE 
maybe explained by increases in mRNA expression of specific fat metabolism enzymes. But this data 
is purely limited to longer term GTE intake [18-20]. On the other hand, Murase et al [21] has recently 
reported that treatment of rat L6 myoblasts with EGCG transiently increased AMPK and ACC 
activity. Both of these enzymes in the skeletal muscle have been proposed to acutely regulate fat 
metabolism [22]. The authors also showed that the increase in AMPK activity was due to the 
activation of the upstream kinase LKB1. The increase in AMPK and ACC was also confirmed 
following the acute feeding of EGCG (200 mg/kg BM) to mice, which was paralleled with an increase 
in fat oxidation at rest. However, while these research findings show promise in explaining the 
previously reported increase in fat oxidation following short term GTE intake [1, 9] they are currently 
limited due to the lack of supporting human evidence. Therefore, future research is required to 
elucidate the mechanisms of short term GTE intake on fat oxidation, potentially focusing on the role 
of AMPK, LKB1 and other fat metabolism regulating signalling molecules 
Alternatively, caffeine, ingested mainly at high doses (>5 mg/kg BM) has previously been shown to 
consistently cause an increase in catecholamines at rest and during exercise [23-26] which has also 
increases plasma FA and glycerol concentrations [26-28]. Therefore, the presence of caffeine in GTE 
may be responsible for augmenting the SNS and stimulating lipolysis. But regardless of the presence 
of caffeine in the GTE drink in Chapter 2, no difference in plasma catecholamine response was 
observed. This is likely explained by the lower dose of caffeine (120 mg) ingested in Chapter 2 
compared to previous caffeine studies [5-7]. Further, despite the increase in the SNS and lipolysis 
following moderate to high caffeine intake (>5 mg/kg BM) very few have observed an increase in fat 
oxidation [29-32]. This is supported by the findings in Chapter 3, whereby caffeine (5 mg/kg BM) 
consumed 1 hour prior to exercise caused a significant increase in plasma fatty acid and glycerol 
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concentrations at rest, but did not cause any difference in whole body fat oxidation when compared to 
coffee, placebo or decaf coffee. Collectively this evidence suggests that the metabolic significance of 
increasing catecholamines at rest and during exercise with GTE and/or caffeine is unclear. In support, 
previous evidence has shown that increasing circulating adrenaline concentrations (within a 
physiological range), through infusions, has not led to an increase in fat oxidation, despite an increase 
in lipolysis [33]. Furthermore, increasing the availability of FA during exercise following GTE and 
caffeine, as observed in Chapter 2 and 3, also suggests a lack of metabolic significance for increasing 
fat oxidation. Previous studies have shown that plasma FA oxidation is the predominant fat source 
oxidised during low to moderate intensity exercise, with a concomitant reduction at higher exercise 
intensities [34, 35]. However, increasing the availability of FA through intralipid plus heparin 
infusions during exercise under high glycolytic conditions, such as high intensity exercise or 
carbohydrate feeding, partly rescues the blunted fat oxidation rates [36, 37]. However, it would appear 
that the magnitude of plasma FA concentration change is crucial in order to augment fat oxidation. 
The magnitude of FA change with GTE and caffeine, shown in Chapter 2 and 3 and other previous 
caffeine [26, 38] and GTE [1, 9, 12], may not be large enough to cause significant changes in fat 
oxidation. In addition, Chapter 2 and 3 studied the effects of GTE and Caffeine, respectively, during 
moderate intensity exercise which has previously been shown not to limit FA availability or oxidation 
[34, 35]. Therefore, increasing fat oxidation during exercise may only be apparent when FA 
availability and oxidation is limited, such as at high exercise intensities (>75 % VO2 max) [36] or in 
individuals who have impaired metabolic flexibility [39], as seen in obesity and non-insulin –
dependent diabetes mellitus. 
The metabolic effects of GTE, with caffeine, during exercise has been rarely studied [9]. When the 
findings of Chapter 2 and 3 are taken together, the increase in lactate observed, may suggest the 
presence of caffeine in GTE could possibly alter the metabolic response during exercise when 
compared to GTE alone. These findings are in contrast to previous hypotheses that state the GTE and 
caffeine may have a synergistic effect [13]. The duration of GTE intake may also be a significant 
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factor in determining not only the effects on fat metabolism but also the mechanisms of action (as 
previously discussed). In Chapter 2, the metabolic effects observed during exercise can largely be 
attributed to the acute (single dose) post-GTE-supplementation, while the effects at rest are due to 
chronic (7 days) GTE supplementation. Firstly, the different metabolic effects induced at rest and 
during exercise in the current thesis may have been explained by the chronic and acute feeding of 
GTE, respectively. Secondly, considering that longer term GTE intake in human [40-43] and in 
animals [20] has shown promise at increasing fat oxidation, it remains to be determined whether 
longer term intake is more effective then shorter term intake at altering fat metabolism. Therefore, 
future research is required to examine the longer term effects of GTE supplementation on whole body 
fat metabolism at rest and during exercise. In addition, evidence in animal studies have shown that 
longer term GTE intake, when combined with endurance exercise training, results in superior 
adaptations to fat metabolism when compared to exercise alone [18, 19, 44]. Considering the well 
documented evidence to show that endurance exercise training is highly effective at augmenting fat 
oxidation and improving endurance exercise capacity [45-48], future research should include the 
effects of GTE on skeletal muscle adaptations at rest and following endurance exercise training in 
humans. In turn this may provide evidence for the use of GTE as a nutritional support to endurance 
exercise training as well as improve our understanding of the mechanisms of actions to describe the 
metabolic effects of GTE.  
In Chapter 3, the ergogenic effects of coffee compared to caffeine were examined. It had been 
suggested that caffeine resulted in increases in exercise capacity but coffee (including caffeine) did not 
[49]. Chapter 3 offers new evidence to support the use of coffee as nutritional support for endurance 
athletes. Coffee (5mg/kg BM) consumed 1 hour prior to exercise was equally as effective at improving 
endurance exercise performance when compared to caffeine (5mg/kg BM). Prior to the presented 
work, only two studies have used both caffeine and coffee combinations within the same study [49, 
50], with contradicting results regarding the ergogenic effect of coffee. Graham et al [49] found that 
anhydrous caffeine (4.5 mg/kg BM consumed as a capsule) significantly improved running time to 
Chapter 6  General Discussion 
 
-187- 
 
exhaustion when compared to placebo (consumed as a capsule) and decaf coffee (consumed as a 
beverage). However, coffee (4.5 mg/kg BM consumed as a beverage) did not result in a significant 
improvement to running time to exhaustion when compared to placebo or decaf coffee. On the other 
hand, McLellan et al [50] reported that consuming coffee (1.1mg/kg BM) prior to the ingestion of 
different doses of caffeine (3-7mg/kg BM) did not to affect the ergogenic effects of caffeine when 
using a time to exhaustion test. The discrepancies in findings may be explained by the mode of 
delivery of caffeine, coffee, decaf and placebo or maybe explained by the performance tests selected in 
each study. In both of the aforementioned studies a time to exhaustion test was used. However, it has 
been questioned whether assessing performance using a time to exhaustion test is reliable or has 
sufficient ecological validity [51]. With this in mind, Chapter 3 follows a well designed and 
controlled study by only using beverages as the format of caffeine administration, using a double 
placebo control (decaf coffee and placebo) and using a highly validated time trial protocol.  
In contrast to the similar performance effects of caffeine and coffee in Chapter 3, differences in the 
metabolite responses at rest and during exercise were observed between the beverages. However, these 
differing metabolite responses did not alter fat oxidation during exercise. This firstly demonstrates that 
the performance benefits of caffeine, either delivered as anhydrous caffeine or coffee, is not explained 
by changes to fat oxidation. During the steady state exercise bout, caffeine caused a significant 
increase in plasma glucose, FA and glycerol whereas coffee had a small non-significant attenuated 
response to each metabolite. Further, decaf coffee resulted in a lower plasma FA and glycerol 
concentration when compared to placebo. The mechanisms to describe the varying metabolite 
responses following each beverage are difficult to explain. Previous evidence has shown an increase in 
plasma FA and glycerol concentrations in spinal cord injured individuals, who have an impaired 
sympathoadrenal response, following caffeine intake [52]. The metabolite response induced by 
caffeine was independent of adrenaline and explained by the antagonism of adenosine receptors on 
adipose tissue or skeletal muscle. This is because adenosine has been shown to inhibit lipolysis [53] 
and enhance insulin stimulated glucose uptake in contracting skeletal muscle in vitro [54]. Therefore, 
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it is likely that compounds in coffee may induce subtle effects on antagonism of adenosine receptors 
(A1 and A2A) in a variety of tissues [55]. This is partly supported by the findings of Graham et al [49] 
who showed that coffee lead to a blunted adrenaline concentration following coffee intake when 
compared to caffeine. These conclusions are limited due to the lack of research. However, while the 
differing metabolic effects of caffeine and coffee do not alter the ergogenic effects, they may have 
implications on health outcomes [55]. Therefore, future research is required to understand the 
metabolic effects of compounds found in coffee and the significance they have on health outcomes.  
6.2 Future research questions – Green tea and caffeine: 
Following on from Chapter 2 and 3, a number of key questions still remain to be answered: 
1. Does longer term (> 7 days) GTE supplementation augment fat metabolism at rest and during 
exercise when compared to shorter term (< 7 days) GTE supplementation? 
2. Can GTE supplementation provide additive adaptations to fat metabolism when combined 
with endurance exercise training in humans?  
3. What are the mechanisms to describe the metabolic effects of longer term GTE 
supplementation within the skeletal muscle in humans? 
4. Which of the green tea catechins are bioactive in humans following short and long term GTE 
supplementation?  
5. What is the metabolic effect of GTE at rest and during exercise in individuals who have an 
impaired ability to oxidise fat? 
6. Can coffee be used as a nutritional support to improve endurance exercise performance at 
lower doses (1-3 mg/kg BM)? 
7. What are the physiological and metabolic effects of compounds found in coffee in vivo? 
6.3 Part B: Vitamin D  
Vitamin D has been discussed extensively to date in relation to bone health [56]. However, it also has 
an important role on optimal skeletal muscle function, structure and composition, particularly in the 
Chapter 6  General Discussion 
 
-189- 
 
elderly skeletal muscle [57]. This evidence in the elderly could suggest that vitamin D may have an 
important role in determining exercise performance [58]. This is alarming when considering the high 
prevalence of vitamin D deficiency that is observed worldwide today [59]. Taking together the 
importance of vitamin D in elderly skeletal muscle combined with the high prevalence of vitamin D 
deficiency in our population could translate into negative impacts on exercise performance in healthy 
skeletal muscle. These deleterious effects of vitamin D deficiency to skeletal muscle function would 
be highly important to athletes. Yet despite this, little is known about the prevalence of vitamin D 
deficiency in athletes or the impact it may have on exercise performance.  
Currently, the definition of categorising vitamin D status is complicated due to multiple 
recommendations currently available in the literature which are based on varying health outcomes. 
This thesis defines vitamin D status as severe deficiency, deficiency, insufficiency and sufficiency 
corresponding to 25(OH)D concentrations of <25 nmol/L, <50 nmol/L, 50-75 nmol/L and >75 
nmol/L, respectively. These cut offs for vitamin D status are in unison with the majority of guidelines 
to date [60, 61]. Chapters 4 and 5 assessed vitamin D status in athletes living at high latitude during 
the winter, both of which are known to impede upon cutaneous vitamin D synthesis [62]. Chapter 4 
showed that 44% (21/48) and 29% (14/48) of university athletes from a variety of indoor and outdoor 
sports were vitamin D deficient and insufficient, respectively. Similarly Chapter 5, found that 53% 
(19/36) and 33% (12/36) of endurance trained cyclists were also vitamin D deficient and insufficient, 
respectively. The extent of deficiency and insufficiency reported in these studies is in line with recent 
evidence in athletes living and training at slightly higher latitude in the UK (53⁰N), whereby 64% of a 
variety of outdoor athletes [63] and 65% of elite football players were vitamin D deficient (<50 
nmol/L) [64]. Moreover, in the results presented in Chapter 4 even outdoor athletes had high 
prevalence of vitamin D deficiency and insufficiency, despite athletes retrospectively reporting that 
they spent large amounts of time outdoors training/competing during the summer and spring where 
cutaneous synthesis of vitamin D is high [65]. This was also true of the endurance cyclists in Chapter 
5, who all trained/competed outdoors regularly. These findings are in keeping with evidence from 
Chapter 6  General Discussion 
 
-190- 
 
outdoor athletes both at high [66-69] and low [63, 64, 70, 71] latitudes. However, despite the similar 
trends in vitamin D status between the current thesis work and others, it is difficult to compare 
between studies due to the different methods used to quantify vitamin D status [72]. The differences 
between methods include the ability to extract 25(OH)D from the sample, the traceability and the 
accuracy of the assay. Previous studies have shown a lack of correlation between commercially 
available vitamin D assays [73] which are likely attributed to the lack of a standardised reference 
material. The thesis took these methodological issues into account by using a commercially available 
kit in Chapter 4 that has been shown to be highly comparable to other methodologies as approved by 
the Vitamin D External Quality Assessment Scheme (DEQAS www.deqas.org [73]. Furthermore, in 
an attempt to further improve the accuracy of measuring vitamin D status in athletes, Chapter 5 used 
liquid chromatography tandem mass spectrometry (LC-MS/MS). Recent reports have shown that LC-
MS/MS produces more accurate and sensitive measurements of 25(OH)D when compared to 
immunoassay methods [72]. With these methodological justifications in mind, the data in Chapter 4 
and 5 clearly demonstrate that vitamin D deficiency is highly prevalent in both indoor and outdoor 
athletes living and training in the UK during the winter.  
The data presented in Chapter 4 and 5 also highlighted the importance of dietary vitamin D intake. 
Both studies observed that UK athlete‟s vitamin D intake was below the current RNI (106 ± 131 IU/d 
and 116 ± 162 IU/d), which supports previous evidence in athletes [63, 67] but also in UK adults [74]. 
Studies have shown that in order to prevent vitamin D deficiency and insufficiency, far higher doses of 
vitamin D above the RNI (400IU) are required in the diet [75]. These recommendations are evident in 
the strong correlation observed in Chapter 4 between vitamin D supplement intake, which would 
increase dietary vitamin D intake, and 25(OH)D concentrations In further support, Chapter 5 
demonstrated the efficacy of short term (28 days) vitamin D supplementation at high doses in 
improving vitamin D status to sufficient concentrations. This was achieved by using 1500IU/d, 
3000IU/d and 6000IU/d in just 28 days. However, no difference in changes to 25(OH)D following 
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supplementation was observed between vitamin D groups. This suggests that doses above 1500IU/d do 
not provide any additional benefit to vitamin D status.  
The effect that vitamin D deficiency and sufficiency may have on athletic performance is currently 
unclear. In Chapter 4, results showed that muscle function was not positively correlated with 
25(OH)D when using basic assessments of leg and forearm muscle function (vertical jump and MVC 
hand grip). In addition, in Chapter 5, 25(OH)D was not correlated with any aerobic, anaerobic or 
strength performance measurement during the winter in endurance athletes. However, while the 
majority of athletes were vitamin D deficient and insufficient, very few were severely deficient (< 25 
nmol/L). It has been suggested that the deleterious effects of vitamin D deficiency on skeletal muscle 
function may only occur at concentrations below 25 nmol/L [76-78]. Alternatively, Chapter 5 
examined the paradigm that improving vitamin D status to sufficient concentrations with vitamin D 
supplementation may improve muscle function and exercise performance compared to those who 
remain vitamin D deficient. The results presented show that despite elevating 25(OH)D to sufficient 
vitamin D status in all participants in the supplemented groups (> 100 nmol/L), no difference in 
aerobic, anaerobic or strength performance measurements were observed when compared to placebo. 
These findings are in contrast to causative and longitudinal evidence in the young adults [79, 80] and 
the elderly [81-85] that show an association between vitamin D status and physical performance. Yet, 
the findings from Chapter 4 and 5 bring into question the optimal concentration of 25(OH)D that 
impairs or improves skeletal muscle function. It would be argued that the benefits to skeletal muscle 
function following vitamin D supplementation would only be apparent when deficient in the first 
place. In support, a recent meta analysis concluded that there was no significant effect of vitamin D 
supplementation (range of doses included 400IU/d to 60,000IU/wk) on leg or grip strength in the 
elderly when baseline 25(OH)D was >25nmol/L [86]. Further, in the limited number of studies in 
athletes, it has been shown that improvements to exercise performance only occurred when the 
majority of athletes were severely vitamin D deficient [71] while no improvement was observed when 
sufficient [87] prior to supplementation. On the other hand the target concentration of 25(OH)D 
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following supplementation may also be important, with many suggesting that 25(OH)D > 100 nmol/L 
may be required to improve exercise performance in athletes [71, 88, 89]. However, Chapter 5 shows 
no benefit to exercise performance when endurance athletes 25(OH)D concentration was 
predominantly above 100 nmol/L. Therefore, it remains to be determined whether it is the extent of 
deficiency prior to supplementation or the concentration following supplementation that dictates the 
improvements to musculoskeletal performance.  
The data presented in Chapter 4 and 5 does not support the hypothesis that vitamin D status 
influences muscle function or exercise performance in athletes. This may be explained by the large 
number of factors that may alter vitamin D status and the response to supplementation to include: 
latitude, season, ethnicity, habitual diet, physical activity levels and body composition [56, 90]. Future 
research is yet to be conducted to elucidate the role these factors have on vitamin D metabolism and 
physiological outcomes. In addition, given the large number of factors that may alter vitamin D status 
and response to supplementation, future research should focus on larger sample sizes than used in the 
current thesis. The limited sample sizes, relative to the numerous factors that may have reduced the 
ability to detect changes in skeletal muscle function and exercise performance, used in Chapter 4 and 
5 is recognised as a limitation of the work.  
The effect of vitamin D on skeletal muscle function, especially within an athletic population, is timely 
and novel. In order to gain further insights into the potential benefits of vitamin D for athletes, future 
long term intervention studies are required in combination with muscle biopsy methods. In turn this 
will identify the mechanisms of actions, the time course and optimal 25(OH)D concentration required 
to induce the specific mechanisms within the skeletal muscle. In addition, considering the limited 
evidence to date that illustrates that long term vitamin D supplementation when combined with 
exercise training may lead to superior adaptations to the skeletal muscle [91-98], it may also be of 
interest to study this hypothesis in athletes. In support, Carrillo et al [97] demonstrated that 12 weeks 
of resistance training, combined with vitamin D (4000IU/d), in overweight and obese adults showed 
significant improvements to upper body peak power above the placebo group. In the elderly it has 
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been shown that the response to training was attenuated when 25(OH)D was <47.5 nmol/L [98]. More 
recently it has been shown that elderly individuals supplemented with HMB, arginine and lysine 
significantly improved lean muscle mass, but the improvements to strength only occurred when 
vitamin D status was sufficient [99]. Therefore, vitamin D may be an important nutritional support 
when undergoing exercise training by inducing pro anabolic effects within the skeletal muscle [84, 
100, 101]. However, the pro anabolic effects of vitamin D on healthy skeletal muscle adaptations, as 
seen in athletes when compared to the elderly [102], are yet to be investigated.  
6.4 Future research questions - Vitamin D: 
Following on from the studies presented in chapters 4 and 5, a number of key questions still remain 
to be answered: 
1. Is the prevalence of vitamin D deficiency and insufficiency in athletes dependent on season of 
the year in the UK? 
2. What is an effective supplementation protocol (dose and duration) to achieve vitamin D 
sufficiency in all seasons of the year? 
3. What is the optimal 25(OH)D concentration to elicit benefits to muscle function? 
4. Does long term vitamin D supplementation augment muscle function and performance in 
athletes? 
5. What are the mechanisms to describe the improvements in skeletal muscle function and 
adaptations following vitamin D supplementation in humans? 
6. What is the combined and independent effect of exercise training and vitamin D 
supplementation on performance and training adaptation outcomes?  
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6.5 Conclusions 
Chapter 2 illustrated that GTE increases metabolites related to fat and energy metabolism at rest, but 
not during moderate intensity exercise when using a metabolomics approach. The alterations to energy 
and fat metabolism at rest were independent of changes to catecholamines, which questions the 
relevance of the COMT mechanism in vivo. Chapter 3 revealed that coffee is as effective as caffeine 
in improving exercise performance but the ergogenic effects were independent of changes in fat 
metabolism. Chapter 4 and 5 highlighted that UK athletes require nutritional support to avoid vitamin 
D deficiency. Chapter 4 showed a high prevalence of vitamin D deficiency and insufficiency in UK 
university athletes from a variety of sports during the winter. The poor vitamin D status was likely 
explained by the high latitude and climate of the test site as well as low dietary intake of vitamin D by 
the athletes. It was also shown that vitamin D status was not associated with muscle function in the 
athletes tested. Chapter 5 also showed a high prevalence of vitamin D deficiency and insufficiency, 
which was corrected when high doses of vitamin D (1500IU, 3000IU or 6000IU) above the RNI 
(400IU) were supplemented for 28 days. The results showed that 1500IU/d improved vitamin D status 
to sufficient concentrations, with the higher doses of vitamin D providing no further increases. Despite 
all vitamin D groups becoming vitamin D sufficient, exercise performance (aerobic, anaerobic and 
strength) was not altered following supplementation in endurance trained athletes.  
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